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Summary 
 
 
 
The main objective of this work is to determine the atomic structure of 
mammalian respiratory complex I. Mitochondrial complex I (also known as 
NADH:ubiquinone oxidoreductase) is one of the central enzymes in the 
oxidative phosphorylation pathway. It couples electron transfer between NADH 
and ubiquinone to proton translocation across the inner mitochondrial 
membrane, contributing to cellular energy production. Complex I is the largest 
and most elaborate protein assembly of the respiratory chain with a total mass 
of 970 kilodaltons. It consists of 14 conserved ‘core subunits’ and 31 
mitochondria-specific ‘supernumerary subunits’. Together they form a giant, L-
shaped molecule, with one arm buried in the mitochondrial membrane and 
another protruding into the mitochondrial matrix.  
 
Here, a novel method for the purification of ovine (Ovis aries) complex I was 
developed and suitable conditions for cryo-EM imaging established, after 
extensive screening of detergents and additives. Cryo-EM images were 
acquired with the recently developed direct electron detector and processed 
using the latest software. This allowed the solution of the nearly complete 
atomic model of mitochondrial complex I at 3.9 Å resolution. The membrane 
part of the complex contains 78 transmembrane helices, mostly contributed by 
conserved antiporter-like subunits responsible for proton translocation. These 
helices are stabilized by tightly bound lipids (including cardiolipins). The 
hydrophilic arm harbours flavin mononucleotide and 8 iron–sulfur clusters 
involved in electron transfer. Supernumerary subunits build a scaffold around 
the conserved core, strongly stabilizing the complex. Additionally, subunits 
containing cofactors (NADPH, zinc ion and phosphopantetheine) may play a 
regulatory role. Two distinct conformations of the complex are observed, which 
may describe the active and deactive states or reflect conformations occurring 
during the catalytic cycle of the enzyme.  
 
Currently this is the most detailed model of this molecular machine, providing 
insight into the mechanism, assembly and dysfunction of mitochondrial complex 
I. It also allows molecular analysis of numerous disease-causing mutations, and 
so the structure may serve as a stepping-stone for future medical 
developments.   
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Chapter 1. Introduction 
 
 
 
1.1 Mammalian mitochondria 
 
Mitochondria are organelles present in most eukaryotic organisms (Karnkowska 
et al., 2016). They are double membrane entities of around 5 μm in size. 
Although the most prominent function of mitochondria is the production of 
adenosine triphosphate (ATP), they are involved in many other, very distinct 
and important processes such as cell signalling, apoptosis or protein maturation 
(Friedman & Nunnari, 2014).  
The number of mitochondria varies depending on the cell type, from none in 
human erythrocytes (Moritz, Lim, & Wintour, 1997) to a few thousand in skeletal 
muscle cells, taking up to 20% of the whole cell volume (Alberts, 
2015).However on average they are present in numbers of around several 
hundred. The shape of mitochondria also differs depending on the organism 
and tissue (Campello & Scorrano, 2010). They are mostly oval but elongated or 
branched forms are not unusual. The location of mitochondria in the cell is not 
fixed. Due to cytoplasmic movements or cytoskeleton transporting machinery 
they can move around or travel in the direction of higher energy demand like 
myofibrils or synaptic ends of the nerve cells (Anesti & Scorrano, 2006).  
 
1.1.1 Evolution 
The currently most popular theory states that mitochondria (and similarly 
plastids) developed during endosymbiosis of bacteria by ancient eukaryotic 
organisms. The most likely precursor of mitochondria is Rickettsiales family 
(Dyall, Brown, & Johnson, 2004)(Emelyanov, 2001). The first one to propose 
the endosymbiotic theory was Ivan Wallin in 1922 (Wallin, 1923). The theory 
was mostly forgotten for the next few decades until 1967 when it was re-
published more completely and with stronger evidence by Lynn Margulis 
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(Margulis, 1970). It is estimated that the first endosymbiosis events happened 
almost two billion years ago. During evolution, the ancestral endosymbiotic 
organism has undergone vast modifications. The host overtook most of its 
genetic material by moving genes to the nucleus and took control of division 
regulation, in order to synchronise it with the cell cycle. Nevertheless we can 
still trace a number of similarities of mitochondria to their bacterial ancestors. 
They divide by fission; contain circular DNA; contain their own ribosomes – the 
mito-ribosome – which is more similar to the bacterial 70S ribosome than 
eukaryotic 80S ribosome; the translational start amino acid residue is N-
formylmethionine; and many transport systems and enzymatic pathways of 
mitochondria strongly resemble bacterial versions (Gray, Burger, & Lang, 
1999).  
An alternative, less likely, theory states that mitochondria are a product of cell 
membrane invagination in a process similar to the separation of the nucleus 
(Gray et al., 1999). Regardless of their origin, development of mitochondria was 
a tremendous step in evolution enabling cells to perform oxidative respiration on 
internal membranes and thus more efficiently use available energy sources.  
 
1.1.2 Mitochondrial architecture 
In mitochondrial morphology we can indicate four different compartments: the 
internal mitochondrial membrane (IMM), the external (outer) mitochondrial 
membrane (OMM), the inter membrane space (IMS) and the mitochondrial 
matrix (MM) (Logan, 2006) (Fig. 1.1.1). External and internal mitochondrial 
membranes are distinctly different both in function and protein/lipid composition.  
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Figure 1.1 Mitochondrial structure. A. The baffle model. As proposed by 
Palade (Logan, 2006). B. Ultra fine structure of mitochondria revealed by 
high-resolution scanning electron microscopy form rat pancreas exocrine 
cells. Fracture plane revealing the surface (left) and interior structure (right) 
of mitochondria (M). The right-hand side mitochondrion appears to have 
both tubular and lamellar cristae. Labelled features are outer mitochondrial 
membrane (OM), inner mitochondrial membrane (IM), cristae (C), tubular 
cristae (tC), rough endoplasmic reticulum (rER) and ribosome (r) (Perkins & 
Frey, 2000). 
 
The outer mitochondrial membrane separates the organelle from the cytosol. It 
has a composition characteristic of other mammalian membranes. It contains 
many porins (2-3 nm in diameter), thus is very permeable for molecules under 5 
kDa. Small molecules like water or carbon dioxide freely diffuse through the 
membrane as well. Bigger proteins are actively transported by translocases 
(Walther & Rapaport, 2009). The OMM interacts with other cellular organelles 
like the endoplasmic reticulum (ER) forming the so-called mitochondria-
associated ER-membrane (MAM) (Fujimoto & Hayashi, 2011). Enzymatic 
reactions catalysed on the surface of OMM are mostly involved in secondary 
metabolism and lipid synthesis (Walther & Rapaport, 2009).  
 
The inter membrane space is the area between the internal and external 
mitochondrial membranes. Because of the high permeability of the OMM the ion 
composition there is identical to the cytosol. It is the smallest of all the 
mitochondrial compartments but plays many very important roles: it oversees 
the transport and modification of proteins – by the mitochondrial inter 
A B 
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membrane space assembly machinery – and other particles to and from the 
mitochondria; and it regulates the respiratory chain complexes and coordinates 
apoptosis (Herrmann & Riemer, 2010). In spite of the general oxidative 
environment, it contains thioredoxins and thioredoxin reductases that provide 
the reductive capacity of the compartment important during transport of 
oxidation sensitive proteins and as a protection from reactive oxygen species 
(ROS) (Conrad et al., 2004)(Kim et al., 2003). In yeasts it has been shown that 
Cu,Zn-superoxide dismutase and its metallochaperone (CCS) localize in the 
IMS and are very important for reactive oxygen physiology (Sturtz, Diekert, 
Jensen, Lill, & Culotta, 2001). 
 
The internal mitochondrial membrane separates the mitochondrial matrix from 
the rest of the cell. It is rich in proteins. The weight/weight (w/w) protein-to-lipid 
ratio is 3:1 (Karp, 2013). Permeability of this membrane, contrary to OMM, is 
very low (Paradies, Paradies, De Benedictis, Ruggiero, & Petrosillo, 2014). The 
transport of ions and other small molecules is tightly regulated to maintain their 
concentrations, enabling preservation of the electrochemical gradient required 
for ATP production. Twenty percent of all mitochondrial proteins are localised in 
IMM. Many are involved in electron transfer proton pumping and ATP synthesis 
(Alberts, 2015). The rest is responsible for the translocation of metabolites, and 
the synthesis/degradation of proteins. The area of the internal membrane is a 
few times larger than the outer membrane, most likely to increase the capacity 
for ATP production. The surface size of IMM varies between types of cells and 
is bigger in the cells that require more energy (Mannella, 2006). 
 
The mitochondrial matrix (MM) is the inner space of the mitochondria. It 
contains most of mitochondrial proteins. This is where the β-oxidation and 
Krebs cycles are localised. Mitochondria just like plastids contain their own DNA 
(mDNA) stored in the MM (Fig. 1.1.A). It encodes several proteins required for 
mitochondrial function. To process the mDNA mitochondria posses transcription 
and translation machinery that is independent from the cellular ones. The 
mitochondrial genome of humans contains up to 10 copies of circular mDNA of 
16569 base pairs (Fig. 1.2) per mitochondrion (Wiesner, Ruegg, & Morano, 
1992). They encode 37 genes including 13 proteins, 22 transfer RNAs (tRNA) 
  5 
and 2 ribosomal RNAs (rRNA). The genetic code of mDNA in higher eukaryotes 
is similar to that in bacteria and in most cases does not contain introns 
(Friedman & Nunnari, 2014).  
 
Figure 1.2 Schematic of human mitochondrial DNA. Human mtDNA 
encodes 13 proteins, two rRNAs and 22 tRNAs in a 16 kbp circular 
chromosome. Genes encoding components of complexes I, III, IV and ATP 
synthase are coloured green, magenta, turquoise and red respectively. 
Genes encoding tRNAs are coloured gold. Figure adapted from that 
created by Dr David T. Gallagher. 
 
In mammals, mitochondria are inherited maternally in many copies. The copies 
are not always identical (heteroplasmic) and can change throughout the life of 
an individual. During cell division they allocate randomly to the daughter cells 
(Mishra & Chan, 2014). Damage caused by reactive oxygen species (ROS) – 
produced mostly by respiratory complex I – can lead to mDNA disease-causing 
mutations (Murphy, 2009). Such alterations mostly affect tissues of high-energy 
demand like the brain or skeletal muscles (Gorman et al., 2016). In spite of the 
mDNA repair pathways (Kazak, Reyes, & Holt, 2012) damage to genetic 
material is accumulated over time. This phenomenon is the basis for the widely 
accepted but still unproven mitochondrial free radical theory of ageing, which 
states that ROS provoke mutations altering mitochondrial function that 
negatively affect life span in mammals (Sanz & Stefanatos, 2008).  
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1.2 ATP production in mammalian mitochondria  
 
The most important role of mitochondria is the production of ATP. This oxygen 
dependent process is mostly based on the oxidation of the degradation 
products from glucose and fatty acids, namely NADH and pyruvate (Berg, 
Tymoczko, & Stryer, 2002) (Fig 1.3 Stage I). Two distinct mitochondria-located 
processes are involved in ATP production. First, in the Krebs cycle – located in 
the mitochondrial matrix (Fig. 1.3 Stage II) – NADH is produced (Akram, 2014). 
Second, the oxidative phosphorylation (OXPHOS) chain enzymes – located in 
the IMM (Fig. 1.3 Stage III) – transform adenosine diphosphate (ADP) into ATP 
(Kuhlbrandt, 2015).  
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Figure 1.3 Schematic overview of the metabolic processes that take place 
within mitochondria. These pathways, such as glycolysis, fatty acid β-
oxidation (Stage I) and the TCA cycle (Stage II), break down metabolites 
thus donating electrons to NAD+ and FAD+. The highly reducing electrons 
are then donated to the respiratory chain machinery: complexes I-IV (Stage 
IV). The respiratory chain pumps protons from the matrix to the IMS, 
thereby generating a proton electrochemical gradient. Energy released by 
protons moving back along this gradient can be harnessed to make ATP or 
drive other processes (Stage IV). Note the difference in IMM and OMM 
permeability and location of metabolites transporters. Figure adapted from 
(Lodish, 2008).  
 
1.2.1 Krebs’ Cycle (Citric Acid Cycle, CAC; Tricarboxylic acid (TCA) Cycle) 
The final product of glycolysis in the cytosol is pyruvate, which is actively 
transported to the mitochondrial matrix. It undergoes oxidation and together 
with coenzyme A (CoA) creates acetyl coenzyme A (acetyl-CoA). As by-
products CO2 and NADH are produced. Acetyl-CoA enters the Krebs’ cycle in 
the mitochondrial matrix (Berg et al., 2002). All of the enzymes in the CAC are 
soluble proteins except for succinate dehydrogenase (complex II) that is bound 
to the internal mitochondrial membrane. As a result of the process acetyl-CoA is 
oxidised to CO2 and three types of molecules are produced: 3 molecules of 
NADH, one of flavin adenine dinucleotide (FADH2)–which will be the source of 
electrons for the respiratory chain–and a molecule of guanosine tri-phosphate 
(GTP) – which is eventually converted to ATP by nucleoside - diphosphate 
kinase (Fig. 1.4) (Berg et al., 2002).  
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Figure 1.4 Schematic overview of CAC. The acetyl group from acetyl CoA 
is attached to a four-carbon oxaloacetate molecule to form a six-carbon 
citrate molecule. Through a series of steps, citrate is oxidized, releasing 
two carbon dioxide molecules for each acetyl group fed into the cycle. In 
the process, three NAD+ molecules are reduced to NADH, one FAD 
molecule is reduced to FADH2, and one ATP or GTP (depending on the cell 
type) is produced (by substrate-level phosphorylation). Because the final 
product of the CAC is also the first reactant, the cycle runs continuously in 
the presence of sufficient reactants. Figure adapted from work published by 
Rice University (under a Creative Commons Attribution License 3.0) 
 
1.2.2 Respiratory chain overview 
NADH and FADH2 are electron sources for the respiratory chain. The molecules 
are produced mostly by the Krebs’ cycle and the ones formed in the cytoplasm 
are transported into mitochondria via glycerophosphate or malic acid-
asparagine carriers (Nicholls & Ferguson, 2002). Harvested electrons are used 
by NADH dehydrogenase, cytochrome bc1 and cytochrome c oxidase to pump 
protons (H+) across the mitochondrial membrane and create an electrochemical 
gradient (Nicholls & Ferguson, 2002). Protons returning to the mitochondrial 
matrix promote the catalytic movement of ATP synthase, which synthesizes 
ATP form ADP and an inorganic phosphate anion (Pi) (Fig. 1.5) (J. E. Walker, 
2013)(Kuhlbrandt, 2015).  
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Figure 1.5 Components of the mitochondrial electron transport chain. 
Structures of the respiratory complexes are depicted as molecular surfaces 
overlaid with cartoon representations. Each individual subunit of a protein 
complex is coloured differently. Complexes I, II and IV pump protons across 
the inner mitochondrial membrane, thereby generating a proton gradient 
(Δp). Protons moving back down this electrochemical gradient provide the 
driving force for ADP phosphorylation by the F1FO-ATPase. Complex II 
does not translocate protons, instead it serves as an entry point for 
electrons from the CAC intermediate succinate and contributes to the 
reduction of the quinone (Q) pool. Electrons are transferred from complex 
III to complex IV by the small soluble protein cytochrome c (coloured 
purple). Figure adapted from (L. A. Sazanov, 2015). 
 
1.2.3 Mitochondrial complex I (NADH:ubiquinone oxidoreductase) 
The mitochondrial complex I is the first and largest enzyme of the respiratory 
chain. In mammals it is composed of 45 subunits making it almost 1 MDa total 
(J.E. Walker, 1992)(Hirst, 2013).  
 
Complex I harbours eight iron-sulphur (FeS) clusters, of which seven have 
known catalytic functions. It accepts electrons from NADH produced in the 
Krebs’ Cycle through the two electron acceptor flavin mononucleotide (FMN) 
non-covalently bound in the 51 kDa subunit. Electrons are transferred through 
the iron-sulphur clusters to the ubiquinone-10 (Q) molecule. Reduction of the 
ubiquinone-10 to ubiquinol-10 (QH2) is coupled to proton translocation across 
the IMM. Proton pumping is performed by the anti-porter like subunits in the 
membrane part of the protein (Efremov & Sazanov, 2011)(L. A. Sazanov, 
2015). From the oxidation of one NADH molecule, complex I reduces one Q 
molecule and transfers 4 protons across the IMM (Fig. 1.6) (Alexander Galkin, 
Dröse, & Brandt, 2006).  
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Figure 1.6 Schematic overview of the catalytic compartments and putative 
mechanism of respiratory complex I. Upon electron transfer from the last 
FeS cluster N2, negatively charged quinone (Q) (or charged residues 
nearby) initiates a cascade of conformational changes, propagating from 
the E-channel (orange and green blocks) to the antiporters (yellow, blue, 
magenta blocks) via the central axis (indicated by grey arrows) comprising 
charged and polar residues that are located around flexible breaks in key 
transmembrane helices (TMHs). Cluster N2-driven shifts (dashed arrows) 
may help in the process. Helix HL either helps to coordinate conformational 
changes by linking discontinuous TMHs between the antiporters or 
stabilizes the structure. Key charged residues can be protonated from the 
cytoplasm through several possible pathways, including inter-subunit 
transfer (indicated by black arrows). Following the reduction of quinone and 
completion of conformational changes, the antiporters and the E-channel 
each eject a proton into the periplasm. Crucial TMHs are numbered and 
key charged residues are indicated by red circles for negative, blue circles 
for positive, and white circle for uncharged. FMN, flavin mononucleotide. 
Figure modified from (L. A. Sazanov, 2015). 
 
1.2.4 Mitochondrial complex II (succinate dehydrogenase) 
The mitochondrial complex II does not contribute to the electrochemical 
gradient across the mitochondrial membrane and is neutral in respect of H+ 
balance. Oxidation of succinate produces two H+ which are bound again during 
the reduction of Q. Complex II via covalently bound flavin adenine dinucleotide 
(FAD) collects electrons from succinate and via three iron-sulphur centres 
transfers them to the Q molecule (Fig. 1.7). Overall complex II enlarges the pool 
of ubiquinol-10 (Crofts, 2004).  
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Figure 1.7 Overall structure of the mitochondrial respiratory Complex II. 
The ribbon diagram of the complex is superimposed on the 
semitransparent molecular surface. The FAD binding protein (Fp) is shown 
in blue; the iron-sulphur protein (Ip) is shown in cream; the two 
transmembrane proteins CybL and CybS are shown in pink and gold, 
respectively. The putative membrane region is shaded in grey. FAD, [2Fe-
2S], [4Fe-4S], [3Fe-4S], heme, ubiquinone (Q) phosphatidylethanolamine 
(PE1) and hydrophobic sunken region are labelled. Figure adapted form 
(Sun et al., 2005). 
 
1.2.5 Mitochondrial complex III (cytochrome bc1 complex) 
The mitochondrial complex III oxidises the ubiquinol-10 pool in the process 
known as the Q-cycle (Fig. 1.8.C) (Mitchell, 1975). The first of the electrons 
harvested from the ubiquinol molecule that binds at the IMS site (Qo) is 
transferred to the final electron acceptor of complex III – cytochrome c (cytc). 
The second electron is transferred through the hemes bL and bH to a ubiquinone 
molecule at the matrix binding site (Qi) creating ubisemiquinone. 
Ubisemiquinone is fully reduced to ubiquinol after the second ubiquinol 
molecule at Qo gets oxidised, another cytc is reduced and the remaining 
electron is passed to the ubisemiquinone at the Qi site forming a fully reduced 
molecule of ubiquinone. Transfer of electrons from the Qo site to cytochrome c1 
(CYC1) is mediated by movement of the 2Fe-2S cluster of the Rieske subunit 
between its b-state proximal to QH2 and its c-state proximal to CYC1 (Fig. 1.8A 
- B). The possible reason for this complicated mechanism is that the ubiquinol 
molecule is completely reduced when binding to the Qo site but cyt c is only 
12 
able to accept one electron at a time. In the Q-cycle process two protons are 
consumed from the matrix, four protons are released into the inter membrane 
space and two electrons are passed to two cyt c molecules (Moser, Farid, 
Chobot, & Dutton, 2006).  
 
Figure 1.8 Overview of structural elements and major functional principles 
of mitochondrial complex III. A. Subunit composition of mitochondrial 
cytochrome bc1 with three catalytic subunits of one monomer coloured. B. 
Spatial arrangement and distances between cofactors and catalytic sites in 
the dimer. C. Scheme of electron and proton transfers within the monomer 
in the forward mode. Note that dotted lines in B. and C. denote large-scale 
movement of the FeS head domain harbouring the Rieske cluster between 
b- and c-states. Figure adapted from (Sarewicz & Osyczka, 2015). 
 
1.2.6 Mitochondrial complex IV (cytochrome c oxidase) 
Mitochondrial complex IV is the acceptor of the reduced cyt c. Here cyt c is 
oxidised and electrons meet their final acceptor–molecular oxygen (O2). As a 
result of the oxidoreduction reaction catalysed by complex IV, two molecules of 
A B 
C 
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water are formed using electrons harvested from four cyt c molecules and four 
protons from MM (Fig. 1.9). Additionally four protons are pumped out from the 
mitochondrial matrix through the complex (Verkhovsky, Jasaitis, Verkhovskaya, 
Morgan, & Wikstrom, 1999).  
 
 
Figure 1.9.Overall structure of the mitochondrial respiratory Complex IV. 
Subunits I (yellow) and II (green) are depicted in the phospholipid 
membrane, together with docked cyt c. Electrons from cyt c are transferred 
(curved red arrow) via the CuA site and haem a to the active site (haem 
a3/CuB). Proton transfer from the MM side of the membrane via the D-
pathway (grey arrow) leads to E278. E278 donates protons, both to the 
haem a3/CuB site to produce water from reduced O2 (light red arrow), and 
for pumping across the membrane (blue arrows). The red spheres are 
crystallographically observed water molecules in the D-pathway. Figure 
adapted form (I. Belevich, Verkhovsky, & Wikstrom, 2006). 
 
This gives the final number of ten net protons translocated from the 
mitochondrial matrix to inter membrane space by complexes I-IV per one NADH 
molecule oxidised (Kuhlbrandt, 2015).  
 
1.2.7 Mitochondrial complex V (F1FoATP synthase) 
The ATP synthase is the last element of the OXPHOS system. In general it is 
built of two components: the Fo domain embedded in the inner mitochondrial 
membrane and the F1 domain protruding in to the matrix. After the 
electrochemical gradient has been built up, it is used by the ATP synthase for 
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ATP production. The Fo domain is built mainly of the so - called c – ring and 
works as an ion transporter enabling proton’s re-flux into the MM. This creates a 
motive force in the F1domain facilitating ADP phosphorylation (Fig. 1.10). In this 
way energy stored originally in the form of NADH and transformed into an 
electrochemical gradient across IMM is harvested in the form of ATP (J. E. 
Walker, 2013). 
 
Figure 1.10.Schematic overview and the mechanism of ATP synthase. 
Rotation of the asymmetric γ-stalk drives the interconversion between α 
and β subunits of the F1 domain facilitating ATP synthesis. Proton 
translocation through the hydrophobic domain drives c-ring rotation of the 
Fo domain. Subunit a is proposed to provide a pathway for protons from 
the IMS to access binding sites on the c subunits as well as a channel for 
proton release into the matrix. Sequential proton binding and release 
events drive c-ring rotation, which is transferred to the catalytic domain by 
the γ-stalk. The peripheral stalk formed by the two b subunits prevents 
rotation of the F1 α-β domains. Figure adapted from (Lodish, 2008). 
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1.3 Other mitochondrial Functions  
 
1.3.1 Reactive Oxygen Species  
During the OXPHOS process most of the electrons eventually reach oxygen at 
cytochrome c oxidase to produce water. However, electron transport through 
complexes I-IV is not perfect and some of the “leaked” electrons reduce oxygen 
in an ungoverned manner creating ROS. This contributes to oxidative stress, 
alters mitochondrial function and leads to cell decay. It is estimated that in 
isolated mitochondria 0.1 – 2% of OXPHOS electrons reduce oxygen 
incompletely, mostly at complex I and III producing superoxide radicals (O2-•) 
(Murphy, 2009). 
At high concentrations ROS can wreak havoc to mitochondrial DNA but at 
moderate concentrations is a desirable cell regulator and a very important 
component of the cell signalling system. It is produced by tightly regulated 
enzymes, such as thenitric oxide (NO) synthase and NAD(P)H oxidase isoforms 
(Thannickal & Fanburg, 2000). It is also produced in a process referred to as 
the respiratory burst, an important immunological response of phagocytic cells 
(Robinson, 2008).  
 
1.3.2 Apoptosis 
In the case of serious damage to the mitochondria, the cell undergoes 
apoptosis. The Bcl2 protein is a sensor for mitochondrial damage. When 
activated it heterodimerises with a Bax class protein and together, by interaction 
with the mitochondrial voltage-dependent anion channel (VDAC), they increase 
permeability of the mitochondrial inner membrane. As a result the membrane 
potential is lost and cyt c is released. In the cytoplasm cytc interacts with the 
Apaf-1 protein and together forms the apoptosomes. The outcome is caspase-9 
activation and triggering of processes directly leading to death of the cell (C. 
Wang & Youle, 2009). 
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1.3.3 Heat production 
In some cases protons can return to the mitochondrial matrix without 
involvement of the ATP synthase. This process is called ‘proton leaking’ and 
occurs by passive facilitated diffusion through the ion channel thermogenin 
(UCP1). The energy from the electrochemical gradient is dispersed as heat. 
This reaction is characteristic for brown adipose tissue (BAT). BAT is present in 
mammals shortly after birth and is important for those organisms that undergo 
winter hibernation.  
 
1.3.4 Calcium homeostasis 
Calcium homeostasis is maintained and regulated through mitochondria. 
Calcium is a very important ion for cell signalling. Most of the calcium in the cell 
is stored in the endoplasmic reticulum (ER). However, extensive interactions 
between ER and mitochondria (Chapter 1.1.2) enable easy exchange of this 
ion. Calcium diffuses freely through the OMM and can be transported from the 
IMS to MM by the mitochondrial Ca2+ uniporter. Mitochondria can uptake 
calcium from the cytoplasm and release it rapidly if necessary. That makes 
them a temporary storage organelle and a very good calcium buffer (Rizzuto, 
De Stefani, Raffaello, & Mammucari, 2012). Expulsion of the ions causes 
changes in the membrane potential that invokes certain reactions, for example 
in a nerve cell, release of a neurotransmitter (Sudhof, 2012). 
 
1.3.5 Biosynthesis of proteins and co-factors 
Mitochondria are also very important places for the synthesis of different 
classes of molecules, such as porphyrins (Straka, Rank, & Bloomer, 1990), 
iron-sulphur-proteins (Ye & Rouault, 2010) and steroids (Ghayee & Auchus, 
2007). 
 
Porphyrins are heterocyclic molecules composed of four pyrrole rings 
connected with methine (-CH=) groups. They mostly provide prosthetic groups 
of proteins like haemoglobin (Fig 1.11). Since they are often key components of 
important enzymes their biosynthesis is very well studied (Straka et al., 1990). 
Porphyrin synthesis is a multistep process taking place in the cytoplasm and 
IMS. It starts form δ-aminolevulinic acid (dALA) formed from glycine and 
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succinyl CoA in a reaction known as the Shemin pathway (Straka et al., 1990). 
Two molecules of dALA are then combined to porphobilinogen (PBG) (a pyrrole 
ring containing molecule). Four PBGs are fused together to create 
tetrapyrroleuroporphyrinogen III (UPPIII). UPPIII is decarboxylated to form 
coproporphyrinogen III, the main porphyrin precursor imported into 
mitochondria. In the IMS it forms the main product: protoporphyrin IX that can 
be modified to obtain different compounds and co-factors, for example haem by 
iron incorporation (Straka et al., 1990).  
 
 
Figure 1.11 The haem biosynthetic pathway. Enzymes of haem 
biosynthesis are indicated by numbers. (1) 5-aminolevulinic acid (ALA) 
synthase. (2) ALA dehydrase. (3) porphobilinogen.(PHG) deaminase. (4) 
uroporphyrinogen III synthase. (5) uroporphyrinogen decarboxylase. (6) 
coproporphyrinogen III oxidase. (7) protoporphyrinogen IX oxidase. (8) 
ferrochelatase. N.E. = nonenzymatic. Figure adapted form (Straka et al., 
1990). 
 
Iron-sulphur clusters (ISCs) are ancient co-factors of proteins that are involved 
in electron transport, catalysis or gene expression (Brzoska, Meczynska, & 
Kruszewski, 2006). A wide range of functions requires their presence in many 
different cellular compartments. In non-photosynthetic eukaryotes the 
machinery of ISC assembly for all cellular ISC-proteins involves mitochondrial 
components (Ye & Rouault, 2010). The synthesis system is oxidation sensitive, 
for that reason the reduced environment of the MM provides a perfect location. 
Mitochondria contain ISC assembly machinery similar to the bacterial ISC 
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system (Chapter 1.1.1). Pyridoxal phosphate-dependent cysteine desulfurase is 
the sulphur donor for the mitochondrial ISCs. Sulphur is donated via a 
cysteinepersulphide intermediate. Iron is most likely delivered by a frataxin 
protein. Sulphurs of the clusters are initially attached to the scaffold protein Isu1 
that works together with a number of other enzymes to form ISC in the MM. 
Then clusters are exported from mitochondria to the cytoplasm (Rouault, 2015) 
where they are taken over by the cytosolic iron-sulphur protein assembly 
machinery (Lill et al., 2015) and incorporated into target proteins. Iron sulphur 
cluster synthesis is one of the most ancient enzymatic pathways of life. 
Mutations in any of the involved enzymes cause severe, mostly neurological 
diseases (Rouault, 2015).  
 
1.4 Complex I  
 
Complex I is essential for ATP production. This L-shaped enzyme is an 
assembly of 45 protein subunits with one arm (membrane domain, MD) buried 
in the inner mitochondrial membrane and the orthogonal arm (peripheral arm, 
PA) protruding into the mitochondrial matrix. With 14 central and 30 unique 
accessory subunits complex I is one of the largest membrane bound 
assemblies in cells. The function of the enzyme is to couple electron transfer 
from NADH to quinone with translocation of protons across the inner 
mitochondrial membrane (IMM) (Chapter 1.2.3).  
 
In mitochondria the PA is composed of 7 core subunits (75 kDa, 51 kDa, 49 
kDa, 30 kDa, 24 kDa, PSST and TYKY) binding 8 ISCs (Table S6) and 10 
supernumerary subunits (18 kDa, 13k Da, 10 kDa, B17.2, B8, 14.5a, 39 kDa, 
B13, SDAP-α and B14) (Table S7). The MD is composed of 7 core subunits 
(ND1, ND2, ND3, ND4, ND5, ND4L and ND6) (Table S6) and 21 
supernumerary subunits of which 15 contain transmembrane helices (MWFE, 
B16.6, B9, B14.7, B17, KFYI, ASHI, B14.5b, AGGG, MNLL, SGDH, B15, ESSS, 
B12), three are associated with the MD form the matrix site (42 kDa, SDAP-β 
and B22) and four are associated with the MD from the IMS (15 kDa, PGIV, 
PDSW and B18) (Table S7). Detailed description of the mitochondrial complex I 
structure can be found in Chapter 4.2. 
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1.4.1 Evolution of mammalian complex I 
Complex I is located in the IMM, however the enzyme itself predates the 
emergence of mitochondria (Moparthi & Hagerhall, 2011). It can be found in 
bacteria and archaea in a simpler version.  
 
Most likely complex I evolved form already present smaller protein building 
blocks. In chloroplast, cyanobacteria, archaea and some eubacterial phyla the 
enzyme contains only 11 subunits (Moparthi & Hagerhall, 2011). It lacks the 
NADH oxidizing part comprising FMN and the first ISCs. In some archaea the 
N-module of the complex I homologue is substituted by F420 dehydrogenase 
subunit. It is hypothesised that the primordial enzyme, and the many 11 subunit 
versions present, operate without a designated partner interacting with several 
electron donors. The 14-subunit complex I is the so-called “minimal catalytically 
active form” of the “traditional” enzyme and is present in eubacteria and α-
proteobacteria (Moparthi & Hagerhall, 2011). Understanding complex I 
evolution can provide key information on its assembly and mechanism. 
However, tracing the evolution of complex I is a difficult task. Over the years 
there have been a number of studies investigating this topic but the process still 
remains very enigmatic (Moparthi & Hagerhall, 2011) (Gabaldon, Rainey, & 
Huynen, 2005) (Friedrich & Scheide, 2000) (C. Y. Yip, Harbour, Jayawardena, 
Fearnley, & Sazanov, 2011). Nevertheless, based on available data, we can 
sketch the most probable order of events. 
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Core subunits 
The first progenitor is likely common to all complex I forms and other 
hydrogenases. In complex I, it gave rise to the Q module. Most likely it was an 
ancient form of electron transferring hetero dimer that later formed the 
PSST/49kDa subunit compartment of complex I and soluble [NiFe] 
hydrogenases (Friedrich & Scheide, 2000). This theory is also supported by the 
fact that the quinone binding site of complex I corresponds to the NiFe-active 
site in hydrogenases (Tocilescu, Zickermann, Zwicker, & Brandt, 2010). The 
next step was the assembly of the PSST/49kDa module with a progenitor for 
the TYKY subunit (most likely a ferredoxin - like protein) and an additional 
molecule that did not play a catalytic role but provided stability and a platform 
for interactions with electron donors (the 30kDa subunit homologue) (Friedrich 
& Scheide, 2000). All together these peptides formed the Q module.  
 
The following event was acquiring the membrane binding domain (homologues 
to ND1 and from one to three antiporter - like subunits) which led to gain of ion 
transferring capabilities and formation of the common ancestor of complex I and 
membrane bound hydrogenases. Functionally unrelated to any known ancient 
proteins the ND1 subunit homologue later, when hydrogenase activity was lost, 
also allowed for quinone accommodation (Efremov & Sazanov, 2012)(Moparthi 
& Hagerhall, 2011). It connected the ancestral Q module with a H+/Na+ 
antiporter protein – Mrp (L. A. Sazanov, 2015). Subunits MrpA (the ND5 subunit 
homologue), MrpD (the ND4 and ND2 subunits homologue) and MrpC (the 
ND4L subunit homologue) gave rise to the proton pumping part of complex I 
(the P module). The origins of the ND3 and ND6 subunits, which compose most 
of the proximal proton translocation pathway (ND3+ND4L+ND6 (L. A. Sazanov, 
2015)) linking the Q and P modules and thus are very important for coupling 
mechanism, still remain enigmatic (Moparthi & Hagerhall, 2011). These eleven 
subunits form the most common form of complex I in all organisms (Moparthi & 
Hagerhall, 2011). It can be found in archaea, cyanobacteria and bacteria and 
comprises the core of the chloroplast NDH complex. Such arrangement (without 
the electron “harvesting” module [N module]) suggests that complex I of some 
bacteria may be able to use different oxidation substrates and collect electrons 
from sources like ferredoxin, NADH or NADPH (Friedrich, Steinmuller, & Weiss, 
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1995)(Mi, Endo, Schreiber, & Asada, 1992). In some archaea the function of the 
NADH binding module is taken by F420H2 hydrogenase, so the complex 
functions a as F420:methanophenazine oxidoreductase (Friedrich & Scheide, 
2000).  
 
The N-module (the NADH dehydrogenase) consists of three core subunits. It 
evolved as the last supplement to complex I and connects the Krebs’ Cycle with 
the aerobic respiration chain (Friedrich & Scheide, 2000). In mammals it is 
composed of the 24kDa, 51kDa and 75kDa subunits. However in some 
microaerophilic organisms like Campylobacter jejuni the 51kDa and 24 kDa 
subunits (FP module) homologues are missing and electrons are donated by 
flavodoxin (Finel, 1998). That suggests maturation of the N-module in two 
consecutive steps: first to a 12 subunit complex without a permanently bound 
electron accepting domain and later to the catalytically complete enzyme 
(Weerakoon & Olson, 2008).  
 
Complex I in most bacterial organisms contains 14 conserved catalytic core 
subunits (Sharma, Lu, & Bai, 2009). They are organized in one operon of 
fourteen genes nuoA - N or nqo1 - 14 (nomenclature depending on the name of 
electron acceptor, respectively ubiquinone or quinone) (Friedrich & Scheide, 
2000). The gene order is also very consistent, with the exception of Rickettsia 
prowazekii whose organisation resembles more the one in the mitochondrial 
genome (Chapter 1.1.1) (Moparthi & Hagerhall, 2011).  
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Figure 1.12. Hypothetical scheme of modular evolution of the core subunits 
of complex I. Structures depicted as a cartoon. Approximate lipid bilayer 
boundaries are indicated. An ancestral hydrogenase made up by the 
progenitors of the 49kDa (green) and PSST (red) subunits evolved by 
addition of a ferredoxin (the TYKY subunit, cyan), and a protein of a 
structural function (the 30kDa subunit, navy).Together with the ND1 
homologue protein a progenitor of complex I and the membrane-bound 
hydrogenases was formed. Addition of a proton transporting protein Mrp 
(the progenitor of the ND2, ND4 and ND5 subunits, yellow, blue and purple 
respectively) led to the formation of the common 11 subunits large form of 
complex I. The catalytically independent complex I emerged by acquisition 
of the NADH dehydrogenase module in two steps: by first binding the 
75kDa subunit (pink) and later the 51kDa/24kDa subunits (FP module, 
yellow/teal respectively) Detailed description of evolutionary steps can be 
found in the text. Cartoon models are based on the ovine complex I 
structure (Fiedorczuk et al., 2016).  
 
Supernumerary subunits 
Interestingly already in some branches of α-proteobacteria, which are proposed 
to be mitochondrial ancestors, the presence of supernumerary subunits has 
been discovered. Complex I of P. denitrificans was found to consist of 17 
subunits. The 3 supernumerary subunits are homologous to mammalian B17.2, 
18 kDa, 13 kDa subunits (C. Y. Yip et al., 2011). This indicates that the 
endosymbiont acquired by eukaryotic cells may have had a complex I already 
more developed (possibly more efficient) than most eubacteria (and perhaps 
the host). 
It is believed that eukaryotic complex I originates form an α-proteobacterial 
ancestor, most likely from the Rickettsia genus (Moparthi & Hagerhall, 2011). 
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The comparison of the DNA and protein sequences from different organisms 
shows that in addition to the 14 core subunits of complex I, another 6 proteins 
(SDAP, 39kDa, 13kDa, B17.2, 18 kDa, 42kDa) were adopted from the genome 
of the proto-mitochondrial ancestor (Gabaldon et al., 2005). It has to be noted 
that the presence of the genes for these additional 6 subunits in the genome 
does not necessarily mean that they were part of complex I. For example, the 
supernumerary SDAP subunit is a ubiquitous protein in bacteria playing an 
important role in fatty acid maturation (Byers & Gong, 2007). However, in the 
mitochondrial complex I, it interacts with the core subunits through the LYR-
family proteins (the B14 or B22 subunits) (Angerer et al., 2014), whose 
orthologues have not been identified in α-proteobacteria (Gabaldon et al., 
2005). For that reason, we can assume that orthologues for a number of 
complex I supernumerary subunits are present in bacteria but have little to do 
with the enzyme. Nevertheless, after origination of mitochondria, those 20 α-
proteobacteria proteins (14 core and 6 accessory) were able to combine with 
the extra 14 host-originated proteins (B14.7, ESSS, B8, PDSW, B13, PGIV, 
15kDa, B22, B16.6, B18, B14, B12, MWFE, NUXM) to compose a34 subunit 
complex I (20 α-proteobacteria and 14 host-originated proteins). This form is 
most likely the common ancestor of the complex I enzyme in the three 
eukaryotic kingdoms (Gabaldon et al., 2005). This shows substantial gain in the 
complexity of complex I, doubling the number of subunits before the emergence 
of plants.  
 
After separation of the Plantae but still before the kingdoms of Fungi and 
Animalia have split, homologues of three extra subunits were added to the 
complex: B15, ASHI and B9 resulting in a 36 subunit enzyme (Gabaldon et al., 
2005). After animals diverged, complex I subunit NUXM (found in Fungi) was 
lost, but another 8 subunits – AGGG, SGDH, B14.5a, B14.5b, B17, 10 kDa, 
MNLL and KFYI – were gained building the final giant complex of 44 unique 
subunits in humans (45 total subunits as SDAP is present in two copies) 
(Gabaldon et al., 2005).  
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Figure 1.13 Hypothetical scheme for the evolutionary addition of 
mitochondrial complex I supernumerary subunits. Structures depicted as a 
cartoon, with core subunits in grey and transparent and supernumerary 
subunits coloured and those added at each step labelled. Approximate lipid 
bilayer boundaries are indicated. Important evolutionary events marked in 
red. Detailed description of evolutionary steps can be found in the text. 
Proteins of unknown structure e.g. NUXM not depicted. Cartoon models are 
based on ovine complex I structure (Fiedorczuk et al., 2016). 
 
This is the most likely order of events that led to development of mammalian 
mitochondrial complex I. Available data still do not allow us to confidently re-
track the order of all the steps and leave many doubts with regard to when 
exactly each subunit became an integral part of complex I. In most of the cases 
we can only state when the genes encoding certain protein orthologues 
appeared. Unfortunately, very little is known about the composition of complex I 
in non-model species. Most of the data comes from the 10 - 20 most 
researched organisms. Another elusive aspect of complex I evolution is the 
development of the complex I assembly factors. Understanding how they 
evolved can provide an additional key to the map of complex I evolution. 
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1.4.2 Assembly of mammalian complex I 
 
Assembly and maturation of the mammalian complex I is a very complicated 
and highly regulated process. Although recently progress in understanding of 
this process has been made, including dynamic complexome profiling 
performed on human 143B osteosarcoma cells, many steps still remain 
enigmatic (Guerrero-Castillo et al., 2017; Stroud et al., 2016; Vartak, Deng, 
Fang, & Bai, 2015). 
 
The assembly of complex I is a stepwise process. Firstly, the functionally 
independent modules – N, Q and P – are pre-assembled separately and then 
combined later to form the fully active NADH:Q oxidoreductase (Guerrero-
Castillo et al., 2017). Complex I is created from five major assemblies (after 
Guerrero-Castillo et al.): Q/Pp-a (Quinone/Pumping proximal-a), Pp-b (Pumping 
proximal-b), Pd-a (Pumping distal-a),Pd-b (Pumping distal-b) and N (NADH 
oxidising) (Fig. 1.14). Additionally, a cohort of assembly factors transiently 
associate with specific intermediates to regulate incorporation of the subunits 
(McKenzie & Ryan, 2010). 
 
The initial sub-assemblies 
The most primal complex I sub-assemblies are formed before and regardless of 
the presence of any other subunits (Guerrero-Castillo et al., 2017). That 
includes:  
- Progenitor of the Q module (the 49kDa and 30kDa subunits) 
- Progenitor of the Pd’ module (the SGDH, PDSW and ESSS subunits) 
- N-72kDa module (the 51kDa and 24kDa subunits) 
- N-88kDa module (the 75kDa and B8 subunits) 
 
The full Q module is assembled shortly after by adding the 49 kDa, 30 kDa, 
PSST, TYKY and B13 subunits. At this stage it also contains the assembly 
factors NDUFAF3 and NDUFAF4 (human nomenclature is used for assembly 
factors throughout the thesis).  
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The complete Pd’ module is also formed very quickly by addition of the B17 
subunit. The presence of Pd’ module is very intriguing as all of the subunits 
building that block belong to complex I accessory proteins. This shows that 
supernumerary subunits are not necessarily assembled on the core but may 
create separate sub-assemblies.  
At this stage SDAP and B14.7 subunits are also present. A constant presence 
of the SDAP subunit in mitochondria can be explained by its abundance 
required for the fatty acids synthesis. Most likely the protein is added to the 
complex at much later stages. More interesting is the early synthesis of the 
B14.7 subunit. This trans-membrane (TM) subunit is localized in complex I at 
the end of amphipathic helix of ND5 locking it to the ND2 subunit (Letts, 
Fiedorczuk, & Sazanov, 2016)(Fiedorczuk et al., 2016)(J. Zhu, Vinothkumar, & 
Hirst, 2016). The B14.7 subunits known to be added at the final step of 
maturation (Guerrero-Castillo et al., 2017), so its presence in the IMM from the 
very beginning may be a regulatory mechanism (Chapter 4.1.2).  
 
Formation of the five main assemblies 
Another crucial step during complex I maturation is the formation of the five 
main assemblies (Fig. 1.14) (Guerrero-Castillo et al., 2017): 
- Pp-b: formed form the subunits ND2, ND3, ND4L, ND6, KFYI, B14.5b 
with the assembly factors ACAD9, ECSIT, NDUFAF1 TMEM126B and 
the putative assembly factors COA1 TMEM186 
- Q/Pp-a: formed form the Q module, TIMMDC1 assembly factor, and 
transmembrane subunits: ND1, PGIV, B9 and B16.6 
- N: formed as a result of joining the N-72kDa and N-88kDa sub-
assemblies 
- Pd-a: formed by adding the MNLL, ND4 subunit and assembly factors 
TMEM70 and FOXRED1 as well as putative assembly factor ATP5SL to 
one half of the previously created Pd’ module 
- Pd-b: formed by adding the core ND5 and accessory B18, B12, ASHI, 
AGGG, SDAP (here called SDAP-β) and B22 subunits to the remaining 
half of the Pd’ module  
The Pp-b assembly is formed in two steps: first the ND2, ND4L, KFYI, B14.5b 
subunits associate with the assembly factors ACAD9, ECSIT, NDUFAF1 and 
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the putative assembly factor COA1 to create the Pp-b sub-assembly. Shortly 
thereafter, the remaining proteins ND6, ND3, TMEM 126B, COA1 and 
TMEM186are added (Guerrero-Castillo et al., 2017). The ND4L subunit is 
commonly not detected in mass-spectrometry experiments (Letts, Degliesposti, 
Fiedorczuk, Skehel, & Sazanov, 2016)(Stroud et al., 2016)(Guerrero-Castillo et 
al., 2017). ND4L is very hydrophobic with no tryptic digestion sites and for that 
reason it does not give rise to any readily detectable peptides. However, it 
strongly interacts withND3 and is most likely incorporated into the Pp-b 
assembly.  
Noteworthy is also the fact that the Pd-b assembly migrates in native gels as a 
300 kDa assembly (Guerrero-Castillo et al., 2017) although its predicted mass 
is 154 kDa (Carroll et al., 2006). One of the possible explanations is that it 
forms a homodimer to stabilize the long amphipathic helix of the ND5 subunit, 
which otherwise would be just extending into space (Fiedorczuk et al., 2016).  
 
Joining the main assemblies 
During the next step more global re-arrangements can be observed (Fig. 
1.13)(Guerrero-Castillo et al., 2017): 
 Pd-a and part of Pd-b assemblies are combined and together with the 42 
kDa and B15 subunits form the Pd-680kDa sub-complex  
 Q/Pp-a and Pp-b assemblies join and incorporate the B9 and MWFE 
subunits as well as the NDUFAF2 assembly factor to form the Q/Pp-
736kDa sub-complex 
 
Final maturation of mitochondrial complex I 
The final stage of complex I assembly requires joining of the previously formed 
modules (Guerrero-Castillo et al., 2017). First combination of the Pd-680kDa, 
Q/Pp-736 kDa and the remaining pool of the Pd-b assembly form an almost 
complete complex I termed the Q/P subassembly. Later the N module and the 
remaining supernumerary subunits (including the B14.7 and SDAP-α) are 
added. All of the assembly factors (except the COA1 and TMEM186 proteins) 
leave at this point.  
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Figure 1.14 Hypothetical scheme of mitochondrial complex I assembly. 
Structure depicted as a cartoon, with subunits coloured and labelled. Every 
important assembly intermediate is labelled and two alternative pathways of 
Q/P module assembly are marked with red and green arrows. Assembly 
factors were omitted for clarity. Please note presence of the hypothetical 
Pd-b assembly dimer; dashed line shows the interaction interface and 
asterisk marks the added molecule. Cartoon models are based on ovine 
complex I structure (Fiedorczuk et al., 2016). Figure based on (Guerrero-
Castillo et al., 2017) 
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Supercomplex formation 
After complex I is assembled, it is additionally stabilised by complexes III and 
IV, together forming a 1669 kDa supercomplex (the respirasome). In light of 
recent publications (Guerrero-Castillo et al., 2017; Stroud et al., 2016; Vartak et 
al., 2015) it is more likely that respirasomes are formed only after the individual 
complexes are assembled. That rules out the previously suggested theory of 
supercomplex involvement in the proper complex I maturation (Stroh et al., 
2004). 
 
Complex I recapitulation  
“Ontogeny recapitulates Phylogeny”. The theory of recapitulation is a 19th 
century hypothesis from the field of embryology stating that the development of 
the embryo of an animal goes through stages resembling sequential phases in 
the evolution of the animal's ancestors. Currently the theory is largely 
discredited and treated as a historical side-note (Horder, 2006). Nevertheless, it 
is interesting to compare complex I evolution and assembly in the context of the 
“enzymatic recapitulation”.  
 
There is no mitochondrial complex I “parallelism” visible. Assembly of individual 
subunits does not follow the path of evolution with the core assembled first 
followed by an addition of the supernumerary subunits. However, the modular 
assembly of the enzyme is preserved from bacteria to mammals. It can be 
stated that in a way each of the modules evolved separately. Supernumerary 
subunits are added to the core subunits before the functional modules are 
joined. This order of events prevents the creation of complex I sub-assemblies 
of suboptimal activity. Only when all the regulatory and stabilizing 
supernumerary subunits are present, fragments of the core are assembled and 
the B14.7 subunit locks the distal pumping modules to the coupling site 
(Guerrero-Castillo et al., 2017).  
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1.4.3 The electron transfer, coupling and proton translocation mechanisms 
 
Electron transfer 
Electron transfer in mitochondrial complex I is enabled by 9 co-factors (Chapter 
4.2.1) (L. A. Sazanov & Hinchliffe, 2006), a non-covalently bound FMN and 8 
ISCs (Table S6). Two of the clusters (N1a and N1b) are binuclear [2Fe-2S] and 
the remaining six (N2, N3, N4, N5, N6a and N6b) are tetranuclear (Fig. 4.2.B). 
The FMN molecule is situated at the top of the 51 kDa subunit in a pocket 
formed by a Rossman fold. ISCs form a path along the PA linking the FMN and 
the ubiquinone binding chamber. Most of the clusters are co-ordinated by four 
cysteine residues except for the N5 cluster which is ligated by three cysteines 
and a histidine (Chapter 4.1.1) (L. A. Sazanov & Hinchliffe, 2006).  
 
NADH donates two electrons simultaneously to FMN, however ISCs can 
transfer only one electron at a time. For that reason, FMN plays the role of an 
intermediate electron carrier. It can accept two electrons form NADH, transfer 
one immediately to the first FeS cluster (N3) and remain relatively stable in the 
form of a flavosemiquinone until the N3 cluster can accept the second electron. 
Semi-reduced flavin is very reactive and for that reason the FMN site of 
complex I is the main source of ROS in mitochondria. It has been proposed that 
to prevent excessive ROS production the N1a cluster accepts the electron from 
the flavosemiquinone until the N3 cluster is available for reduction (Leonid A 
Sazanov, 2007). However, the function of the N1a cluster is still debated and it 
may play only a structural role (Chapter 4.1.1) (Birrell, Morina, Bridges, 
Friedrich, & Hirst, 2013). Electrons from the N3 cluster are transported through 
the chain of the ISCs to ubiquinone. All the clusters are separated by <14 Å, 
which allows for electron tunnelling on a physiological time-scale (Page, Moser, 
Chen, & Dutton, 1999). The N2 cluster is the last “stepping stone” for the 
electron on the way through the PA to ubiquinone (T. Ohnishi, 1998). The force 
driving transfer of electrons form NADH to ubiquinone is the difference in the 
midpoint redox potentials (Em; the standard electric potential at which 50% of a 
redox component is in the reduced state) of the system components. At a pH of 
7.0 the Em of NADH is -320 mV; FMN is −340 mV; the N2 cluster is -100mV; 
and ubiquinone is+110 mV. The potential of the other (EPR-visible) FeS 
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clusters oscillates at around -250 mV (Yakovlev, Reda, & Hirst, 2007). More 
detailed description of the electron transfer path in mammalian complex I can 
be found in Chapter 4.1.1.  
 
Proton translocation 
For one NADH molecule oxidized, complex I translocates 4 protons across the 
IMM (Wikstrom, 1984). This stoichiometry is widely accepted although 
differences cannot be ruled out between organisms (Chapter 1.4.1). It has also 
been argued that complex I of some bacteria pump sodium ions instead of 
protons (Steuber, Schmid, Rufibach, & Dimroth, 2000)(Gemperli, Dimroth, & 
Steuber, 2002), however, these proposals remain very controversial (Bertsova 
& Bogachev, 2004). Proton translocation is catalysed by the seven core 
subunits (Chapter 1.4) that evolved from the H+/Na+ antiporters (Chapter 1.4.1). 
On the basis of homology, subunits ND2, ND4 and ND5 were identified as 
proton translocators. The location of the fourth–most proximal to the Q-site–
proton path has been proposed based on the structure of the intact complex I 
form T. thermophilus (R. Baradaran, Berrisford, Minhas, & Sazanov, 2013). 
More detailed description of the proton transfer paths in mammalian complex I 
can be found in the Chapter 4.2.1. 
 
The coupling mechanism 
Whilst the mechanisms by which electron transfer from NADH to Q in the PA 
and protons are transported through the IMM are relatively well understood (L. 
A. Sazanov, 2015), coupling of those two processes is still very enigmatic.  
 
In the recent years a number of different models have been proposed on the 
basis of structural and functional data. Some of them, like that proposed by 
Ohnishi and co-workers (S. T. Ohnishi, Salerno, & Ohnishi, 2010) which rely on 
the presence of two bound Q molecules have been ruled out by the recent 
structural data (R. Baradaran et al., 2013)(Vinothkumar, Zhu, & Hirst, 
2014)(Zickermann et al., 2015). The second reduction site for ubiquinone has 
never been observed. Another proposal in which the lateral helix (HL) ofND5 
acts as a mechanical transmission element, providing long distance energy 
transfer analogous to the coupling rod of a steam engine (Efremov, Baradaran, 
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& Sazanov, 2010), is at odds with some genetic and biochemical data. HL does 
not show a clear pattern of conserved residues, mutating potential contact site 
residues, introducing insertions to reduce helix rigidity or cross links to 
immobilize it did not decrease complex I proton pumping significantly (S. Zhu & 
Vik, 2015)(G. Belevich, Knuuti, Verkhovsky, Wikstrom, & Verkhovskaya, 2011). 
Some substitutions resulted in an unstable enzyme that fell apart during 
purification suggesting that HL might clamp the MD together (G. Belevich et al., 
2011) similar to the β-hairpin elements of the bacterial enzyme (R. Baradaran et 
al., 2013) or the supernumerary subunits of the IMS in the mammalian enzyme 
(Fiedorczuk et al., 2016). However, other mutagenesis experiments (Nakamaru-
Ogiso et al., 2010) provided more controversial results and at least a partial 
coupling role for HL cannot be ruled out yet. 
 
Current models of complex I coupling are based on the presence of a single 
quinone molecule and transmission of conformational changes from the Q site 
to the proton pumping modules directly via the functional residues of the proton 
translocation apparatus. These models can be divided into so-called two-stroke, 
wave-spring and one stroke models.  
 
In the two-stroke model there are two discrete translocation events. First, 
pumping two protons is driven by formation of anionic Q•-. The other two 
protons are translocated upon full reduction of Q•- to QH2 (U. Brandt, 2011). 
However, there are some issues with this model. It postulates that only two 
translocation channels are functional, which is inconsistent with structural and 
conservation data indicating four channels. It also requires the first proton 
translocation event to be faster than the delay between first and second 
quinone reduction events and stands against the experimentally measured 
redox potentials of the Q and ISCs. The predicted potential of the Q/Q•- is 
between Em -330 and -240 mV (Moser et al., 2006)(Efremov & Sazanov, 2012). 
Taking into account that the Em for the N2 cluster is -100mV,indicates that there 
is no overall drop of energy for electron transfer until the quinone is fully 
reduced.  
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The wave-spring model suggest that a key role is played by the MD axis of 
charged residues and solvating water molecules that was observed in the high 
resolution crystal structures of bacterial complex I (Efremov & Sazanov, 
2011)(R. Baradaran et al., 2013). This model proposes that in the oxidised state 
conserved Lys206ND4 is protonated. Upon reduction of Q (to Q2-), the negative 
charge localized on the ligand’s head group repulses nearby amino acid 
residues that eventually translates to a shift in pKa of Lys105ND2. Then 
Lys105ND2collects a proton form matrix and the charge wave continuous along 
the MD axis driving release of the Lys206ND4 proton and causing protonation of 
Lys223ND5. The cycle ends with protonation and disassociation of ubiquinol-10 
(QH2)that triggers proton release form the ND5 and ND2 modules and proton 
uptake by the ND4 module (Verkhovskaya & Bloch, 2013). However, to achieve 
the directionality of the proton transport this model requires exquisite fine-tuning 
of the pKas of all the key residues, which seems difficult to achieve in a flexible 
protein environment. It also does not assign any role to the many conserved 
discontinuous helices observed in the structure in key positions. 
 
According to the one stroke model proposed by Sazanov and colleagues (R. 
Baradaran et al., 2013) all four protons are translocated as a result of long-
range conformational changes in the MD. One proton is released per ND5, 4 
and 2 subunit (Efremov et al., 2010) and the fourth proton through the 
ND1+ND4L+ND6+ND3 subunits translocation pathway (R. Baradaran et al., 
2013). The central hydrophilic axis of the MD has a key role in the proton 
pumping and coupling mechanism. The process of proton translocation is 
initiated by the Q-chemistry and conformational changes nearby (Fig. 4.3.B), 
which propagate via the central axis (using all the flexible discontinuous helices) 
towards the three antiporter-like subunits, resulting in pKa and accessibility 
changes of the key protonatable residues. HL and IMS supernumerary subunits 
(βH motif in bacteria) are the most likely structural elements (however the role 
of HL is still not entirely clear) (Chapter 4.6). 
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1.5 A brief history of structural studies on the respiratory complex I 
 
Complex I was isolated and shown to have DPNH (an obsolete name for 
NADH) - coenzyme Q oxidoreductase activity for the first time in 1962 (Hatefi, 
Haavik, & Griffiths, 1962). That same year mitochondrial complexes I-IV got 
their names and have since been studied as separate entities (Hatefi, Haavik, 
Fowler, & Griffiths, 1962). In 1973, it was shown that in addition to the 
oxidoreductase activity, complex I is also a proton pump (Ragan & Racker, 
1973). This was one of the milestone findings in the field of mitochondrial 
bioenergetics. It supported Peter Michel’s chemiosmotic theory which six years 
later won him the Nobel Prize (Mitchell, 1979). Over the next decades 
developments in the purification methods, mass spectrometry and x-ray 
crystallography contributed to the gradual understanding of the structural basis 
of enzymes involved in ATP production (Saraste, 1999)(Kuhlbrandt, 2015). 
From the mid 90s until 2010 atomic structures of all mitochondrial OXPHOS 
enzymes, except complex I became available (Sun et al., 2005)(Xia et al., 
1997)(Tsukihara et al., 1996)(Abrahams, Leslie, Lutter, & Walker, 1994)(Watt, 
Montgomery, Runswick, Leslie, & Walker, 2010).  
 
Over forty years of studies on complex I resulted in defining the protein and 
cofactor composition of the enzyme across many domains of life (Meyer, 
2012)(Bridges, Fearnley, & Hirst, 2010)(Abdrakhmanova et al., 2004)(Carroll, 
Fearnley, Shannon, Hirst, & Walker, 2003)(C.-Y. Yip, Fearnley, Harbour, 
Jayawardena, & Sazanov, 2010)(L. A. Sazanov, S. Y. Peak-Chew, I. M. 
Fearnley, & J. E. Walker, 2000)(T. Ohnishi, 1998). 
 
The first breakthrough in structural information was the x-ray structure of the 
hydrophilic arm of complex I from T. thermophilus (L. A. Sazanov & Hinchliffe, 
2006), which revealed the electron transfer pathway through the enzyme, the 
arrangement of seven core subunits, all of the redox cofactors, part of the Q 
binding cavity and non-covalently bound FMN located in a Rossmann fold 
(Rossmann, Moras, & Olsen, 1974) of the 51 kDa (Nqo1) subunit. Next came 
the structure of the membrane arm of E. coli complex I (Efremov & Sazanov, 
2011), revealing the organisation of proton translocation pathways. The MD 
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structure contained six core subunits of the complex, composed of 55 TMHs 
forming three proton-pumping modules. It contained the characteristic long 
lateral helix of the ND5 (Nuo12) subunit and conserved key discontinuous 
TMHs in each module. This structure allowed the tracing of the proton 
translocation paths and identified key charged residues in the middle of the 
membrane. Although the partial bacterial structures provided a lot of information 
regarding the NADH oxidation mechanism, the electron transfer path and 
architecture of the proton pumping modules, organization of the quinone-
binding site at the junction of the two arms remained elusive.  
 
The next breakthrough came in 2013 when the first complete atomic structure 
of complex I from T. thermophilus was published (R. Baradaran et al., 2013). It 
provided insight into the quinone reduction site and provided crucial information 
about the possible mechanism of coupling between electron transfer and proton 
translocation in complex I, revealing quinone chemistry as a probable key to 
this coupling. Due to the high conservation of the core subunits across the 
species it was also an essential model for studying the eukaryotic enzyme. The 
T. thermophilus structure was followed by low resolution x-ray structures of the 
eukaryotic enzyme form yeast Yarrowia lipolytica (Zickermann et al., 2015) and 
Iβ subcomplex of Bos taurus (J. Zhu et al., 2015). Those structures did not 
provide much information regarding the mechanism of complex I or function of 
the supernumerary subunits due to their low resolution, however they gave 
valuable insight into the enzyme’s overall architecture. The architecture of yeast 
enzyme revealed that the core subunits are very similar to T. thermophilus, 
allowing their modelling on the basis of homology, while supernumerary 
subunits form a shell around the core.  
 
Meanwhile new developments in cryo-electron microscopy (Chapter 
1.6)(Kuhlbrandt, 2014) gave the ability to solve structures of biological 
complexes in atomic detail. With the new direct electron detectors and better 
software it became possible to obtain high-resolution maps of difficult to 
crystalize biological assemblies like complex I. The first 5 Å resolution map of 
the bovine enzyme was published in 2014 (Vinothkumar et al., 2014). It 
presented the complete architecture of the complex, however moderate 
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resolution prevented modelling of the side chains and the information about 
supernumerary subunits was very limited. Finally last year, almost complete 
cryo-EM structures of mitochondrial complex I became available (Chapter 1.7) 
 
1.6 Electron microscopy 
 
In the early 20th century it was observed that an electron beam in vacuum 
behaves very similarly to light. Additionally, electric and magnetic fields can 
bend and focus electrons much like glass lenses shape visible light (Egerton, 
2007). This finding inspired student Ernst Ruska and his supervisor Max Knoll 
to construct the first electron microscope. The apparatus constructed in April 
1931 was modestly called a cathode ray oscillograph and had a total 
magnification (M) of 14.4X (Ruska, 1987). Very interestingly, at that time neither 
Ruska nor Knoll knew about the wave nature of electrons postulated by de 
Broglie (although it was put forward already in 1925). Thus they thought that the 
resolution of the electron microscope was limited by the size of the electron. It 
was very disappointing for both of them to learn in summer 1931 that, like for 
light microscopes, the wavelength limits the theoretical resolution of the device 
(Ruska, 1987). Fortunately, the theoretical resolution limit of the electron 
microscope is much higher than light microscopes. Already a few years later in 
1934, Ruska and Knoll constructed a microscope which obtained a resolution of 
100 nm, twice as good as that of any light microscope (Ruska, 1987). Modern 
electron microscopes allow reaching resolutions higher than 0.05 nm (Haider, 
Rose, Uhlemann, Kabius, & Urban, 1998). 
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Figure 1.15 A. Sketch of the cathode ray tube for testing the image 
properties of the non-uniform magnetic field of a short coil (Ruska 1929) 
B. Bacterial culture fixed with formalin and embedded in a supporting film 
stained with heavy metal salt (Krause 1937). Images adapted from Ruska 
Nobel Prize Lecture (Ruska, 1987).  
 
Currently electron microscopes are used around the world in many different 
research fields. They have applications in aeronautics, automotive 
manufacturing, clothing and apparel, machining, pharmacology, criminology 
and many more. Because they are used for different purposes special types of 
EMs have been developed. In structural biology the transmission electron 
microscope (TEM) is mostly used but there are also scanning electron 
microscopes (SEM), scanning transmission electron microscopes (STEM, 
combining principles of TEM and SEM) and focused ion beam microscopes 
(FIB, similar to SEM but using beam of ions instead of electrons).  
 
Modern TEM comprise an electron optical column, lenses for focusing and 
deflecting the beam, the high voltage generator for the electron source, a 
vacuum system, operating console, control panels, electron detector and 
control software (Egerton, 2007). Electrons are produced by the source, 
focused and pass through a specimen. Projection of the specimen is displayed 
on a viewing device on the bottom of the column. 
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1.6.1 Single particle cryo - EM 
 
In EM studies of inorganic materials resolutions better than 1Å have been 
achieved routinely for the last few decades (Haider et al., 1998). However, this 
requires high electron doses that cause damage to organic specimens. In the 
study of the structure of ovine mitochondrial complex I, a technique known as 
cryo-electron microscopy (cryo-EM) was used (Cheng, Grigorieff, Penczek, & 
Walz, 2015). This method has been shown to be very powerful for three-
dimensional structure determination of biological molecules. Preparation of the 
microscope sample requires spreading the protein suspension on an EM grid 
and freezing it rapidly in ethane at near liquid nitrogen temperature (appropriate 
for vitreous ice formation). This approach, developed in the 1980s by Jacques 
Dubochet and his colleagues, allows for a great reduction in radiation damage 
(Adrian, Dubochet, Lepault, & McDowall, 1984). To further minimize the 
damage, images are recorded at very low electron dose that in turn also 
decreases signal to noise ratio (S/N) in the micrographs. Low S/N and damage 
by the electron beam require averaging signal from multiple molecular images 
to obtain the cryo-EM map. For that reason the first high resolution (R<4Å) 
structures were obtained by recording images from 2D crystals and averaging 
over many unit cells (Henderson et al., 1990). The obstacle of the necessity for 
sample crystallization was overcome by the development of more powerful 
computer programs. In the first decade of the 21st century the first maps from 
single particles of icosahedral viruses and helically ordered proteins embedded 
in ice reached resolutions good enough to visualize side chains. However, 
averaging of images of millions of asymmetric units was required, similar to 
what was needed for 2D crystals (Grigorieff & Harrison, 2011).  
 
Efforts for EM structure determination from single particles of asymmetric 
proteins started in the 1970s (Hoppe, Schramm, Sturm, Hunsmann, & 
Gassmann, 1976). Statistical methods allowed proper 2D averaging and 
classification and ten years later introduction of angular reconstruction methods 
enabled transition from 2D particle averages to 3D maps for objects without 
symmetry (Radermacher, Wagenknecht, Verschoor, & Frank, 1987)(van Heel et 
al., 2000)(Vinothkumar &Henderson, 2016). The next few decades brought 
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further development of data processing software as well as EM hardware 
(Vinothkumar & Henderson, 2016):  
 The first electronic detectors improved the speed of data collection and 
sample examination, although the detective quantum efficiency [DQE] 
was still worse compared to film when used with high voltage. High DQE 
(ideally 1.0) is essential in maximising the S/N ratio. 
 Field emission guns (FEGs), which provided a 500-fold increase in 
coherence comparing to previously used tungsten filaments.  
 Improvements in both column and cold stage stability reduced image 
drift.  
 Reduction in ice contamination through better vacuum and cryo-
shielding.  
 Increased electron accelerating voltage from 100 to 300 keV, improving 
the microscope resolution, depth-of-focus, aberrations, and beam 
penetration. 
 
In spite of these developments resolution achieved by single particle cryo-EM of 
asymmetric particles oscillated around 10Å. The breakthrough was in 2013 
when new detectors and computer programs became available (Vinothkumar & 
Henderson, 2016).  
 
1.6.2 Recent developments in electron microscopy 
 
Recently introduced direct electron detectors are built based on complementary 
metal oxide semiconductor (CMOS) technology (Milazzo et al., 2005). They 
have a rolling-shutter readout mechanism and can read out images 
continuously with a frame rate that can range from 1 to 1000 Hz or more. That 
allows recording information content in movie mode. Data collected in the form 
of movies is very useful during the processing. Firstly, micrographs can be 
corrected for beam-induced specimen charging and movement by alignment 
and weighting of the individual frames. Secondly frames with low S/N, which 
negatively contribute to the final map, can be discarded. Additionally, the rolling 
shutter mechanism enables identification of individual electron events and 
replacement of their signal by a delta function at the centroid of the event 
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density at sub-pixel resolution, a practice called electron counting (EC). EC is 
used for recording images at higher resolution than might normally be 
achievable and subsequently performing binning, which allows higher DQE over 
broader resolution ranges. The new generation of CMOS detectors are also 
very thin (by backthinning after wafer fabrication). This reduces the noise in the 
image by preventing electrons from backscattering and depositing energy in 
incorrect pixels. Additionally, backthinning improves the detector’s lifetime due 
to lowering the overall energy deposition. All those improvements contributed to 
EM imaging systems with DQE much higher than ever before (Vinothkumar & 
Henderson, 2016).  
 
The second great boost in single particle cryo-EM was the development of 
processing software. Although there are a number of programs (Vinothkumar & 
Henderson, 2016) for use at different steps of data processing  or providing the 
whole working pipeline, the most popular currently, also used in this study, is 
RELION (Scheres, 2012). RELION introduced a major improvement in map 
reconstruction. To determine the orientations of the individual single particle 
images in 2D classification and to calculate the 3D structures it uses a 
regularised maximum likelihood (ML) scoring system, rather than a simple 
cross-correlation maximisation algorithm. ML-scoring itself was not a real 
breakthrough, as it was originally implemented in Xmipp (Marabini et al., 1996) 
but RELION uses also regularisation calculated through the empirical Bayesian 
approach from the data themselves, which leads to optimal weights on the 
reconstruction and on the alignments.  
 
Summarizing, single particle cryo-EM can currently be used to analyse protein 
or nucleic acid structures of sufficient size (which is getting ever smaller). It 
does not require sample crystallization and is able to deal with sample 
heterogeneity by 3D classification in silico. However, it still has not reached its 
full potential and during the next few years it may become the leading method in 
structural biology.  
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1.7 Structural studies on the respiratory complex I using electron 
microscopy 
 
The first electron microscopy work on complex I dates back to the late 1980s. 
The first EM structure of complex I from negatively stained 2D crystals 
(Leonard, Haiker, & Weiss, 1987) provided information about enzyme topology 
and reported it to have an ‘axe’ shape. The first report of the L-shape of the 
molecule with one arm embedded in the lipid membrane comes from the 
reconstruction generated form 2D crystals of the N. crassa enzyme in the early 
1990s (Hofhaus, Weiss, & Leonard, 1991). The first single particle study of 
negatively stained complex at 35 Å resolution (Guenebaut, Vincentelli, Mills, 
Weiss, & Leonard, 1997) confirmed the overall architecture of the enzyme. The 
characteristic, conserved L-shape of the molecule was further confirmed in a 
number of studies on enzymes from E. coli (Morgan & Sazanov, 2008), T. 
thermophilus (Rozbeh Baradaran, 2009), A. aeolicus (G. Peng et al., 2003), P. 
denitfricans (C.-Y. Yip et al., 2010), Y. lipolytica (Djafarzadeh et al., 2000), A. 
thaliana (Dudkina, Kudryashev, Stahlberg, & Boekema, 2011) and B. Taurus 
(Grigorieff, 1998). Although the resolution of these reconstructions varied 
mostly between 20 and 40 Å, they provided valuable data on arrangement of 
subunits and gave the first hints about possible conformational changes during 
catalytic turnover of the enzyme (Morgan & Sazanov, 2008)(Böttcher, Scheide, 
Hesterberg, Nagel-Steger, & Friedrich, 2002).  
The location of the 49 kDa subunit was proposed by immune-staining 
experiments (Guenebaut et al., 1997). The ND5 and ND4 subunits were 
assigned using single particle EM by Sazanov and colleagues (Baranova, Holt, 
& Sazanov, 2007) and 2D electron crystallography studies by the same group 
finally resolved the MD of E. coli to 8 Å resolution revealing 60 trans-membrane 
helices with homology to the Mrp family of cation/H+ antiporters and indicated 
that the coupling of electron transfer to proton pumping may involve long-range 
conformational changes.  
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Figure 1.16 Electron microscopy structures of complex I. Single particle 
analysis and 3D reconstructions of complex I from: A. N. crassa (Guenebaut 
et al., 1997); B. E. coli (Guenebaut, Schlitt, Weiss, Leonard, & Friedrich, 
1998); C. Bovine (Grigorieff, 1998); D. Bovine (Morgan & Sazanov, 2008); 
E. A. aeolicus (L. Peng, Yamamoto, & Shikanai, 2010); F. and G. E. coli 
inactive and active forms, respectively (Böttcher et al., 2002); H. E. coli 
incubated with NAD+ (Morgan & Sazanov, 2008); I. Y. lipolytica 
(Radermacher et al., 2006); J. T. elongates (Arteni et al., 2006); K. A. 
thaliana (Dudkina, Heinemeyer, Sunderhaus, Boekema, & Braun, 2006). 
Figure adapted from that created by Dr Rozbeh Baradaran.  
 
The first high-resolution cryo-EM structure of the bovine complex I was 
published in 2014 when this project had already started (Vinothkumar et al., 
2014). The 5 Å resolution map provided great insights into arrangement and 
structure of the supernumerary subunits and confirmed the high similarity of the 
core subunits to bacterial models. However, it was a poly-alanine model that did 
not provide detailed information about the complex I structure. Finally last year, 
a partial model (65% atomic for core subunits and 27% atomic for 
supernumerary subunits) was published for the bovine enzyme at 4.2-4.3 Å 
resolution (J. Zhu et al., 2016), just before the publication of the first nearly 
complete (88% atomic) ovine model at 3.9 Å from this work (Fiedorczuk et al., 
2016). These publications were followed later by the structure of the porcine 
enzyme at ~ 3.6 Å (~ 84% atomic)in the supercomplex (Wu, Gu, Guo, Huang, & 
Yang, 2016). 
 
 
 
 
 
  43 
1.8 Aims of this work 
 
This project aimed to generate a complete and accurate atomic model of the 
mammalian mitochondrial complex I.  
 
First, three easily available model organisms (B. taurus, S. scrofa and O. aries) 
were evaluated in order to choose the best source for the enzyme, deemed to 
be ovine due to its high stability and activity. Human complex I for the study 
would have been more appropriate, however culturing enough immortalized 
cells is very expensive/time consuming and fresh placentas are difficult to 
obtain and cause many issues.  
 
Second, a purification protocol was developed to obtain pure and stable sample 
of the enzyme that can be used for structural experiments. 
For many years structural biology has been dominated by X-ray 
crystallography. Recent developments in cryo-EM have led to a number of near 
atomic resolution structures for protein complexes difficult to crystallize 
(Vinothkumar & Henderson, 2016). For that reason, cryo-EM was the first 
choice technique for this project. Within time constrains of the PhD project (3-4 
years) it was possible to optimise cryo-EM grid preparation (one of the most 
challenging steps in the process), collect and process the data, and obtain the 
map at a resolution of ~3.9 Å that enabled model building at the atomic level 
(another challenging part of the project due to the size of the complex).  
 
The first nearly completely atomic model of mitochondrial complex I is an 
important step forward in our understanding of its function. It provided crucial 
information about the organisation and function of the supernumerary subunits. 
Additionally, it shed light on complex I assembly and the molecular basis of 
disease-causing mutations. The process of coupling electron transfer to proton 
translocation still remains inscrutable, however, a range of different 
conformations observed in this work provides possible clues. 
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Chapter 2. Materials and Methods 
 
 
 
2.1 Materials 
 
N-dodecyl-β-maltoside (DDM) and lauryl maltose neopentyl glycol (LMNG) were 
purchased from Glycon Biochemicals GmbH (Luckenwalde, Brandenburg, 
Germany); all other detergents were acquired from Anatrace (Maumee, Ohio, 
USA). NADH was purchased from Santa Cruz Biotechnology Inc. (Heidelberg, 
Germany). Complete Protease Inhibitor Cocktail tablets (EDTA free) were 
bought from Roche Diagnostics (Burgess Hill, West Sussex, UK). All other 
chemicals were purchased from Fisher Scientific UK (Loughborough, 
Leicestershire, UK), VWR International (Lutterworth, Leicestershire, UK) and 
Sigma-Aldrich Ltd (Gillingham, Dorset, UK) and were of analytical grade. All 
solutions, unless otherwise stated, were prepared with ultrapure water filtered 
by a Milli-Q system (Merck Millipore, Billerica, Massachusetts, USA). 
Chromatography columns were from GE Healthcare (Amersham, 
Buckinghamshire, UK). Vivaspin concentrators were purchased from Sartorius 
Stedim (Epsom, Surrey, UK). Amicon-Ultra centrifugal filter units were supplied 
by Merck Millipore (Billerica, Massachusetts, USA). Zeba spin desalting 
columns were acquired from Thermo Fisher Scientific Inc. (Rockford, Illinois, 
USA). Bio-Beads SM-2 were purchased from BioRad Laboratories Ltd. (Hemel 
Hempstead, Hertfordshire, UK). Holey carbon-coated grids were supplied by 
Quantifoil Micro Tools GmbH (Jena, Thuringia, Germany) and Protochips, Inc. 
(Raleigh, North Carolina, USA). Ovine hearts were purchased from local 
butcher (Humphreys C & Sons, UK).  
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2.2 Analytical methods 
 
2.2.1 Complex I activity assays  
 
All measurements were made using a Shimadzu UV-1601 (Shimadzu UK Ltd., 
Milton Keynes, Buckinghamshire, UK) spectrophotometer fitted with a peltier 
temperature controller and automated sample changer (Shimadzu DPS-240A) 
with magnetic stirring unit (Electronic Stirrer Model 300, Rank Brothers Ltd. 
Cambridge, UK). The oxidation of NADH was measured by monitoring the 
change in absorbance at a wavelength of 340 nm. Change in [NADH] was then 
calculated using the Beer-Lambert law and the appropriate molar extinction 
coefficient (ε340 [NADH] = 6220 M-1 cm-1). Complex I activity is defined as μmol 
NADH oxidised per min per mg of protein. All reactions were performed at 37 
°C.  
 
Complex I dehydrogenase activity was measured using potassium ferricyancide 
(K3[Fe(CN)6]; FeCN) as an electron acceptor. Assay buffer containing 50 mM 
HEPES pH 7.4, 0.1 % (w/v) LMNG and 1 mM FeCN was pre-warmed in 1.5 mL 
semi-micro disposable cuvettes. Samples containing complex I were added to a 
final volume of 1 ml. Reactions were then initiated by the addition of 100 μM 
NADH and the absorbance at 340 nm was monitored for 30 s. If required, the 
amount of complex I per assay was adjusted to give a linear rate of NADH 
oxidation over this time period.  
 
Complex I reductase activity was measured using a soluble quinone analogue, 
decylubiquinone (DQ), as an electron acceptor. Protein was added to reaction 
buffer containing 20 mM HEPES, pH 7.4, 100 mM NaCl, 10% glycerol, 1.0 
mg/ml BSA, 0.1% CHAPS and 0.25 mg/ml bovine heart total lipid extract in 4 ml 
cuvette. That was followed by addition of 100 μM DQ and incubated in 30 oC for 
10 min. Reactions were then initiated by the addition of 100 μM NADH and the 
absorbance at 340 nm was monitored for 60 s. Sample during incubation and 
data collection was stirred at ~300 rpm.  
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2.2.2 Methods to determine protein concentration 
 
BCA assay  
Protein concentration was measured using the Pierce bicinchoninic acid (BCA) 
assay kit (Thermo Fisher Scientific Inc., Rockford, Illinois, USA) used according 
to the manufacturer’s instructions. A bovine serum albumin (BSA) standard 
curve (0.1 to 1 mg/ml) was prepared in a buffer matching that of the unknown 
sample. Colorimetric reactions were performed in Falcon rigid 96 well plates, 
incubated at 37 °C for 30 min and then read using a SpectraMax M2 plate 
reader (Molecular Devices, Wokingham, Berkshire, UK). The sample protein 
concentration was then estimated by comparison with the standard curve.  
 
Concentration based on theNADH:K3[Fe(CN)6] activity 
Intact O. aries complex I was determined to have an NADH:FeCN 
oxidoreductase activity at ~80 μmol/min/mg (Letts, Degliesposti, et al., 2016). 
This specific activity value was used to convert the measured activity of a 
sample (in μmol/min/ml) to protein concentration value in mg/ml for rough 
estimates of the enzyme concentration during purification.  
 
A280 absorbance  
Protein absorption at 280 nm was measured to estimate protein concentration 
of the samples for the cryo-EM grids preparation. This method was used 
because of its good reproducibility for the protein concentration at the range of 
1-5 mg/ml and very small volume of sample required for the measurements (~2 
μl). Absorption at 280 nm was measured using a NanoDrop 1000 UV-Vis 
spectrophotometer (Thermo Fisher Scientific Inc., Rockford, Illinois, USA). The 
concentration of complex I was calibrated to about 1,65 mg/ml of protein 
concentration per 1 A280 unit.  
 
2.2.3 SDS-PAGE  
12- and 15-well pre-cast Novex Tris-glycine 4% to 20 % (w/v) polyacrylamide 
gradient gels (Life Technologies, Paisley, Renfrewshire, UK) were run 
according to the manufacturer’s instructions. The electrophoresis buffer 
contained 0.25 M Tris base pH 8.3, 1.92 M glycine and 0.1% (w/v) sodium 
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dodecyl sulphate (SDS). Samples were mixed 4:1 with solubilising buffer 
comprising 250 mM Tis pH 6.8, 10% (w/v) SDS, 10% (w/v) dithiothreitol (DTT) 
50% (v/v) glycerol and 0.05% (w/v) bromophenol blue. 10-15 μl of sample was 
loaded per well; one lane on each gel was loaded with 6 μl of Precision Plus 
Protein Standards, unstained (Bio-Rad), gels were then run for 85 min at 150 V. 
Gels were stained overnight with Instant Blue stain (Expedeon Ltd., Harston, 
Cambridgeshire, UK) and destained with water the following day.  
 
2.3 Sample preparation 
 
2.3.1 Preparation of mitochondria  
Mitochondrial purification was conducted following previously described protocols 
(Letts, Degliesposti, et al., 2016). Ovine hearts (36, ~8 kg) are cleaned of fat and 
connective tissue, then chopped and minced. 1400 ml of isotonic buffer (250mM 
sucrose, 10mM Tris- HCl pH 7.8, 5 mM 2-mercaptoethanol) is added per 1 kg of 
minced heart tissue for washing. Buffer is discarded by squeezing the meat 
through a double-layered muslin and added again with minced tissue to a blender. 
Material is blended for 30 s. Mitochondria are obtained during two steps of 
centrifugation. Firstly (H12000 rotor, 4 °C, 2700 rpm, 15 min.), tissue debris, 
unbroken cells and bigger cellular structures are removed. Secondly, by pelleting 
(SLA-3000 rotor, 4 °C, 11k rpm 27 min.), mitochondria are separated from soluble 
proteins and smaller organelles. Mitochondria prepared with this method are 
portioned (10-20 g), and stored frozen at -80 °C.  
 
2.3.2 Preparation of mitochondrial membranes  
Mitochondrial membranes are obtained by homogenisation in glass- Teflon 
homogenizer. 20 g of mitochondria are homogenized in water (100 ml) before 
adding potassium chloride to 150 mM. Soluble proteins are separated from the 
membrane fraction, containing complex I, by centrifugation (SS-34 rotor, 20k rpm, 
25 min.). After this step membranes can be frozen and stored in –80 °C. 
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2.3.3 Complex I preparation  
Protein was purified from Ovis aries heart mitochondria following the protocol 
developed in this work and adapted with some modifications from previously 
published procedure for bovine enzyme (Letts, Degliesposti, et al., 2016)(L A 
Sazanov, S Y Peak-Chew, I M Fearnley, & J E Walker, 2000).  
 
Initial Purification 
Collected membranes were solubilised by incubation in a solubilisation buffer in the 
cold room (20 mM Tris pH 7.4, 1 mM ethylenediaminetetraacetic acid (EDTA), 10% 
glycerol, 2 mM dithiothreitol (DTT), 0.002% phenylmethanesulfonyl fluoride 
(PMSF), 1% n-Dodecyl 𝛽-D-maltoside (DDM). Per 1 g of membrane pellet 8.5 ml of 
solubilisation buffer was added and stirred for 30 min at 4 oC. Any non-solubilised 
mitochondrial fraction was removed by centrifugation (SS-34 rotor, 20k rpm, 30 
min.).The supernatant that contains complex I is loaded onto a Q-Sepharose 
HiLoad 26/10 ion exchange column equilibrated in low salt buffer A (20 mM Tis-
HCl pH 7.4, 2 mM EDTA, 0.1% DDM, 10% Ethylene Glycol, 1 mM DTT and eluted 
with 0-800 mM sodium chloride (NaCl) gradient over 500 ml at 1ml/min (from buffer 
A to buffer A with 1 M NaCl). Complex I elutes at about 220 mM NaCl. Eluted 
NADH:FeCN active fractions were collected, diluted with buffer A to 100 mM NaCl, 
then concentrated and the Q-column step was repeated in order to improve 
purification quality and remove the main contaminant, ATP synthase. The final step 
of the procedure was size exclusion chromatography using a Superdex 200 HiLoad 
16/60 column equilibrated in SizeEx Buffer (20 mM Tris-HCl, 2 mM EDTA, 10% 
Ethylene Glycol, 2 mM DTT, 100 mM NaCl) with 0.2% DDM, which separates the 
~1MDa Complex I from a few remaining proteins. The ÄKTA Explorer 
chromatography system with 280/460 nm absorbance monitor was used for ion 
exchange and size exclusion chromatography.  
 
Improved purification 
Improved purification was performed similarly to the original preparation but it 
differs in details, which improve the purity and quality of the final sample.  
 
Collected membranes were solubilised by incubation in a solubilisation buffer in the 
cold room (20 mM HEPES pH 7.4, 1 mM ethylenediaminetetraacetic acid (EDTA), 
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10% glycerol, 2 mM dithiothreitol (DTT), 0.002% phenylmethanesulfonyl fluoride 
(PMSF), 1% lauryl maltose neopentyl glycol (LMNG). Per 1 g of membrane pellet 
8.5 ml of solubilisation buffer was added and stirred for 30 min at 4 oC. Any non-
solubilised mitochondrial fraction was removed by centrifugation (SS-34 rotor, 20k 
rpm, 30 min.). Protein in a solubilised state was loaded onto a Q-Sepharose 
HiLoad 26/10 ion exchange column equilibrated in low salt buffer Ai (50 mM 
HEPES pH 7.4, 2 mM EDTA, 0.1% LMNG, 10% glycerol, 1 mM DTT) and washed 
with a 30 ml linear gradient of 5-22 mM NaCl followed by150 ml of 22 mM NaCl. 
Complex I was then eluted with a 300 ml linear gradient of 22-305 mM NaCl. 
Gradients were obtained by using Ai buffer and Ai buffer supplemented with 1 M 
NaCl. Complex I eluted at about 220 mM NaCl. Eluted NADH:FeCN active 
fractions were collected and concentrated. At this point sample contains complex I 
and two main contaminates: complex IV and 2-oxo-glutarate dehydrogenase.  
 
The final step was size exclusion chromatography, which separated complex I from 
remaining contaminants, using a Suprose 6 10/30 HR column equilibrated in 
SizeEx buffer (20 mM HEPES, 2 mM EDTA, 1.5% glycerol, 2 mM DTT, 100 mM 
NaCl) supplemented with 0.2% of LMNG. The ÄCTA Explorer chromatography 
system with 280/460 nm absorbance monitor was used for ion exchange and size 
exclusion chromatography.  
 
Sucrose gradient purification 
As a gentler, but less efficient, alternative to size exclusion we experimented with 
using sucrose gradient ultracentrifugation. Solubilized mitochondrial sample after 
the Q column purification step of the initial purification protocol was loaded on 10-
35% sucrose gradient containing buffer A and centrifuged in 4° C for 16.5h with the 
speed of 38k rpm using SW 41 Ti rotor. This method was proven to work for 
complex I purification but due to lower purity has not been used in further 
experiments.  
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2.4 Detergent exchange 
 
2.4.1 Amphipathic polymers 
Protein sample in detergent (LMNG or DDM) was diluted to ~2 mg/ml and 100 µl 
volume with SizeEx buffer. Amphipathic polymer (Amphipol A8-35, NV10 or 
PMALs) in solution was added to protein to achieve a certain w/w ratio (0.3:1, 1:1 
or 1:3 reagent to protein) and 250 µl volume and incubated on ice for 10 min. Next, 
to remove detergent, β-cyclodextrin was added in molar ratio (n/n) 2:1 to detergent 
and incubated for another 5 min. The mixture was loaded on the Superose 6 HR 
10/30 size exclusion column equilibrated with SizeEx buffer without detergent. 
 
2.4.2 Detergents 
Protein sample purified in LMNG or DDM was diluted to final concentration of ~2 
mg/ml and 100 µl volume with SizeEx buffer. Detergent of choice in solution was 
added to protein to the final ~0.2% concentration. Next, the mixture was loaded on 
the Suprose 6 HR 10/30 size exclusion column equilibrated with SizeEx buffer 
supplemented with a detergent of choice at ~0.2% concentration.  
 
2.5 Cryo-electron microscopy 
 
2.5.1 Grids preparation 
2.7 μl of solubilized protein sample concentration of ~1-5 mg/ml was applied to 
copper grids (Quantifoil mesh 300, R 0.6/1, 1.2/1.3 or 2/2) glow discharged in air at 
30 mA for 120 s and blotted for a certain period of time (5-34 s) at 90% humidity in 
the chamber of FEI Vitrobot IV. Immediately after the sample was snap frozen in 
liquid ethane.  
 
2.5.2 Cryo-EM screening conditions 
Initial images were collected at -173 °C on a Tecnai T12 electron microscope (FEI) 
operating at 120 kV using a Gatan UltraScan 1000 2k × 2k CCD camera, following 
low-dose procedure. Grids were mounted on a pre-cooled Gatan 626 model single 
tilt cryo transfer holder and secured using a clip-ring system. Images were 
recorded at a nominal magnification of 30000 X. Defocus was set for -3 to -7 μm, 
electron dose 15-25 e-/s/Å2 and exposure time 3-8 s. Micrographs were inspected 
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using DigitialMicrogprah (Gatan), FIJI and the e2display program from the EMAN2 
package. 
 
2.5.3 Cryo - EM data collection conditions 
Imaging was performed with a 300kV Titan Krios electron microscope equipped 
with direct electron detector FEI Falcon-II (ETH Zurich, ScopeM center) in 
automated data collection mode at calibrated magnification of 1.39 Å/pixel (100720 
X) and dose of 26 e-/s/Å2 with total 3s exposure time. The data were collected as 
seven movie frames fractionated over the first second of exposure and an 
averaged image over 3 seconds. 
 
2.6 Image processing  
 
2.6.1 Initial processing 
Two datasets of total ~2.6 k micrographs in two datasets were collected. All 
processing steps were done using RELION (Scheres, 2012) unless stated. For the 
initial CTF estimations using CTFFIND4 (Rohou & Grigorieff, 2015) and for 
automated particle picking in RELION averaged images from high dose 3 s 
exposure were used. MOTIONCORR (Li et al., 2013) was used for whole-image 
drift correction of movie frames 1 - 7 (1 s) of each micrograph. Contrast transfer 
function (CTF) parameters of the corrected micrographs were estimated using Gctf 
and refined locally for each particle (Zhang, 2016). All the consecutive steps of 
processing were conducted in RELION 1.4 package including focused 3D 
refinements with the subtraction of signal from the remaining parts of the complex 
(Bai, Rajendra, Yang, Shi, & Scheres, 2015). 
 
2.6.2 Separation of different complex I conformations 
Improved 3D classifications on the initial “open” and “closed” subsets into ovine 
classes 1-5 was conducted in RELION 2.0. That includes 3D refinement focused 
on the peripheral domain of combined classes “open” and “close” with the signal 
subtraction,3D classification using masked membrane domain without alignments 
and 3D auto refinements of the separated classes.  
 
 
52 
2.7 Modelling of the ovine mitochondrial complex I  
 
2.7.1 Model building  
As an initial reference for determination of atomic ovine model of mitochondrial 
complex I, so far published structures and protein homology recognition software 
was used. SQWRL4 software (Krivov, Shapovalov, & Dunbrack, 2009) was used 
for the initial core subunits homology models based on T. thermophilus structure 
(R. Baradaran et al., 2013). Homology models for the supernumerary subunits 
were generated with Phyre2 (Kelley, Mezulis, Yates, Wass, & Sternberg, 2015) 
and Swiss-model (Biasini et al., 2014). Secondary structure predictions for all 
subunits were generated with PredictProtein (Rost, Yachdav, & Liu, 2004), PsiPred 
(McGuffin, Bryson, & Jones, 2000) and TMHMM (Krogh, Larsson, von Heijne, & 
Sonnhammer, 2001) servers. The initial models were adjusted to cryo-EM density 
(in cases when homology models were useful) or built manually in COOT.  
 
Initial models were re-built and refined in Rosetta release version 2016.02.58402 
using protocols optimized for cryo-EM maps (DiMaio et al., 2015). For each 
subunit, 100 different models were produced in Rosetta with optimization of density 
fit using elec_dens_fast function (with –denswt = 40, chosen from several trials), 
selection of the best fitting structure and structure relaxation using –FastRelax flag. 
From the produced structures several best-scoring by density fit and geometry 
were selected and used in COOT to guide further model building/optimization. This 
procedure resulted mainly in improvements to backbone geometry, especially in 
coils, still allowing for the good fit of side-chains into density. All the work involving 
Rosetta was done by Dr Karol Kaszuba (IST Austria).  
 
2.7.2 Refinement 
The final model refinement was performed with the Phenix suite (Adams et al., 
2010). The Model was refined against “combined” map (Chapter 3.7.2) using the 
phenix.real_space_refine program with following options 
run=minimization_global+morphingscattering_table=electron 
secondary_structure.enabled=True macro_cycles=3 resolution=3.9. Geometry 
description files for the co-factors and ligands were calculated using GRADE 
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server (Vonrhein et al., 2011). After rounds of refinement model was rebuild using 
COOT and refined again with 5 cycles but without morphing to give the final model.  
 
2.8 Cross-linking  
 
All the cross-linking reactions were performed using purified solutions of complex I 
at a concentration of 1 mg/ml. Following experimental optimisation, ten separate 
experiments were performed. Experiments varied in relation to the detergent added 
to the buffer (DDM, LMNG or LDAO/DDM), the cross-linking reagent (targeting 
lysine or acidic residues) and the protease used to digest the samples (trypsin or 
endoproteinase Glu-C). Cross-linking experiments were performed by collaborators 
Dr Gianluca Degliesposti (MRC-LMB Cambridge, UK) and Dr Mark Skehel (MRC-
LMB Cambridge, UK). Results in detail were analysed and summarised by Dr 
James Letts (IST Austria).  
 
2.9 Preparation of figures 
 
Figures were prepared using: UCSF Chimera (Pettersen et al., 2004), PyMOL 
(Shrodinger, Camberley, Surrey, UK), Adobe Illustrator (Adobe Systems Europe 
Ltd, London, UK). 
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Chapter 3. Results 
 
 
 
3.1 Choice of experimental organism 
 
Ovis aries has been chosen as a source for complex I preparation. Recently it 
has been shown that it may be more suitable for structural studies than the 
extensively studied bovine enzyme because of its stability (Letts, Degliesposti, 
et al., 2016).  
Sequence similarity analysis revealed that sheep complex I is as similar to 
human as bovine (the best characterised so far) or porcine enzymes and for 
that reason it is an equally good model. 
Identity (%) 
Species 
Core 
Nuclear 
Core 
Mitochondrial  Supernumerary 
Bos taurus 96.0 70.6 84.5 
Sus scrofa 95.7 69.9 83.9 
Ovis aries 96.1 70.9 83.1 
Table 3.1 Comparison of complex I subunits of three organisms easily 
available for studies (Sus scrofa, Bos taurus, Ovis areies) in terms of 
sequence similarity to human enzyme. Subunits were divided by encoded 
by nuclear genome, mitochondrial genome, supernumerary and core. 
Sequences of subunits were obtained from NCBI (Altschul, Gish, Miller, 
Myers, & Lipman, 1990). Prior to alignment nucleus encoded subunits were 
truncated to remove mitochondrial targeting sequence based on already 
published biochemical data or sequence similarities (Letts, Degliesposti, et 
al., 2016). Detailed result can be found in Supplementary Table S1. 
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3.2 Protein purification 
 
3.2.1 Initial purification 
The initially developed procedure for the purification of ovine complex I (in 
DDM, Chapter 2.3.3), was based on the original protocol for the bovine enzyme 
(L A Sazanov et al., 2000). This protocol provided reproducibly pure, 
homogenous complex I. As a starting material lamb hearts from animals of the 
same age and sex on the day of slaughter were used. From 36 ovine hearts we 
obtained ~220 g of mitochondria. The intact enzyme was purified from the 
internal mitochondrial membrane. During the process pool 36% of the starting 
amount of complex I is lost on the first Q column step (Fig. 3.1), another 24% 
during second Q column (Fig. 3.2) and 17% during size exclusion 
chromatography step (Fig. 3.3) (Table 3.2). Loss of complex I is compensated 
by increased purity, leaving few minor contaminants after the last step of 
purification (Fig. 3.4) 
Step of purification 
Volume 
(ml) 
Activity 
(U/ml) 
Total 
Activity (U) 
Membrane fraction 100 59.6 5964.9 
Solubilized membrane 100 63.8 6383 
Q-Sepharose I 126 32.9 4152.9 
Q-Sepharose II 144 17.8 2570 
Superdex 200 12 123.6 1486.7 
Table 3.2 Initial purification of complex I from O. aries. Starting material 
was 10g of mitochondria. Final yield of pure complex I was ~15 mg. Activity 
was measured as (NADH):ferricyanideoxidoreduction. 
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Figure 3.1 Elution profile of the first Q column of the initial protocol. In solid 
line absorption at 280nm, in dashed at 420nm, in dots 
(NADH):ferricyanideoxidoreduction activity and in dashed conductance. 
 
Figure 3.2 Elution profile of the second Q column of the initial protocol. In 
solid line absorption at 280nm, in dashed at 420nm, in dots 
(NADH):ferricyanideoxidoreduction activity, and in dashed conductance. 
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Figure 3.3 Elution profile of the size exclusion column of the initial 
protocol. In solid line absorption at 280nm, in dashed at 420nm and in 
dots (NADH):ferricyanideoxidoreduction activity. 
 
 
 
Figure 3.4 SDS-PAGE gel of every second fraction between 43 and 64 ml 
(left to right) from the elution profile presented in Fig. 3.3. Indicated are 
collected fractions of complex I.  
 
Fractions corresponding to complex I (Fig. 3.3) were pooled, concentrated and 
frozen in liquid nitrogen (LN) with 25% glycerol. Final protein concentration was 
36 mg/ml. 
Freezing and thawing of the protein sample did not cause any loss of 
NADH:FeCy activity (Table 3.3), DQ activity (Letts, Degliesposti, et al., 2016) 
nor protein degradation or aggregation (Fig. 3.5). However it influenced the 
quality of cryo-EM grids (Chapter 3.5) 
Pooled Fractions 
50 kDa 
75 kDa 
25 kDa 
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Sample Activity (U/mg prot.) 
Complex I before freezing 101 
Complex I after 3 days in LN 103.8 
Table 3.3 (NADH):ferricyanideoxidoreduction activity of complex I before 
and after freezing. 
 
Figure 3.5 Elution profile of complex I after freezing and storing for 3 days 
in LN. Sample was run in the buffer used for size exclusion 
chromatography during purification (SizeEx buffer with 0.2% DDM).In 
solid line absorption at 280nm.  
 
3.2.2 Improved purification 
The improved procedure for the purification of ovine complex I (in LMNG, 
Chapter 2.3.3), was closely based on the already published protocol for the 
ovine enzyme (Letts, Degliesposti, et al., 2016). This protocol provides 
reproducibly pure, homogenous complex I. It was found that compared to the 
initial DDM preparation, this procedure produces more stable, fully active 
complex and with the easily lost 42 kDa subunit retained (Letts, Degliesposti, et 
al., 2016). During the process 69% of the initial complex I is lost on the first Q 
column step (Fig. 3.6) (possibly due to the fact that by solubilizing mitochondrial 
membranes with LMNG, large percentage of complex I remains in form of 
supercomplex I1III2 and elutes at different NaCl concentration [data available in 
our laboratory, not published]) and 16% during the size exclusion 
chromatography step (Fig. 3.7) (Table 3.3). Loss of complex I is compensated 
by increased purity, leaving few minor contaminants after the last step of 
purification (Table 3.4). 
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Step of purification Volume (ml) Activity/ml  Total Activity 
Membrane fraction 50 63.1 3157.1 
Solubilized membrane 50 59  2964 
Q-Sepharose  63 17.6  1076.2 
Superose 6 6 45.8 *274.8 
Table 3.4. Improved purification of complex I from O. aries. Starting 
material was 5g of mitochondria. Final yield of pure complex I was ~5 mg. 
Activity was measured as (NADH):ferricyanideoxidoreduction. Notice that 
amount of the starting material is twice less than in the initial protocol 
(Table 3.2) 
*Sample was aliquoted and stored in LN after Q-sepharose purification 
(discussed below). Total activity and volume was estimated based on one 
sample thawed and run over analytical size Superose 6 column equilibrated 
in SizeEx buffer supplemented with LMNG. Low total activity may be 
caused by protein loss during this procedure or total volume 
underestimation.  
 
 
Figure 3.6.Elution profile of the Q column. In solid line absorption at 280nm 
in dashed at 420nm and in dots (NADH):ferricyanideoxidoreduction activity. 
 
After the first Q column, run in LMNG, the purification was finished by gel 
filtration chromatography in various detergents as needed for cryo-EM 
experiments. It was noticed that although the protein frozen in Brij-35 does not 
show signs of decay after size exclusion, it produces cryo-EM specimen with 
significantly more aggregates than fresh sample (data not presented). For that 
reason electron microscope grids were always prepared from a sample that 
was not frozen at any step after membranes solubilisation. To save biological 
material complex I purifications were performed starting from 5g of 
mitochondria. Excess protein was frozen in LMNG after the Q-Sepharose 
purification step and used for initial screening of cryo-EM grids prepared with 
complex I in other detergents.  
60 
 
Figure 3.7. Elution profile of the analytical size exclusion column in Brij-35, 
from the sample used for the data collection. In solid line absorption at 
280nm and in dashed at 420nm, activity was not measured in order to save 
sample. 
 
 
Figure 3.8 SDS-PAGE gel of every fraction between 10 and 12.6 ml (left 
to right) from the elution profile presented in Fig. 3.7. Indicated is central 
peak fraction of complex I (~11.5 ml) that was collected, concentrated and 
used for grids preparation.  
  
Pooled Fraction 
50 kDa 
75 kDa 
25 kDa 
  61 
3.2.3 Sucrose gradient purification  
Alternatively, the last step of purification can be substituted by sucrose gradient 
centrifugation (Fig. 3.9 and 3.10). Sample obtained this way was not used for 
later experiments due to relatively poor purity (Fig. 3.9). 
 
Figure 3.9A. Sucrose gradient with complex I present in the lower brown 
band (indicated by arrow). B. SDS-PAGE gel of fractions collected from the 
sucrose gradient. Arrow indicates fraction containing complex I. Fractions 
collected from the tube from top and loaded on the gel from the left. 
 
 
Figure 3.10(NADH):ferricyanide oxidation measurements of fractions from 
the sucrose gradient. In dots (NADH):ferricyanideoxidoreduction activity. 
Fractions collected from the top, arrow indicates complex I fraction. 
 
 
A B 
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3.2.4 Mass spectroscopy analysis of ovine complex I 
In the sample prepared initially with DDM some subunits were not identified. 
However, the missing subunits: 10 kDa, B14.7, 15 kDa, MWFE, KFYI, B15, 
B14.5b, ND3, ND4L, ND6 are very small and/or hydrophobic. Thus their lack in 
the sample can be rather assigned to sub-optimal conduction of the initial mass 
spectroscopy experiment and some limitations of the method (Supplementary 
Table S2, Fig S1).  
Mass spectrometry identification of complex I subunits was performed again on 
complex I purified in LMNG and detergent exchanged to Brij-35 (sample used 
for structural data collection). It revealed presence of all complex I subunits 
except ND4L that does not have any triptic digestion sites (Supplementary Table 
S2). The experiment including SDS-PAGE separation of subunits was 
performed by Dr. Gianluca Degliesposti and the details including gels can be 
found in Letts et al. (Letts, Degliesposti, et al., 2016). 
 
3.3 Detergent exchange 
 
3.3.1 Detergents 
In search of the optimal detergent for cryo-EM imaging, stability of the purified 
complex I was examined in a few common detergents (Table 3.5). Detergent 
exchange was performed by running the sample after Q-column or size 
exclusion purification step on the analytical Superose 6 10/30 size exclusion 
column in SizeEx buffer containing the detergent of choice. The effectiveness of 
the exchange and stability of the complex was judged by gel filtration 
chromatography, with intact complex I eluting at 11.5 ml (Fig. 3.11). Disruption 
of the complex would result in peak broadening and shift to later elution 
volumes. More extensive experiments were performed by Dr James Letts and 
not repeated (Letts, Degliesposti, et al., 2016).  
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Tested detergent and used concentration Complex I stability 
lauryl maltose neopentyl glycol  
(LMNG) 0.01% 
 stable 
Triton X-100 0.05%  stable 
Brij-35 0.05%  stable 
Cymal 7 0.05%  stable 
Table 3.5 Stability of complex I in some common detergents derived from 
gel filtration chromatography experiments. 
 
Figure 3.11 Representative elution profile of detergent exchange run (in 
this case Brij-35 at 0.05%) yielding stable enzyme. In solid line absorption 
for 280nm and in dashed for 420nm. 
 
3.3.2 Amphipathic polymers 
Amphipathic polymers provide an alternative method to solubilise membrane 
proteins and avoid potential problems of detergent background and “lensing 
effect” in cryo-EM imaging (Flotenmeyer, Weiss, Tribet, Popot, & Leonard, 
2007). The effectiveness of the exchange was judged by gel filtration 
chromatography, with intact complex I eluting at 11.5 ml (Fig. 3.12).  
 
Tested amphipathic 
polymer  
Exchange ratio 
protein/polymer (w/w) 
Complex I stability 
Amphipol A8-35 1:3 stable 
Amphipol A8-35 1:1 stable 
Amphipol A8-35 3:1 stable 
PMAL C-8 1:1 not stable  
PMAL C-12 1:1 not stable 
PMAL C-16 1:1 not stable 
NV10 1:1 poor stability 
Table 3.6 Stability of complex I tested amphipatic polymers. Derived from 
gel filtration chromatography experiments 
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Only Amphipol A8-35 was found to be a good solubilisation molecule for 
complex I. All tested w/w exchange ratios (Table 3.6) gave a mono-disperse 
peak at the expected elution volume. 
 
 
Figure 3.12 Representative elution profile for complex I sample with DDM 
exchanged to Amphipol A8-35 (in this case 1:1 protein:amphipol ratio).  
 
PMAL polymers were found to cause immediate aggregation of complex I (Fig. 
3.12) that could not have been reversed by adding detergent back to the 
sample. Protein stability test was conducted by a quick method of measuring 
the absorbance in the range of 220-350 nm (Porterfield & Zlotnick, 2010). In 
each of the cases the overall absorbance profile and the A260/280 ratio was 
examined. For PMAL C16 and PMAL C12 protein aggregation was easily 
visible by eye due to the  milky colour of the protein solution. Complex I with 
PMAL C8 was transparent and showed A260/A280 ration only slightly higher 
than expected for proteins ~0.6 (Porterfield & Zlotnick, 2010). However sample 
injected on the analytical size exclusion column equilibrated in SizeEx buffer 
with no detergent did not elute, suggesting that protein aggregated and was 
retained on the filtering system of the purifier.  
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PMAL C8 A260/280: 0.69 PMAL C12 A260/280: 1.13 
PMAL C16 A260/280: 1.27 
Figure 3.13 Absorption spectrum for complex I sample with PMALs in 1:1 
w/w ratio. The purple vertical line indicates absorption at 280 nm.A260/280 
ratios are indicated. 
 
The complex I sample exchanged from detergent to NV10 remained soluble on 
the size exclusion column in SizeEx buffer without detergent as mono-disperse 
peak, however the protein eluted 1 ml later than expected (Fig. 3.14). A 
possible explanation is that the enzyme broke down into the peripheral and 
membrane domains that co-eluted. Grids prepared from this sample contain 
aggregates and particles reassembling membrane and matrix arms sub-
complexes (Fig. 3.20). Thus NV10 may be a useful reagent for complex I sub-
complexes studies.  
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Figure 3.14. Elution profile for complex I sample with DDM exchanged to 
NV10 at 1:1 protein:polymer ratio. The peak at the column volume (22 ml) 
may contain detached small supernumerary subunits.  
 
3.4 Salt concentration screens 
 
In order to examine minimal NaCl concentration required for complex I stability 
in detergent a number of conditions were screened. Protein purified in DDM 
detergent was diluted in SizeEx0.2% DDM buffer ranging in the final NaCl 
concentration from 100 to 2 mM. Results suggest that enzyme aggregates in 
concentration below 30 mM NaCl however it can be rescued by adding the salt 
back. The 100 mM NaCl used for cryo-EM grids preparation as well as the 50 
mM NaCl used for the Q-column equilibration during purification are sufficient to 
keep the protein intact.  
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Figure 3.15. Absorbance profile for complex I sample with DDM in different 
NaCl concentrations. A. 100 mM NaCl A260/280: 0.58 B. 50 mM NaCl 
A260/280: 0.57 C. 35 mM NaCl A260/280: 0.60 D. 22.5 mM NaCl 
A260/280: 0.88 E. 11.3 mM NaCl A260/280: 1.16 F. 2 mM NaCl 260/280: 
0.9 G. 100 mM NaCl (salt added to sample with 2 mM NaCl like panel F.) 
260/280: 0.58  
 
3.5 Preparation and optimization of cryo-EM grids  
 
3.5.1 Blotting time optimization 
The first parameter optimized during grids preparation was the blotting time. In 
most cryo-EM studies blotting time of grids varies in between 2-10 seconds 
(http://www.emdatabank.org/search.html). For the ovine complex I grids, a 
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much longer  blotting time was required. For a sample containing 0.2% DDM 
and applied on a Quantifoil holey carbon R2/2 Cu-300 grid, blotting times 
varying from 3 to 25 seconds were tested. Relatively long 20 seconds blot was 
found to be optimal (Fig. 3.16). However during later experiments it become 
clear that blotting time depends heavily on the type and concentration of 
solubilisation reagent, grid type and protein concentration. For the 0.2% Brij-35 
solubilized sample at 5 mg/ml applied on R0.6/1 grids (like those used for the 
data collection) 34s blotting time was used. For samples in Amphipol A8-35 (1 
mg/ml protein and R0.6/1 grids) usually ~15 s blotting time was optimal. 
 
A 
  
B 
 
Figure 3.16.Cryo-EM micrographs of complex I in SizeEx buffer 
supplemented with 0.2% DDM using Quantifoil R2/2 grids. A. 13s blotting 
time, M=~5000X, the mark burned in a thick ice using the electron beam 
shows an edge of the grid hole B. 20s blotting time, M=30000 X, image 
shows part of the grid hole with particles around the carbon support 
edge.  
 
3.5.2 Choice of electron microscopy grids 
Initially Quantifoil holey carbon R2/2 Cu-300 grids were used for the microscope 
sample preparation. However, the high detergent and protein concentration and 
long blotting time needed were causing the so called “lens effect” caused by 
uneven ice thickness distribution in the holes (Flotenmeyer et al., 2007). As a 
result the ice in the center is much thinner than on the edges causing clustering 
of the protein particles only at the rim of the hole. To overcome this difficulty, 
grids of the smallest available hole diameter on the market (Quantifoil holey 
carbon R0.6/1 Cu-300) were used. 
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A 
  
B 
 
Figure 3.17.Cryo - EM micrographs of complex I in SizeEx buffer 
supplemented with 0.1% DDM A. Quantifoil R0.6/1 grid, M=30000 X B. 
Quantifoil R2/2 grid, M=30000 X. Protein concentration ~ 5 mg/ml. 
 
3.5.3 Screening and optimization of detergent conditions for complex I cryo-EM 
studies 
As mentioned in chapter 3.3 a number of detergents were found to keep 
complex I soluble outside the lipid membrane environment. Detergents that 
have proven to be good solubilisation reagents for complex I in size exclusion 
chromatography were used for the cryo-EM grids preparation.  
After grid preparation, complex I in Triton X-100, DDM and LMNG was either 
broken into subcomplexes or aggregated (Fig. 3.18 A., C., D., E.). Disruption of 
the complex probably happened due to strong water-air interface interactions 
during grid blotting (see below). Detergents giving best results were Brij-35 and 
Cymal-7 (Fig. 3.18 B., F.). However, for two reasons it was decided to use the 
Brij-35 sample for the data collection. First, it gives good quality grids more 
consistently, second, it has a very low density (1.05 g/ml at 25 °C), so almost 
does not contribute to the background noise in the micrographs.  
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Figure 3.18 Cryo-EM micrographs of complex I in different detergent 
buffers. A. 0.1% DDM B. 0.4% Cymal-7 C. 0.05% Triton X-100 D. 0.2% 
Triton X-100 E. 5% Brij-35, black dots presumably are detergent micelles F. 
Brij-35 0.2% G. LMNG 0.4% H. LMNG 0.2%. In all of the cases protein 
concentration is ~5 mg/ml, grid Quantifoil R0.6/1, nominal microscope 
magnification 30000 X. 
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Final optimization of the cryo-EM sample involved testing the optimal 
concentration of the Brij-35 detergent. Complex I gives a mono disperse size 
exclusion peak in SizeEx buffer containing only 0.02% of Brij-35 (~2x critical 
micelle concentration [CMC]). For the cryo-EM sample preparation, 
concentrations of the detergent from 0.04 to 0.2% were tested. It was noticed 
that around ~0.12% or less protein starts to show signs of aggregation. For that 
reason 0.2% Brij-35 was found to be optimal for complex I cryo-EM gird 
preparation.  
 
A 
 
B 
 
C 
 
D 
 
Figure 3.19 Cryo-EM micrographs of complex I in Brij-35 of different 
concentrations. A. 0.04% B. 0.12% C. 0.14% D. 0.2%. In all of the cases 
protein concentration is ~5 mg/ml, grid Quantifoil R0.6/1, nominal 
microscope magnification 30000 X. 
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3.5.4 Screening and optimization of amphipathic polymers conditions for 
complex I cryo-EM studies 
Complex I exchanged to Amphipol A8-35 and NV10 gave a single 
monodisperse peak when run over size exclusion column equilibrated in SizeEx 
buffer without detergent. Sample in NV10 as expected from the retention 
volume contained enzyme broken into sub-complexes (Fig 3.20.A, 3.14). 
Surprisingly complex I exchanged to Amphipol A8-35 also showed signs of 
degradation.  
 
A 
 
B 
 
C 
 
D 
 
Figure 3.20Cryo-EM micrographs of complex I in amphipathic polymers A. 
NV10 pre-incubated with protein in 1:1 (w/w) ratio B. Amphipol A8-35 pre-
incubated with protein in 3:1 (w/w) ratio C. Amphipol A8-35 pre-incubated 
with protein in 1:1 (w/w) ratio D. Amphipol A8-35 pre-incubated with protein 
in 1:3 (w/w) ratio. In all of the cases protein concentration is ~1 mg/ml, grid 
Quantifoil R0.6/1, nominal microscope magnification 30000 X. 
 
From the size exclusion profile (Fig. 3.11) and cryo-EM micrographs (3.20.B-D) 
it was concluded that complex I in amphipol A8-35 breaks during sample 
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concentration or (more likely) during blotting. To test these hypotheses the 
sample was supplemented with a number of different additives just before 
application on the cryo-EM grid: CaCl2 (final concentration 10mM), glycerol 
(final concentration 2%), amphipol A8-35 (final concentration 0.05%), CHAPS 
(final concentration 0.05%), Triton X-100 (final concentration 0.05%), LMNG 
(final concentration 0.05%), Cymal-7 (final concentration 0.05%), octyl-
glucoside (final concentration 0.05%) and fluorinated octyl-maltoside (final 
concentration 0.05%) 
 
A 
 
B 
 
C 
 
D 
 
E 
 
F 
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Figure 3.21 Cryo-EM micrographs of Complex I in Amphipol A8-35 with 
different additives. A. 10mM CaCl2 B. 2% glycerol C. 0.05% Triton X-100 D. 
0.05% Chaps X-100 E. 0.05%LMNG F. 0.05% Cymal-7 G. 0.05% 
octylglucoside H. fluorinated octyl maltoside 0.2% I. Amphipol A8-35 
0.05%. In all of the cases protein concentration is ~1 mg/ml, grid Quantifoil 
R0.6/1, nominal microscope magnification 30000 X. 
 
The results indicated that the complex broke during the blotting procedure due 
to attraction of the protein particles to the air-water interphase (Glaeser et al., 
2016). Some detergents in close-to-CMC concentrations were able to decrease 
the surface tension resulting in increase of the number of intact complex I 
particles. Most promising results for complex I were obtained with Chaps 
detergent.  
Results obtained from grids containing complex I in Amphipol A8-35 
supplemented with CHAPS detergent were very promising. However, data 
obtained from complex I in Brij-35 were still better and more reproducible.  
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3.6 Oxido:reductase activity of sample used for data collection. 
 
DQ activity of complex I sample in Brij-35 was measured. The result is 
consistent with published studies (Okun, Zickermann, Zwicker, Schagger, & 
Brandt, 2000) and shows that polyoxyethylene-ether detergents act as specific 
inhibitors of complex I. In 0.1% Brij detergent (half the concentration used for 
grids preparation) complex I activity was completely inhibited similarly to 1μM 
piericidin A or rotenone (Letts, Degliesposti, et al., 2016). 
 
3.7 Data collection and processing  
 
Since the sample of ovine complex I in 0.2% Brij-35 detergent gave the most 
consistently cryo-EM grids of good quality, it was chosen for high-resolution 
data collection.  
 
3.7.1 Data collection 
Two datasets of ~2600 images total were collected in a total of ~72 hours. 
Micrographs were collected in standard FEI Falcon II system at a rate of 7Hz. 
Movie frames were recorded only for the first second of exposure. Frames from 
the second and third second were averaged to one frame per second. Thus, for 
each 3 s exposure 9 frames were collected. The data were collected at defocus 
ranging from ~2.3 to 3.4 μm. Even in micrographs recorded with low defocus 
(~2 μm) particles are clearly visible and S/N ratio did not limit particle picking.  
 
3.7.2 Data processing  
An average of ~100 complex I particles per image were picked automatically 
with RELION 1.4 using 3 s averaged micrographs. Contrast transfer functions 
(CTFs) were estimated using CTTFIND4 (Mindell and Grigorieff, 2003).On the 
basis of poor CTF models as well as visual inspection, bad micrographs were 
discarded. Low CTF figure of merit values consistently correlated with images 
blurred due to drift or ice contaminants. This resulted in the removal of ~7.5% of 
micrographs. For the remaining images, movie frames 1-7 (1 s) were whole-
image drift corrected with MOTIONCORR (Li et al., 2013) followed by extraction 
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of ~241k particles. Finally, the defocus value for each particle was estimated 
and locally refined with the program Gctf (Zhang, 2016).  
 
Figure 3.22. Typical micrograph obtained during automated data collection. 
Some representative complex I particles have been marked with black 
circles.  
 
The particles were extracted using 2962 pixel box and sorted by reference-free 
2D classification, resulting in ~171k particles selected from good 2D classes.  
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Figure 3.23 Examples of the 2D classes used for further processing.  
 
These were used for 3D classification with a regularization parameter T of 8 
and 30 Å low-pass filtered initial model from a previous low resolution model of 
the bovine enzyme (Vinothkumar et al., 2014). This resulted in ~130k particles 
of good quality, however, it was clear that the relative orientation between the 
two arms of the complex is slightly variable, producing 3D classes with either an 
“open” or “closed” angle between the arms (Fig. 3.24). A third class grouped 
mostly artefacts and broken particles yielding a low-resolution map with 
characteristic spurious density peaks. Particles in the “open” (~82k particles) 
and “closed” (~ 46k particles) conformations were selected for high-resolution 
map calculation (Fig.3.24).  
 
For all high-resolution refinements, particles were re-extracted from the motion 
corrected micrographs with a 5122 pixel box (to allow for high-resolution CTF 
correction (Rosenthal & Henderson, 2003)). After initial auto-refinement, 
particle-based beam-induced motion correction and radiation-damage 
weighting (particle polishing) was performed (Fig. 3.25) (Scheres, 2014). Final 
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refinement was also performed in RELION, in this process two random half-
datasets are refined independently in order to prevent the over fitting of noise. 
This allows so-called gold standard Fourier shell correlation (FSC) curves to be 
calculated such that a reliable estimate of overall map-resolution can be 
calculated (Scheres & Chen, 2012) (Fig.3.26). Finally, the two reconstructed 
maps were post-processed with a mask around the reconstructed volume to 
estimate the final resolution and to produce the final combined map. The map 
was then sharpened using a manually chosen negative B-factor (~100 Å2) 
(Rosenthal and Henderson, 2003). After masking, the gold-standard Fourier 
Shell Correlation (FSC) fell below the 0.143 threshold at a resolution of 3.9 Å 
for class “open” and 4.6 for class “closed” (Fig.3.24 and 3.26).  
 
 
Figure 3.24 Overview of 3D classification and refinement strategy. 
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Figure 3.25Radiation-damage weighting from the RELION particle 
polishing procedure A. Relative B-factors (Bf) B. Intercepts (Cf). 
 
This 3D class selection probably still allows for small variations in the 
conformation, therefore the local resolution varies within the maps, especially 
at the extremities of both arms. At the periphery of the molecule the resolution 
drops not only due to the usual decrease in the precision of particle alignments 
in these areas, but also due to differences in the protein conformation, greatest 
at the edges of the molecule. To overcome this limitation we performed 3D 
refinement focused on the peripheral and membrane domains of “open” class 
(since it gave the highest resolution) separately (with the subtraction of signal 
from the remaining parts of the complex (Bai et al., 2015)). This resulted in a 
3.9 Å map of the peripheral arm (PD), very well resolved in all areas, including 
the edges of the domain (Fig. S2). The membrane domain (MD) refined to 4.1 
Å, however, the map was more uniform and so better resolved for the distal 
part of the domain (near subunit ND5) as compared to the density from the 
refinement of the entire complex (Fig. 3.26 and S2).  
A 
B 
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Figure 3.26 Gold-standard (two halves of data refined independently) 
Fourier shell correlation (FSC) curves for the maps of the “open” complex 
I map (Complete Map) (resolution at FSC = 0.143 is 3.9 Å), membrane-
arm-focused refinement (4.1 Å resolution) and peripheral-arm-focused 
refinement (3.9 Å resolution). 
 
Higher quality refinement of the peripheral arm probably stems from the fact 
that high electron density of 8 FeS clusters helps in particle alignment. The 
least ordered part of the complex is the 42kDa subunit, loosely attached to the 
membrane domain. Extended 3D classification of the “open” class have been 
performed in order to identify the most homogeneous population, especially 
with respect to 42 kDa subunit. This class (64k particles) was refined to 4.0 Å, 
and the resulting density was used to model the 42 kDa subunit (Fig. 3.24 and 
S2). To assist with overall model building and refinement, several maps were 
carved around specific parts of the complex and combined into one map in 
UCSF Chimera (Pettersen et al., 2004): the peripheral arm from PD-focused 
refinement, the area around ND4/5 subunits (tip of the membrane domain) 
from the MD-focused refinement, the 42 kDa subunit density as above, and the 
rest of the complex from the overall 3.9 Å map for the “open” class (Fig. 3.27). 
The final model was refined against this combined map (Fig. 3.27).  
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Figure 3.27 A. The final “combined” map was produced by combining 
maps with the best local resolution features, i.e. for peripheral arm – PA 
focused refinement map (orange), for the distal part of membrane domain 
– MD focused refinement map (green), for 42 kDa subunit – map from the 
selected homogenous complex I class (64k particles; blue) and the rest of 
the complex from the best map of the entire complex (magenta).B. 
Example coils, α-helices and β-sheets from core and supernumerary 
subunits. Cryo-EM density is shown with the model represented as sticks 
and coloured by atom with carbon in grey, oxygen in red, nitrogen in blue 
and sulphur in yellow. Panel B modified from one prepared by Dr James 
Letts.  
 
The final map is of high quality, clearly showing large, medium and some small 
side-chains (Fig. 3.27 B). Carboxylates (Asp, Glu) have much lower density 
than other residues owing to early radiation damage, as observed previously 
(Allegretti, Mills, McMullan, Kuhlbrandt, & Vonck, 2014). Disulphide bridges also 
are subject to early damage, as in X-ray crystallography (Meents, Gutmann, 
Wagner, & Schulze-Briese, 2010). Map filtered to lower resolution is very similar 
A 
B 
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to the previous 5 Å resolution map for the bovine enzyme (Vinothkumar et al., 
2014), suggesting that the mammalian complex I structure is very well 
conserved. One difference is that in the ovine complex the accessory 4TM 
subunit B14.7 is disordered in the detergent used for microscopy samples (Brij-
35). It is likely to be disordered rather than detached as B14.7 was identified by 
mass-spectrometry in the sample used for EM (Table S2). For that reason the 
model for B14.7 subunit was build based on cryo-EM maps of ovine respiratory 
supercomplexes (Letts, Fiedorczuk, et al., 2016). In these maps all the subunits 
of complex I are well ordered, and so the final complex I model includes the 
poly-ALA structure of B14.7 based on 5.8 Å resolution map of the “tight” 
respirasome. Loss of B14.7 also results in the disorder of nearby C-terminal half 
of traverse helix HL and TM16 from ND5, as well as TM4 from ND6, which were 
also modelled as poly-ALA (designated as UNK residues in the model) based 
on the “tight” respirasome map. The density for the 42 kDa subunit is rather 
weak but this subunit clearly preserves the nucleoside kinase family fold, which 
allowed us to model most of it using Rosetta and visible large side-chains as a 
guide. 
 
3.7.3 Separation of different complex I conformations 
PD-focused, MD-focused maps significantly improved the quality of the protein 
density on the distal ends of complex I. This result also suggested that the 
initial 3D classification did not result in optimal separation of complex I 
conformations. Classes “open” and “closed” most likely contain particles that in 
fact belong to intermediate classes. In order to investigate this topic and obtain 
better separation of the particles the following approach was developed. 
Original classes “open” and “closed” were combined and 3D refined focusing 
on the peripheral domain (with the MD signal subtraction as previously (Bai et 
al., 2015)). Then the signal for the membrane domain was re-introduced and 
the particles were 3D classified masking only the membrane part of the protein 
without alignments. For best particles separation number of classes and 
regularization parameter tau (T) was empirically optimized to 10 and 20 
respectively. Since positions of individual particles were fixed, they preserved 
orientations assigned during PA focused refinement and were separated based 
on the position of the MD (Fig. 3.28). The described protocol allowed for much 
  83 
better separation of different complex I classes and resulted in five classes at 
final resolution varying between 4.0 - 4.5 Å. The highest resolution class of 4.0 
Å (class 3) is very similar to the original class “open”. The class most similar to 
class “closed” is class 1 of 4.5 Å resolution. In both cases the new classes 
have very similar resolution to the original “open” and “closed” classes however 
they have much less particles suggesting that they are much more 
homogenous (Table 4.1).  
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Figure 3.28 A. Overview of the improved 3D classification strategy and 
refinement strategy. B. Membrane domains of the five high resolution 
classes aligned to PA. Note that the membrane domain not only changes 
the position in wedge like movement (left) but also rotates (right). Five good 
classes were numbered 1 to 5 from most “closed” to most “open” class 
respectively (Chapter 4.2) 
  
A 
B 
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3.8 Cross - linking 
 
Subunits assignment is fully consistent with the cross-linking experiments 
performed by the collaborators Dr Gianluca Degliesposti (MRC-LMB 
Cambridge, UK) and Dr Mark Skehel (MRC-LMB Cambridge, UK) (Chapter 2.8) 
and analysed by Dr James Letts (Fiedorczuk et al., 2016). 
 
In total 218 unique cross-linked peptides were identified, of which 87 were 
between residues of different subunits (inter subunit), 73 were between 
residues within the same subunit (intra-subunit), and 58 were clear false 
positives (Table 3.8).  
 
Cross - 
linker 
Number of 
experiments 
Detergent 
Spacer 
length 
(Å) 
Approx. 
max 
length 
(Å) 
Total cross - 
links 
observed 
Inter-
subunit  
cross - links 
Intra-
subunit  
cross - links 
False 
positive 
cross - 
links 
False 
positive 
rate  
DSS 4 DDM 11.4 23.4 174 82 67 25 0.14 
DSS 2 LMNG 11.4 23.4 72 14 42 16 0.22 
DSS 2 LDAO/DDM 11.4 23.4 72 37 20 15 0.21 
BS3 1 DDM 11.4 23.4 25 10 10 5 0.20 
DSA 1 DDM 8.9 20.9 14 8 4 2 0.14 
SDH 1 DDM 13.5 25.4 28 19 5 4 0.14 
ADH 1 DDM 11.1 23.0 26 12 6 8 0.31 
   Total Observed 411 182 153 75 0.18 
   Total unique 218 87 73 58 0.27 
Table 3.8 Summary of cross-linking experiments 
 
False positives were identified by comparison to all known biochemical and 
structural information on complex I and the cross-links that are considered false 
positives are either between residues that are too distant from each other (>32 
Å after allowing for exposed side chain flexibility from their modelled position), 
located on opposite sides of the membrane or the reactive residues are buried 
and not solvent accessible in the intact structure. Many of the false positive 
cross-links are found on unstructured coils at the edges of the complex I 
structure, indicating that they likely result from transient interactions between 
different molecules of complex I during the reaction (inter-complex cross-links). 
True positive cross-links were more likely to be observed in more than one 
experiment. Some high-scoring cross-links were observed between disordered 
termini or loops of subunits that could not be modelled in our structure, hence 
the accurate determination of distance for these cross-links was not possible. 
Good quality cross-links were observed for all supernumerary subunits except 
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for B14.7, KFYI and AGGG. No cross-links were observed for any of the 
mitochondria encoded core subunits, which are buried in the membrane and 
coated with a layer of supernumerary subunits (Fig. 3.29).  
 
Figure 3.29 Inter-subunit cross-link schematic. Core subunits coloured in 
cyan, previously assigned supernumerary subunits in magenta, newly 
assigned or newly built regions of supernumerary subunits in green, poly-
alanine regions in orange and un-modelled regions in red. Observed cross-
links are indicated by dashed black lines between either blue circles (lysine 
reactive cross-links) or red circles (acid reactive cross-links). No cross-links 
were observed to the core subunits of the membrane arm and hence they 
were omitted for clarity. The horizontal black lines indicate the approximate 
boundaries of the inner mitochondrial membrane. Subunits B14.7, B15 and 
ASHI are shown as being behind the membrane boundaries as they are 
found on the opposite (far) side of the membrane arm. Figure prepared by 
Dr James Letts.  
 
3.9 Model building and refinement 
 
Structures of highly conserved core subunits were build based on T. 
thermophilus X-ray structure (R. Baradaran et al., 2013). Using SQWRL4 
software (Krivov et al., 2009) the bacterial model was modified to match ovine 
sequence. This model was manually adjusted and re-built to fit the experimental 
cryo-EM density using COOT (Emsley & Cowtan, 2004).  
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Positioning of accessory subunits was more challenging since in most cases 
their exact position was not known (Vinothkumar et al., 2014). In order to assign 
all supernumerary subunits unambiguously, data from mass spectrometric 
identification of chemically cross-linked peptides (XL-MS) was analysed 
(Chapter 3.8, Fig. 3.30, Table S8-9). These data in conjunction with the EM 
map allowed for correct positioning of all the subunits. Many of the previous 
assignments of supernumerary subunits were based on indirect biochemical 
data, secondary structure prediction and homology (B13, B15, B18, PDSW, 18 
kDa, 15 kDa, B14.5band B17.2(J. Zhu et al., 2015)(Letts, Fiedorczuk, et al., 
2016)), and thus, were tentative. Cross-links involving these subunits now 
provided experimental data confirming their positions. For example, single trans 
membrane domain (STMD) subunit B15 was tentatively assigned in the bovine 
structure to be associated with ND4 adjacent to helix HL based on its presence 
in subcomplex Iβ (containing core subunits ND4 and ND5) and the presence of 
comparable density in Y. lipolytica, which harbours a homologue of B15 
(NB5M)(J. Zhu et al., 2015). This assignment has now been experimentally 
verified by a cross-link between B15 and PDSW in the inter membrane space.  
 
The assignment of subunits PDSW and B18 to the helical density in the IMS 
has been confirmed by cross-links between PDSW, B15, ESSS and ASHI. The 
STMD subunit MNLL was identified by a cross-link to the B14.5b 
supernumerary subunit, containing two TMHs. MNLL binds to ND4 in the 
membrane near the interface with ND2. STMD subunits SGDH, B17, B12 and 
ASHI are known components of subcomplex Iβ (L A Sazanov & Walker, 2000) 
so are likely to surround ND4 and ND5. The assignment of the long helix in the 
IMS to SGDH is supported by cross-links to B14.5b, PGIV and the 15 kDa 
subunit. After the helix ends the C-terminus of SGDH extends along the IMS 
side of the complex as a coil interacting with the 15 kDa subunit and reaching to 
ND3 and ND6. The short N-terminal region of SGDH interacts with both ND4 
and ND5 in the matrix. Therefore, SGDH spans nearly the entire length of the 
membrane arm of complex I from ND3 to ND5 (Chapter 4.12).  
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STMD subunit B17 has been identified in an assembly intermediate that lacks 
ND4 and ND5 but contains the ND6, ND3, ND4L and ND2 core subunits 
instead (Lazarou, McKenzie, Ohtake, Thorburn, & Ryan, 2007). Our cross-
linking data unambiguously place B17 adjacent to core subunit ND5. The N-
terminus of B17 contains an α-helix in the matrix that cross-links to the adjacent 
α-helix of B22, which binds on the matrix side of ND5.  
 
Two cross-links between the N-terminus of B12 and SDAP-β place B12 at the 
tip of the membrane arm, adjacent to AGGG. Subunit ASHI has also been 
found in an assembly intermediate that lacks subunits ND4 and ND5(Vogel et 
al., 2007). Cross-links from the C-terminus of ASHI and the C-terminus of 
PDSW in the IMS place ASHI on the same side of the membrane arm as B15 
and B14.7, claiming the last remaining unassigned TM helix density on this side 
of complex I. ASHI has a large N-terminal globular domain, and cross-links are 
observed between this N-terminal domain of ASHI and B15 and ESSS in the 
matrix. The density in this region is sufficient only for a poly-alanine model for 
the N-terminal domain of ASHI. The TM helix is partially disordered but a partial 
atomic model was build for the C-terminal half of the helix interacting with ND5. 
The C-terminus of ASHI in the IMS forms an extended coil, which nearly wraps 
around the long C-terminal helix of B18.  
 
Previously there was ambiguity between the positions of B9 and MWFE, both 
STMD subunits known to associate with core subunit ND1. Cross-links between 
the N-terminus of PGIV and the C-terminus of MWFE and the N-terminus of 
TYKY and the N-terminus of B9 unambiguously place these subunits into the 
structure.  
 
The 10 kDa subunit is known from biochemical studies to be part of subcomplex 
Iλ, which contains only the hydrophilic arm of the complex (L A Sazanov & 
Walker, 2000)(Finel et al., 1994)and to be part of an assembly intermediate 
made up of the N-module (Lazarou et al., 2007). Cross-links between the 10 
kDa subunit and the 24 kDa and 51 kDa core subunits locate it to a cleft 
between those subunits. Supernumerary subunit B14.5a is also known to be a 
component of subcomplex Iλ(Hirst, Carroll, Fearnley, Shannon, & Walker, 
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2003)(L A Sazanov et al., 2000), but has not thus far been identified in any 
assembly intermediates. Cross-links of B14.5a with B17.2, B16.6, 75 kDa, 49 
kDa, 30 kDa and B13 across its entire length (from Lys22 to Lys101) 
unambiguously place it in extended density along the surface of the Q-module.  
 
In addition to these newly assigned subunits, the positions of large extensions 
to the previously assigned subunits were also identified by cross-linking. The C-
terminus of PGIV extends as a coil along the IMS side of the matrix arm until it 
reaches the cleft between ND2 and ND4. This C-terminal extension is 
confirmed by cross-links between the C-terminus of PGIV, B14.5b and SGDH 
(Fig. 3.30). The position of the long N-terminal coil of PDSW is confirmed by an 
intra-subunit cross-link between PDSW residues Lys6 and Lys126. The N-
terminus of B15 contains a long α-helix and its assignment is supported by a 
cross-link between the N-termini of B15 and adjacent ASHI. This B15 helix 
interacts with complex III in the supercomplex (Letts, Fiedorczuk, et al., 2016). 
 
Several rounds of re-building and refinement resulted in high quality model in 
terms of geometry (Molprobity score 2.6 (corresponding to average structure at 
2.6 Å resolution), very high EMringer score of 1.96 (model to map correctness 
validated by EMringer should result in scores above 1.0 for well-refined 
structures with maps in the 3 to 4Å range) (Barad et al., 2015) and fit to density 
(Table 3.9 and S3, Fig. 3.30). 
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Statistics of complex I structure determination 
Data collection  
EM Titan Krios 300kV, FEI Falcon II 
Pixel size (Å) 1.39 
Defocus range (μm) -0.5 to -3.5 
Reconstruction 
(RELION) 
Overall Membrane 
domain 
Peripheral Arm 42 kDa 
focused 
Accuracy of rotations 
(o) 
0.573 0.711 0.728 0.732 
Accuracy of 
translations (pixel) 
0.308 0.400 0.400 0.430 
Final resolution (Å) 3.9 4.1 3.9 4.0 
 
Model refinement 
(PHENIX) 
 
 
Complete model 
Resolution limit (Å) 3.9 
Residue number 9510 
Map CC (whole unit 
cell) 
0.758 
Map CC (around 
atoms) 
0.782 
rmsd (bonds) 0.009 
rmsd (angles) 1.54 
All-atom clash score 27.67 
Ramachandran plot  
Outliers (%) 1.07 
Allowed (%) 12.8 
Favored (%) 86.13 
Rotamer outliers (%) 0.09 
Molprobity score 2.50 
EMringer score 1.96 
Table 3.9Statistics of refinement 
 
Figure 3.30 FSC curve of the combined map vs. final model shows good 
agreement of the model with the map (FSC=0.5 at 4.0 Å resolution). FSC 
curve against the entire complex complete map, which was not used in 
refinement, is shown as a control 
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Chapter 4. Discussion 
 
 
 
4.1 Current knowledge on mammalian complex I structure. 
 
The structure described in this work was published nearly simultaneously with 
the lower resolution (~ 4.2 Å) work on bovine complex I structure (J. Zhu et al., 
2016). Our paper was submitted before the bovine work was published and so 
the identification and modelling of all supernumerary and core subunits in the 
structure was done by us independently. The bovine model has relatively low 
completeness (65% atomic for core subunits and 27% atomic for 
supernumerary subunits) due to lower resolution and so our model is the first 
nearly complete atomic model of mammalian complex I. 
 
Later in 2016, a cryo-EM structure of porcine respiratory supercomplex at ~4.0 
Å was reported, including an atomic model of complex I at 3.6 Å (Wu et al., 
2016). This publication suffers from several drawbacks. These include the 
implausible proposal for complex III mechanism, dispensing with the well 
established Q-cycle. The paper describing the same supercomplex at lower 
resolution was published just a couple of months before (Gu et al., 2016) and 
remarkably, most EM maps describing the intermediate states of processing are 
of the wrong hand (mirror image) in both papers. Furthermore, even though the 
Cell paper was submitted one month after the publication of our structure, it 
purports to present the first structure of mammalian complex I, describing as 
novel all the complex I features we reported previously. In the porcine model 
(PDB 5GUP) the B-factors are set to random values and not refined, the FeS 
clusters geometry and environment are incorrect, the FMN isoalloxazine ring is 
flipped, and the statistics of model refinement or model completeness were not 
reported. Porcine PDBs were released only recently, 4-6 months after 
publications (Gu et al. and Wu et al. respectively) and we had to urge authors to 
92 
release focused EM maps, on which the models were actually built. Otherwise 
the structural features are well consistent with our model (backbone RMSD 
between ovine and porcine models for many subunits is only about 1 Å), 
showing the high degree of conservation of mammalian complex I structure. 
Despite higher overall resolution, there are no additional features observed in 
porcine structure, which were not reported for ovine enzyme (therefore the 
ovine structure remains the most complete fully refined model of mammalian 
complex I to date). 
 
4.2 Model description 
 
The structure of the 970 kDa complex comprises 45 different subunits, with a 
total of 78 transmembrane helices and a number of co-factors: FMN, NADPH, 
zinc and 8 iron–sulphur clusters. The core 14 subunits show conserved folds 
similar to bacterial homologues (L. A. Sazanov, 2015).  
 
The ubiquinone chamber, like in the bacterial enzyme (R. Baradaran et al., 
2013), is linked to the proton pumping modules by a central axis of charged 
residues suggesting a similar coupling mechanism. The structure shows that all 
the supernumerary subunits form a shell around the core and so probably 
mostly play a stabilizing role. Some of them, especially those containing 
additional co-factors (39 kDa, SDAPs, B14, B22 and 13 kDa) and 
phosphorylated residues (42 kDa, ESSS, MWFE, B14.5a, B14.5b and B16.6), 
may provide regulatory links to the redox status of the cell, lipid biosynthesis 
and mitochondrial homeostasis. Twelve identified bound lipid molecules likely 
stabilise interfaces between membrane subunits.  
 
Intensive particles sorting and classification enabled distinguishing of five 
classes which differ by the relative position of complex I arms and accessibility 
of the ubiquinone binding site. In the most “open” classes it is blocked, 
suggesting the de-active state of the enzyme (Chapter 4.3) (Zickermann et al., 
2015)(Fiedorczuk et al., 2016). However a subset of particles shows accessible, 
likely active conformations (Chapter 4.2) as in bovine (J. Zhu et al., 2016) and 
later porcine models (Wu et al., 2016). 
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The atomic model discussed in this chapter was build based on the so-called 
Combined Map (Chapter 3.6.2) (Fiedorczuk et al., 2016).  
 
4.2.1 Core subunits 
The architecture of the seven core subunits in the peripheral arm in O. aries is 
very similar to T. thermophilus complex used as an initial reference during 
model building (R. Baradaran et al., 2013). There are small relative shifts and 
rotations but the overall rigid body structure of the mitochondrial enzyme mirrors 
bacterial complex I.  
 
Figure 4.1. Structure depicted as a cartoon, with core subunits coloured and 
labelled, and supernumerary subunits in grey and transparent.  
 
Core peripheral arm subunits  
The peripheral arm of complex I (PA) can be divided into two functional 
modules: the N module responsible for NADH binding and transfer of electrons 
to the Q site and the Q module accommodating ubiquinone and triggering the 
coupling mechanism leading to proton translocation (in the P module). 
The core of the N module consists of three conserved subunits (Fig. 4.2.A): 
 51 kDa subunit (harbouring the FMN, the [4Fe-4S] cluster N3)  
 24 kDa subunit (harbouring the [2Fe-2S] cluster N1a)  
 75 kDa subunit (harbouring the [2Fe-2S] cluster N1b and the [4Fe-4S] 
clusters N4 and N5)  
The core of the Q module comprises four conserved proteins (Fig. 4.2.A):  
 TYKY subunit (harbouring the [4Fe-4S] clusters N6a and N6b)  
 PSST subunit (harbouring the [4Fe-4S] cluster N2)  
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 30 kDa subunit (the only of the core subunits not binding ligands or co-
factors) 
 49 kDa subunit (building the reduction site for ubiquinone) 
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Figure 4.2 A. Structure of PA core subunits depicted as a cartoon coloured 
and labelled. Co-factors and quinone depicted as spheres. Q modelled 
based on T. thermophilus structure. B. Fe–S clusters are shown as spheres 
with centre-to-centre and edge-to-edge (in brackets) distances indicated in 
Å, overlaid with transparent grey depictions from T. thermophilus. Both 
traditional and structure-based (in brackets) nomenclature for clusters is 
shown. C. 75 kDa subunit (pink) overlay with T. thermophilus analogue 
(rainbow). FeS clusters co-ordinated by 75 kDa and termini of bacterial 
analogue labelled. D. NADH-binding site (overlay with T. thermophilus 
structure in grey, containing NADH). Cryo-EM density for flavin 
mononucleotide (FMN) is shown in blue. Key residues involved in 
interactions with FMN and NADH are shown as sticks. NADH modelled 
based on T. thermophilus reduced complex I structure (PDB 3IAM).  
 
The core subunits of the mammalian and bacterial complex I vary mostly by the 
N and C terminal extensions. Compared to T. thermophilus, the biggest 
difference is folding of the C-terminus of the 75 kDa subunit (Fig. 4.2.C). 
Instead of a terminal β-barrel (T. thermophilus), the ovine molecule has two 
short α-helices separated by a roughly 30 amino acids loop. Extensions and 
A B 
C D 
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loops in TYKY, PSST and 30 kDa subunits are adjusted to better interact with 
supernumerary subunits. The N-terminal extension of the 49 kDa subunit 
(missing in T. thermophilus) is running along the membrane domain interacting 
extensively with the proton pumping module. This part is poorly resolved in the 
ovine model but is clearly visible in the bovine and porcine models (Chapter 
Comparison of the recent complex I structures) (J. Zhu et al., 2016).  
 
The chain of the mitochondrial electron transfer starts from harvesting of two 
electrons from NADH (Fig. 4.2.B, 4.2.A) (L. A. Sazanov & Hinchliffe, 2006). The 
electron donor is oxidized at the FMN site at the 51 kDa subunit. Electrons are 
transferred along the FeS chain to the terminal N2 cluster and eventually to 
ubiquinone. All edge-to-edge distances in the redox chain are up to 14 Å, which 
is a maximal distance for electron transfer within physiological time scales (Fig. 
4.2.B) (Page et al., 1999). Iron sulphur clusters are commonly regarded to be 
“stepping stones” for the electrons on the way from NADH to quinone. Most of 
them are co-ordinated by four cysteines in tetrahedral or planar geometry. 
However some clusters have a different environment, suggesting that they may 
have more prominent functions.  
 
The N5 cluster is coordinated by 3 cysteines and one conserved histidine. It is 
separated by 13.6 Å from the next N6a cluster (the longest distance in the 
chain) and has a very low potential (Bridges, Bill, & Hirst, 2012). For that reason 
it is regarded to be a bottleneck on the path and can be considered as a control 
point for the overall rate of transferred electrons (L. A. Sazanov, 2015). The 
environment of the N5 cluster is composed of many polar and chargeable 
residues. Some of them like Asp10475-kDa directly interact with the 
supernumerary 13 kDa subunit, the only complex I subunit binding metal ion, 
Zn2+andproposed to be a redox sensor of the system (Fiedorczuk et al., 2016). 
 
Another uniquely coordinated cluster is the terminal [4Fe-4S] N2 cluster. It is 
the last in the line and donates electrons to quinone (Fig. 4.2.B). It is 
coordinated by two conserved consecutive cysteines (54PSST and 55PSST), 
leading to strained geometry. The resulting flexibility of those cysteines may 
help link the conformation of neighbouring protein chains and redox potential of 
  97 
the cluster. In T. thermophilus helices connected to this cluster shift upon 
cluster reduction (Berrisford & Sazanov, 2009)which may suggest catalytically 
driven conformation change in this area. Arg8549-kDa, which undergoes rare 
symmetrical dimethylation (Carroll, Ding, Fearnley, & Walker, 2013), is in direct 
contact with the N2 cluster and is adding some hydrophobicity to the cluster’s 
surrounding, probably also affecting its redox potential.  
 
Function of the N1a cluster is not entirely understood. It is placed off the main 
electron transfer path but in a distance that enables electron transfer. It plays a 
structural role stabilizing the 24 kDa subunit (Birrell et al., 2013). However it 
may also assist in regulation of reactive oxygen species production at the flavin 
site (Chapter 1.4.3) (Esterhazy, King, Yakovlev, & Hirst, 2008)(L. A. Sazanov & 
Hinchliffe, 2006) (P. Holt et al., unpublished).  
 
One of the most interesting features of the Q site of the ovine model is the 
conformation of theβ1-β249-kDa loop. It is positioned in a way that disables 
ubiquinone access close enough to the N2 cluster to be reduced. The head 
group of the molecule can get only as close as 20Å, a distance too far to accept 
electrons. This conformation of the β1-β249-kDa loop is very similar to the one 
described in the Y. lipolytica crystal structure (Fig. 4.3.A) (Zickermann et al., 
2015). It has been proposed that this conformation reflects the de-active state 
of the enzyme. The recently published cryo-EM structures of the bovine and 
porcine complex I present states of the enzyme where the β1-β249-kDa loop is 
retracted, enabling reduction of Q. This conformation is consistent with the 
crystal structure of T. thermophilus (R. Baradaran et al., 2013) and was 
proposed to represent the active form of the enzyme (Fig. 4.3.A). However, one 
of the low-resolution classes obtained after extensive re-classification of 
particles used in the ovine study (Chapter 3.6.3) also shows such a state of the 
enzyme. Based on this finding it can be assumed that the sample used for the 
cryo-EM studies of the complex contained particles in the de-active and active 
conformation in uneven proportion (Fig 3.27). Alternatively, it is possible that 
different observed conformations reflect intermediate steps in the catalytic cycle 
(randomly driven by thermal energy before the protein is snap-frozen). In this 
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case the movement of the β1-β249-kDa loop into the cavity may help to eject 
reduced ubiquinol into the membrane upon the completion of the catalytic cycle. 
 
The Q cavity is mainly created by four loops: β1-β249-kDa, TMH5-6ND1, TMH1-
2ND3 and α2-β2PSST. Except for several hydrophobic amino acids in β1-β249-kDa 
the cavity is mostly covered with polar residues (Fig. 4.3.B).  
In the ovine structure we can see that Arg77 at a very long loop α2-β2PSST is 
partially blocking the Q tunnel; interestingly this arginine undergoes a very rare 
hydroxylation modification (Carroll et al., 2013). The exact role of this amino 
acid is not well understood.  
 
 
Figure 4.3 Quinone-binding site. A. Key β1–β249-kDa loop (magenta) 
deviates from bacterial structure (grey) and is more similar to Y. lipolytica 
(orange), clashing with the decyl-ubiquinone (Q) head group position in T. 
thermophilus B. Environment surrounding the Q cavity (brown surface, 
entrance point indicated by an arrow), with some of the functionally 
important residues shown as sticks and labelled subunit names in brackets.  
  
A B 
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Core membrane domain subunits 
Seven core subunits encoded by mitochondrial DNA are embedded in the inner 
mitochondrial membrane (L. A. Sazanov, 2015): 
 ND1 subunit (composing quinone binding site, the first proton 
translocation site and involved in coupling between the Q and P 
modules) 
 ND3 subunit (composing the first proton translocation site and involved in 
coupling between the Q and P modules) 
 ND4L subunit (composing the first proton translocation site and involved 
in coupling between the Q and P modules) 
 ND6 subunit (composing the first proton translocation site and involved in 
coupling between the Q and P modules) 
 ND2 subunit (composing the second proton translocation site) 
 ND4 subunit (composing the third proton translocation site) 
 ND5 subunit (composing the fourth proton translocation site) 
 
 
Figure 4.4Structure of MA core subunits depicted as a cartoon, coloured 
and labelled. Note that the Q reduction site is over 10Å above the 
membrane level and entry site in ND1 subunit. The long chain ubiquinone 
modelled based on the T. thermophilus structure is shown in grey. 
 
Most of the membrane arm comprises of three homologous anitiporter-like 
subunits: ND2, ND4 and ND5. Each is build of 14 trans membrane helices 
(TMH), except of the ND2 subunit, which in metazoa lost first three TM helices. 
In spite of that, for clarity reasons, I will refer to it as 14 TM helices protein so 
numbering of ND2 helices follows 14 helices system and is consistent with ND4 
and ND5. The cavity that arose as a result of deletion of 1-3 TMH of ND2 has 
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not been filled by any supernumerary subunits (Fiedorczuk et al., 2016), neither 
evolved to interact with other respirasome complexes (Letts, Fiedorczuk, et al., 
2016). It is densely covered with specifically bound lipids molecules, including 
cardiolipin, which help to stabilize this site.  
 
Distal ND5 subunit contains a long amphipathic lateral helix spanning ND4 and 
ND2 subunits and ends with TMH 16, locked in between ND2, ND4L and B14.7 
subunits. This amphipathic lateral helix most likely does not play catalytic role 
(Chapter 1.4.3) (R. Baradaran et al., 2013)(G. Belevich et al., 2011) but acts as 
a scaffold stabilizing the trans membrane part of the complex from the matrix 
side. All three anitporter-like subunits are responsible for proton pumping 
across the inner mitochondrial membrane. Structure of this part of the protein is 
consistent with bacterial models. It confirms that the H+ pumping machinery is 
very conserved. Each of the antiporter-like subunits contain symmetry related 
two half-channels composed by TMH 4-9 and TMH 9-13. They are open 
respectively to the matrix and IMS, and are connected in the middle of the 
membrane by conserved charged residues, which enable proton translocation 
(Efremov & Sazanov, 2011). This architecture of MD indicates that each 
antiporter-like subunit translocates one proton per catalytic cycle (total three). 
One more proton is likely transferred by the so-called E channel (R. Baradaran 
et al., 2013) with a similar architecture of two half-channels. It comprises ND3, 
ND4L and ND6 subunits contributing to the IMS half-channel and TMH 2-6 of 
ND1 forming the matrix side half-channel (Fig. 4.4). That gives a total number of 
four channels, each translocating one proton per one molecule of NADH 
oxidised.  
 
The half channels are connected through protonatable residues in the middle of 
the membrane (L. A. Sazanov, 2015): Lys in TMH7 that belongs to the matrix 
half channel, Lys or His from TM8 that connect both half channels and Lys or 
Glu from TMH12 of IMS half-channel. Additionally, transport may be facilitated 
by conserved glutamic acids in TMH5. They are positioned in a way that 
enables interactions (affect pKa’s) with Lys of TM7 and Lys/Glu of TMH12 from 
the neighbouring subunit. This feature is present in bacteria as well.  
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In the E channel possible analogues of Lys TMH7 and Glu TMH5 from ND2, 
ND4 and ND5 are respectively Glu192 and Glu143 of ND1 (Fig. 4.5). The 
antiporter role of TM12 is most likely fulfilled by TMH3 of ND6. Essential Tyr60 
of ND6 and Glu34 of ND4L are placed in close proximity and also maybe 
involved in proton translocation or coupling mechanism. Those key residues are 
all included into a conserved continuous axis of charged and polar amino acids 
that extends from the Q site to the end of the membrane domain (Fig. 4.5).  
 
It has been recently suggested that additional input channels for protons from 
the matrix may exist (L. A. Sazanov, 2015). Protonation of the central axis could 
happen through conserved Glu of TMH5 and along central axis of TM8 in the 
input channels of ND2, ND4 and ND5 pumping modules (Fig. 4.5).  
 
Preserved from bacteria are also π–bulge like distortions in the TMH of the 
membrane domain (R. Baradaran et al., 2013). They are present at TMH3 of 
ND6 and TM helices 8 of ND2, ND4, and ND5. Distortions are formed at glycine 
pairs 62-63 and 239-240 in ND6 and ND4 respectively, serine pair 249-250 in 
ND5 and tryptophan 167 flanked by two glycine pairs in ND2.  
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Figure 4.5. Structure of the core subunits of ovine complex I, coloured as in 
Fig. 1b, with polar residues in proton channels shown as sticks, with carbon 
in blue, orange and green for input, connecting and output parts, 
respectively. Key residues, Glu (TM5), Lys (TM7), Lys/His (TM8) and 
Lys/Glu (TM12) from the antiporters and the corresponding residues in the 
E-channel (near Q site), are shown as small spheres and labelled. These 
residues sit on flexible loops in discontinuous transmembrane helices 
shown as cylinders. Polar residues linking the E-channel to the Q cavity 
(brown) are shown in magenta. Tyr10849-kDa and His5949-kDa are shown in 
cyan near the position of bound Q in bacteria. Possible proton translocation 
pathways are indicated by blue arrows. 
 
It has been reported that conserved cysteine 39 in TMH1-2ND3 loop becomes 
accessible to chemical modifications only in the D state (de-active) of the 
enzyme (A. Galkin et al., 2008). This indicates that Cys39ND3 or even the whole 
loop is important for the active/de-active state transition. It is difficult to judge if 
Cys39 is available for any modifications in our model because this residue is 
partially covered by the poly-alanine chain of ND6 built at low resolution. 
However, the comparison of the model with other mitochondrial complex I 
structures indicates a big displacement of the loop correlated with the 
movement of PA (Fig. 4.28). 
 
4.2.2 Supernumerary subunits 
 
Supernumerary (also called accessory) subunits are crucial to the structure, 
stability and assembly of mitochondrial complex I. Although they are not directly 
involved in catalytic turnover of the enzyme, they are proposed to play 
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regulatory and redox sensing roles (Fiedorczuk et al., 2016). Accessory 
subunits are solely encoded by the nuclear genome, translated in the cytoplasm 
and imported into mitochondria. The number and composition of accessory 
subunits varies across the phylogenetic tree (Gabaldon et al., 2005). The 
general rule is that their number grows throughout evolutionary time, from none 
in bacteria to 30 unique proteins in mammals. Most supernumerary subunits in 
complex I associate with either matrix or membrane domain. The exception is 
B16.6 that mostly binds to the MD but also has a long N-terminal extension 
interacting with the PA. In the previously published maps (Vinothkumar et al., 
2014)(Zickermann et al., 2015), supernumerary subunits were impossible to 
assign due to low resolution. The 3.9Å ovine map enabled assignment of all of 
the subunits, additionally confirmed by extensive cross-linking experiments 
(Chapter 3.8) (Fiedorczuk et al., 2016). Based on the location we can divide the 
supernumerary subunits into three groups (Fig. 4.6): 
 Subunits associated with the peripheral domain (10 kDa, 13 kDa, 18 
kDa, 39 kDa, B8, B13, B14, B14.5a, B17.2, SDAP-α) 
 Subunits associated with the membrane domain (42 kDa, 15 kDa, B18, 
B22, PDSW, PGIV, SDAP-β) 
 Subunits associated with the membrane domain containing trans 
membrane motifs (B9, B12, B14.5b, B15, B16.6, B17, AGGG, ASHI, 
ESSS, KFYI, MNLL, MWFE, SGHD) 
104 
 
 
Figure 4.6A.Cryo-EM density coloured by subunit, with core subunits in 
grey (left–right view)B. Structure depicted with core subunits in grey and 
supernumerary subunits coloured and labelled (left–right, IMS–matrix 
views). Amphipathic helices at the ‘heel’ of the complex, probably attached 
to the lipid bilayer, are indicated as AH. 
 
Supernumerary subunits associated with the peripheral domain  
B17.2 and B14.5a (together with TM B16.6 subunit) subunits stabilize the 
PA/MD interface. They contain N-terminal amphipathic α-helices bound at the 
surface of the membrane (Fig. 4.6.B and 4.7-8). The N-terminus of B17.2 is 
formed by two short perpendicular α-helices partially buried in the matrix side of 
the IMM, very close to the ND1 and PSST core subunits at the “back” of 
complex I. The α-helices are followed by a coil that at the level of the PSST 
subunit that becomes a three-strand β-sheet, almost parallel to the membrane 
A 
B 
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plane. From that point the protein snakes through the groove between the 39 
kDa and TYKY subunits, and underneath the 13 kDa subunits up to 75 kDa 
subunit. Thus it connects the mitochondrial membrane, Q and N- modules (Fig. 
4.7 and 4.8). The B17.2 subunit is incorporated into complex I at a very late 
stage of maturation (Chapter 1.4.2). It associates in the localization previously 
occupied by a homologous assembly factor B17.2L (Lazarou et al., 2007). Upon 
addition of the N module B17.2L leaves the complex, B17.2 subunit binds and 
13 kDa (already bound to N module) wraps on top of the B17.2 C-terminal coil 
(Chapter 1.4.2).  
 
Figure 4.7 Back view of complex I. The surfaces of the B17.2 and B14.5a 
subunits are shown. AH indicates position of the amphipathic C-termini of 
the proteins. 
 
The B14.5a subunit just like B17.2 bridges the surface of IMM, Q and N 
modules. It starts with a short amphipathic α-helix on the N-terminus (Fig. 
4.6.B). Then it winds between the PSST and 49 kDa subunits up to the N 
module where it turns in the direction of SDAP-α subunit. At the level of B13 the 
density for B14.5a disappears because residues 71-89 form a flexible loop. The 
C-terminus of the protein runs down the Q module between the B13, 30 kDa 
AHs 
49 kDa 
106 
and 49 kDa subunits, to finish not far from where the N-terminal α-helix is 
localized. Thus B14.5a subunit wraps around the whole Q module from the 49 
kDa solvent exposed site (Fig. 4.7).  
The space between amphipathic α-helices of B17.2, B14.5b and PSST is 
accommodated by a cardiolipin molecule that probably helps to stabilize this 
region (Fig. 4.23). 
 
 
Figure 4.8Side view of complex I. The surface of the 39 kDa subunit is 
shown. Notice the position of the B17.2 subunit. Top left panel shows the 
NADPH binding site with the interacting residues. NAPH is shown with 
experimental cryo-EM density carved to within 5 Å. 
 
The 39 kDa subunit is presumably involved in securing the right position of PA 
over the lipid bilayer and in sensing the redox state of the environment 
(Fiedorczuk et al., 2016). It belongs to the short-chain 
dehydrogenase/reductase family (Fearnley & Walker, 1992) although it has 
been shown not to display any catalytic activity (Abdrakhmanova, Zwicker, 
Kerscher, Zickermann, & Brandt, 2006). The protein binds close to the junction 
between MD and PA, interacting with the PSST and TYKY subunits (Fig. 4.8). It 
can possibly provide a support to PA through a hydrophobic loop (amino acids 
AH 
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187-19439-kDa) localized very close to the membrane. In the native environment 
that part may interact with the membrane surface. The α/β short-chain 
dehydrogenase/reductase motif of the protein contains an NADP(H)-binding 
Rossmann fold with a parallel seven-strand β-sheet accommodating a NADP(H) 
molecule. The co-factor plays a structural and stabilizing role but is not likely to 
be redox-functional since the nicotinamide ring of the molecule is 45Å away 
from the nearest FeS cluster. The NADP(H) molecule is trapped in between the 
central seven-strand β-sheet and a short peripheral α-helix, thus is absolutely 
crucial for the protein integrity. The co-factor is also coordinated by an 
Arg178PSST linked to PSST helix that interacts with the N2 cluster and 
undergoes conformational change upon its reduction (Berrisford & Sazanov, 
2009). It is possible that such architecture allows the complex to “sense” the 
redox state of the matrix through NADPH/NADP+ ratio and communicate the 
information to N2 cluster. The 39 kDa subunit also interacts with the N-terminal 
α-helix of the 13 kDa subunit, another subunit proposed to be a redox sensor.  
 
Figure 4.9Back/side view of complex I. The surface of the 13 kDa subunit 
is shown. Right panel shows the zinc-binding site with the interacting 
residues. The closest FeS clusters to the metal binding site are N5 and N6a 
are labelled. Zinc is shown with experimental cryo-EM density carved to 
within 5 Å. 
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At the N-terminus the 13 kDa subunit binds to the B17.2 subunit and forms an 
exposed coil running to the 75 kDa subunit linking the Q and N modules. At the 
C-terminus the protein forms two beta-sheets coordinating a Zn2+ ion through 
four conserved residues: three cysteines and a histidine (Fig. 4.9). The metal 
ion is 13.4Å away from the N6a cluster and 15.3Å from the N5 cluster. It is not 
likely that Zn2+ takes part in electron transfer. Although it is in the appropriate 
distance, it has been shown to be redox inactive (Oteiza, 2012). The Zn2+ is 
likely to play a structural role, although some influence on the N5 and N6a 
clusters cannot be ruled out. It has been shown that loss of the13 kDa 
homologue in Y. lipolytica results in loss of EPR signal for the N6a cluster, 
destabilization of the N5 cluster and loss of the B17.2 subunit homologue 
(Kmita et al., 2015). As discussed above the 13 kDa subunit clamps on top of 
B17.2 and extensively interacts with TYKY, stabilizing both. Its absence would 
cause disassociation of the B17.2 subunit and exposure of the N6a cluster to 
the solvent. Zinc-binding proteins are known to often be redox state sensors 
(Maret, 2005) and conserved Tyr8613-kDa of the zinc-binding domain interacts 
with the residues coordinating the N5 cluster, so any changes at the metal 
binding site of the 13 kDa subunit may directly influence the cluster. 
Additionally, the13 kDa subunit interacts with the NADPH-binding 39 kDa 
subunit, another possible sensor for the redox state of the mitochondrial matrix. 
The unusual coordination, environment and interacting partners of the N5 
cluster perhaps enable it to “sense” the redox state of the whole system or 
downstream clusters and adjust the electron flow. 
 
The B13 subunit forms a three-helix bundle placed on the 30 kDa subunit with 
an extended C-terminal coil anchored on the interface of the 30 kDa, 49 kDa 
and 18 kDa subunits (Fig. 4.10). It does not seem to play any clear structure-
stabilizing role like the B17.2 or 13 kDa subunits. On the other hand in the 
“closed” complex I map it comes very close to 42 kDa subunit and thus may 
help stabilise this state. It has been also implicated previously in the A/D 
transition (Ushakova, Duarte, Vinogradov, & Videira, 2005).  
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Figure 4.10 Matrix side view of complex I. The surface of the B13 and 18 
kDa subunit is shown.  
 
On the opposite side of the 42 kDa subunit, also bound to the 30 kDa subunit, 
an ACP (acyl carrier protein)/LYR (leucine-tyrosine-arginine motif family) 
couple, the dimer of SDAP-α and B14 subunits, is located. It forms a large sub-
domain placed between the 42 kDa and 39 kDa subunits (Fig. 4.11). There are 
two copies of ACP in mammalian complex I, SDAP-α and -β. Both interact with 
LYR family proteins: B14 and B22 respectively. Although it is not clear if SDAP 
proteins have any catalytic activity when incorporated into complex I, they 
definitely play a stabilizing role. In general ACPs are involved in fatty acid 
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production (Byers & Gong, 2007). They work as shuttles, transporting growing 
acyl chain between different enzymes. The chain is attached to a 
phosphopantetheine moiety covalently bound to Ser44. During the transport, 
the acyl chain is hidden in a hydrophobic cavity of the three ACP α-helices. 
Upon interaction with a fatty acid synthesis enzyme, the chain “flips out” and is 
accommodated into the cognate enzyme active site. The map clearly displays 
the density for phosphopantetheine in the “flipped out” position for both 
ACP/LYR pairs. Additionally for SDAP-α we see a 12-carbon long extension 
carried by phosphopantetheine predicted by mass-spectroscopy experiments 
(Carroll et al., 2005). 
 
The B14 subunit has a similar fold to the B13 subunit, a three α-helix bundle 
and extended C-terminal coil docking it between the 39 kDa, 75 kDa and 18 
kDa subunits (Fig. 4.11). The N-terminal bundle interacts with the TMH1-2ND3 
loop shown to change conformation upon A/D transition (Babot & Galkin, 2013). 
This fact together with the presented structure explains why deletion of the B14 
subunit yields fully assembled (of course lacking also the SDAP-α subunit) but 
inactive complex (Angerer et al., 2014). It is tempting to speculate that since the 
acyl chain is required for the coupling of the ACP/LYR pair, in this way the 
OXPHOS system in mitochondria may be linked to the production of lipids. 
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Figure 4.11Matrix/side view of complex I. The surface of the SDAP-α and 
B14 subunits is shown with PNS shown as spheres. Left-top panel shows 
PNS in SDAP-α site with the experimental density for the co-factor. PNS is 
shown with experimental cryo-EM density carved to within 5 Å. Notice that 
the angle of the panel differs slightly to better show the acyl chain.  
 
The 18 kDa subunit is also interacting extensively with other subunits and 
improving integrity and stability of the enzyme. It has two long coils on the N- 
and C-termini, wrapping around the B14 subunit and binding between the75 
kDa, 51 kDa and 24 kDa subunits respectively (Fig. 4.10). The central part of 
the protein contains a four-stranded β-sheet, buried deeply in a cleft between 
the 49 kDa, 75 kDa and 30 kDa subunits. Additionally, a long β2-β3 loop runs 
under the 75 kDa subunit to the TYKY and 39 kDa subunits. That explains why 
patients with certain mutations in the 18 kDa subunit accumulate late stage 
complex I subassemblies lacking the N-module (Chapter 4.4.3) (Lazarou et al., 
2007).  
 
B8 is a small protein with a thioredoxin fold (Brockmann et al., 2004), which 
binds to the C-terminal domain of the75 kDa subunit (Fig. 4.12). It is the only 
matrix subunit that contains two conserved cysteines positioned accurately for 
disulphide bond creation (Cys23 and Cys57), although the reducing 
environment of the mitochondrial matrix likely prevents the residues from 
forming a bridge. Intriguingly, patients suffering Parkinson’s disease lose the B8 
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subunit from complex I (Keeney, Xie, Capaldi, & Bennett, 2006). That can be 
correlated with accumulation of oxidative damage to the enzyme in Parkinson’s 
patients and possibly indicate the role of B8 subunit as another redox sensor.  
 
The last supernumerary subunit attached to the peripheral domain of complex I 
is the 10 kDa subunit, located on the very top of the peripheral domain (Fig. 
4.12). It has a long coiled structure that snakes through the groove between the 
24 kDa and 51 kDa subunits. In our model we were able to build only the C-
terminal half of the protein. It starts from the tip of the N module and ends at the 
75 kDa subunit. The remaining part of the peptide is disordered. Most likely, like 
other coiled subunits it stabilizes this region. It has been reported that the 10 
kDa subunit in complex I from rat’s tissues can be present in two isoforms: short 
or long (Bridges, Mohammed, Harbour, & Hirst, 2017). Mass spectrometry data 
revealed the presence of only the short form in the ovine cryo-EM sample 
(Fiedorczuk et al., 2016). 
 
 
Figure 4.12Side view of the complex I N-module. The surfaces of the B8 
and 10 kDa subunits are shown.  
 
Subunits associated with the membrane domain 
Soluble proteins that associate with mitochondrial complex I are located on both 
sides of the membrane. On the matrix side the 42 kDa, B22 and SDAP-β 
subunits form proximal and distal bulges visible even in very low-resolution 
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maps or 2D classes (Chapter 3.6.2 and Fig. 1.15). In the inter membrane space 
15 kDa, B18, PDSW and PGIV subunits stabilize the complex.  
Matrix side  
On the matrix side close to the tip of the MD another ACP/LYR protein pair 
(SDAP-β/B22) together with the N-terminal domains of the B15, ASHI, B12, 
AGGG, B17 and SGDH form the distal bulge of the TM arm. The whole 
structure is formed from highly intertwined protein chains and the PNS ligand 
(Fig. 4.13). The SDAP-β/B22 pair is the main element of this structure and it 
extensively interacts with the ND5 subunit around proton entry sites (Fig. 4.14). 
Thus it may influence the pumping activity of the module. 
 
 
Figure 4.13Side view of complex I. The surface of the SGDH, B17, AGGG, 
B12, SDAP-α, B22, B15 and ASHI subunits composing the distal bulge on 
the matrix side of complex I is presented.  
 
The B22 subunit (like the B14 subunit) belongs to the LYR family. Based on our 
results it is possible to understand the importance of the LYR motif for 
heterodimer formation. Leucine (residue 34 in B14 and 18 in B22) helps to form 
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a hydrophobic pocket accommodating the PNS-acyl chain, tyrosine (35 in B14 
and 19 in B22) is responsible for stabilizing the alpha-helices forming the cavity 
and interacting with ACPs, finally arginine (36 in B14 and 20 in B22) forms a 
salt bridge with conserved Asp64 of the SDAP subunit. Previously, it was 
expected that the interaction between ACP and LYR proteins in complex I is 
formed solely by the phosphate of the PNS and arginine of the LYR motif 
(Angerer, 2015).  
 
 
 
Figure 4.14Matrix/side view of complex I. The surface of the B22 and 
SDAP-β subunits composing the distal bulge on the matrix side of complex 
I is presented. Top-right panel shows PNS in SDAP-β site with the 
experimental density for the co-factor. The co-factor is shown with cryo-EM 
density carved to within 5 Å. 
 
The more proximal bulge on the membrane arm of complex I is the42 kDa 
subunit. It belongs to a nucleoside kinase family and presents a characteristic 
globular fold (Johansson et al., 2001). It has a central alpha/beta nucleoside 
kinase fold with a parallel five-strand beta-sheet. It resides on the ND2 subunit 
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docked by three extensions, very close to PA (Fig. 4.15). It is stabilized by the 
B14.5b and KFYI of the TM supernumerary subunits and possibly the B13 and 
SDAP-α/B14 pair attached to the PA via the 30 kDa subunit. In the “closed” 
class map B13 and SDAP-α/B14 dimer come to within 3Å from 42 kDa subunit 
which enables direct interaction and possibly regulation of PA hinge-like 
movement. Any catalytic function of the 42 kDa subunit has not been described 
in the literature so far, although it contains all the key residues and the active 
site of the protein is accessible (Johansson et al., 2001).  
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Figure 4.15Side (top) and matrix (bottom) views of complex I. The surface 
of the 49 kDa subunit is presented. 
 
Inter membrane site 
Three subunits of complex I (PGIV, 15 kDa and B18) contain Cx9C (CHCH) 
domains that stabilize their helix turn helix motifs (Szklarczyk et al., 2011).  
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Figure 4.16.Side (top) and IMS (bottom) views of complex I. The surface of 
the B18, PDSW, PGIV and 15 kDa subunits are presented. 
 
The two CHCH domains of PGIV form the ‘heel’ of mammalian complex I. Short 
α-helices lock the B16.6 subunit and a long C-terminus runs on the surface of 
the IMS site all the way to the ND2/ND4 interface where it binds a hydrophobic 
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Phe-Phe-Trp motif. This way it works as a “clamp”, holding tightly the 
scaffolding subunits (B14.5b, SGDH, 15 kDa and B16.6) (Fig. 4.16). 
 
Another structurally important Cx9C containing protein is the 15 kDa subunit. It 
contains a CHCH motif that stabilizes two short α-helices placed on the ND2 
subunit form the IMS site. The subunit winds itself between the core ND2 and 
ND4L subunits and the supernumerary B16.6, SGDH, PGIV subunits. The15 
kDa subunit is clearly very important for integrity of this region since it makes 
many extensive interactions with a number of partners (Fig. 4.16).  
 
The B18 subunit is placed directly underneath the ND5 subunit. One of its Cx9C 
motif α-helices is exceptionally long and protrudes almost 30Å away from the 
complex. It is pointing in the direction of complex IV in the supercomplex (Letts, 
Fiedorczuk, et al., 2016). The loops of the CHCH motif and N-terminal coil of 
the B18 subunit are placed close to another protein containing di-sulphide 
bridges, the PDSW subunit (Fig. 4.16). 
 
The PDSW subunit contains four cysteines placed in positions that enable 
disulphide bond formation. The bonds presumably stabilize the protein fold, 
resulting in stabilization of the interactions between ND5-ND4 and surrounding 
accessory subunits. Additionally, it contains a conserved cysteine in position 
154 on the C-terminal α-helix that faces a conserved (in mammals) Cys112 of 
the ESSS subunit and so together they are likely to form the only inter-subunit 
disulphide bond in the complex (Fig. 4.17). The C-terminal α-helix (alike in the 
B18 subunit) is involved in the supercomplex formation interacting with complex 
III (Fig. 4.16)(Letts, Fiedorczuk, et al., 2016). 
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Figure 4.17. Close up of the C-terminal helix of supernumerary subunit 
PDSW at the centre of the membrane arm on the IMS side. This helix 
extends away from complex I and is encircled by the C termini of 
supernumerary subunits B14.5b, ESSS and B15. The side chains of 
residues involved in stabilizing interactions are shown. A possible disulfide 
bond between PDSW (Cys154) and ESSS (Cys112) and stabilizing salt 
bridges are indicated by dashed lines. Figure prepared by Dr James Letts. 
 
Most of the proteins in the intermembrane space contain helix-turn-helix motifs 
stabilized by sulphur bridges. This feature and their location make them very 
important for complex I integrity. The PGIV and B15 subunits have probably 
overtaken the function of β-hairpin/helix motifs (βH) that stabilizes MD’s 
periplasmic side in bacteria but are mostly missing in mammals (Efremov & 
Sazanov, 2011)(R. Baradaran et al., 2013). The B18 and PDSW subunits 
additionally may play a regulatory role in supercomplex formation (Letts, 
Fiedorczuk, et al., 2016). Upon a change in the redox conditions, disulphide 
bonds of CHCH motif can break and the interactions between CHCH α-helices 
and complexes IV and III may be disrupted.  
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Subunits associated with the membrane domain containing 
transmembrane motifs 
Most of the supernumerary proteins interacting with the MD are defined by a 
single transmembrane α-helix that separates the N- and C-terminal ends. They 
form eighteen transmembrane helices, which in addition to TMHs of the core 
subunits give a total number of 78 α-helices embedded in the internal 
mitochondrial membrane. Accessory subunits in the membrane create a cage 
around the core that presumably increases stability. In all cases, they have the 
C-terminus located in the IMS, determined by the mechanism of insertion 
(Stuart, 2002).  
 
The TM helices of the B15, ASHI, B12, AGGG, B17 and SGDH subunits 
surround the tip of the MD, stabilize it and contribute to the distal bulge (Fig. 
4.13). 
The highly tilted (~60˚ relative to the plane of the membrane) TM helix of B17 is 
unique because all the other TM helices of the complex are approximately 
perpendicular to the plane of the membrane. It has a C-terminal extension that 
together with a β-hairpin of the ND5 subunit makes a three-stranded anti-
parallel β-sheet, expected to stabilize the IMS side of the ND5 subunit. On the 
matrix side it has a long alpha helix interacting with SDAP-β and B22 that 
stabilizes this ACP/LYR pair. N-terminus and TM helix of B17 are connected 
through a flexible linker with a short α-helix. That part of the protein is very 
flexible and therefore disordered in the cryo-EM map and impossible to build 
(Fig. 4.18).  
 
The SGDH subunit binds between the ND4 and ND5 subunits, in a groove filled 
with two cardiolipin molecules (Fig. 4.18). The C-terminus of the protein wraps 
around the PDSW chain and continues along the ND4 subunit in the direction of 
the ND2 subunit. The SGDH and PDSW subunits are interlocked and together 
build two long α-helices traversing across the three antiporter-like subunits from 
ND5 to ND2,stabilizing this region from the IMS side. The N-terminal end of the 
SGDH subunits ends with a coil anchored deep in the “heel” of the enzyme.  
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The B12 subunit is placed at the distal end of the MD. It forms the most distal 
TM α-helix that interacts with complex IV in the supercomplex (Letts, 
Fiedorczuk, et al., 2016). The TM helices are also slightly tilted with respect of 
the membrane plane. The C-terminal part of the B12 subunit forms an 
unstructured coil, binding in proximity of the B18 and ND5 subunits. The N-
terminus of the protein forms two parallel α-helices stabilizing the position of the 
SDAP-β subunit (Fig. 4.18).  
 
The TM helix of AGGG is locked in betweenthetheB12 and ND5 subunits. It is 
leaning at a similar angle as the B12 subunit but in the opposite direction. The 
short N-terminus binds to the ND5 subunit and the C-terminal end can be 
traced as a coil running along the external α-helix of the B18 subunit interacting 
with complex IV (Fig. 4.18) (Letts, Fiedorczuk, et al., 2016).  
 
Figure 4.18.Left side and front views of complex I. The surface of the 
SGDH, B17, B12 and AGGG subunits presented. 
 
The ASHI subunit binds to the ND5 subunit across the B17side. It has a 
relatively big globular N-terminal domain forming extensive interactions with the 
ND4, B22 and mostly B15 subunits. This part of the protein is disordered in the 
ovine map, for that reason it was only possible to trace the backbone of the 
peptide. The distortion may be caused by increased flexibility of the 
amphipathic α-helix of the ND5 subunit in the sample used. The C-terminus 
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forms a coil that runs between the ND5 and ND4 subunits interacting with both 
(Fig. 4.19).   
The B15 subunit stabilizes a long lateral helix of the ND5 locking it to the ND4 
subunit. The N-terminus forms two α-helices connected by a flexible linker. The 
first helix lays on the surface of the ND4 subunit close to the proton input 
channels, the second one runs away from the centre of the MD and interacts 
extensively with the B22 subunit. Those two α-helices lock the whole N-terminal 
domain of ASHI in between them (Fig. 4.19).  
 
 
Figure 4.19 Right side view of complex I. The surface of the ASHI, B15 and 
B14.7 subunits presented 
 
The MWFE subunit is bound at the very back of the complex I MD domain. It 
strongly interacts with the ND1 subunit through a TMH placed anti-parallel to 
the TMH1 of the ND1 subunit, which builds the entry point for the ubiquinone 
channel. The N-terminal domain of the MWFE subunit is very short and barely 
sticks above the membrane level, where it is locked in between the B17.2, 
TYKY and ND1 subunits. The C-terminus of the subunit forms a short α-helix 
interacting extensively with other proteins building the “heel” of the complex, 
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namely accessory subunits B16.6, PGIV and the core ND1 and ND6subunits 
(Fig. 4.20).  
The B16.6 subunit is one of the most interesting supernumerary subunits of 
mammalian complex I. It has a very long α-helix that runs continuously through 
the lipid bilayer, kinks and continues through the “heel” of complex I to the 
opposite side of the enzyme. The long α-helix is followed by a linker and a short 
helix locked in between the ND1, ND6, ND3 and MWFE subunits with a motif of 
large side chains and hydrophobic amino acids: Phe-Ile-Trp-Tyr-Thr. Close to 
the C-terminus of the B16.6 subunit a lipid binding site has been identified (Fig. 
4.23). The N-terminus of the protein is a coil that stretches almost to the N 
module. The B16.6 subunit is the only protein of complex I that spans both arms 
of the enzyme. Its location suggests that it has an important stabilizing role, 
however it is also found to be a cell death regulator (also called GRIM19) (Lu & 
Cao, 2008). It can be hypothesized that upon miss-assembly or degradation of 
complex I, free B16.6 subunit may be released to the cytoplasm and promotes 
a cascade that leads to destruction of the cell.  
 
 
Figure 4.20.Back view of complex I. The surface of the MWFE and B16.6 
subunits is presented.  
 
Near the TMH of the B16.6, the B9 subunit is located. It has a trans membrane 
helix that interacts with the last TMH of the ND1 subunit and a short 
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amphipathic α-helix at the N-terminus proposed to anchor and stabilize this side 
of the complex in the membrane. The C-terminus is built of an α-helix followed 
by a coil, mostly interacting with the PGIV subunit (Fig. 4.20).  
 
The B14.5b subunit is the only supernumerary subunit with two TMHs. The first 
of the helices is of the length (~25Å)approximating the internal mitochondrial 
lipid bilayer. The second is twice longer and protrudes deep into the 
intermembrane space. The protein binds next to the void of the ND2 subunit 
with both ends on the IMS site. The N-terminus, followed by the short TMH 
forms a short coil that circles the long TM helix and ends binding in between the 
ND2 and SGDH subunits, very close to a lipid molecule that was assigned as 
phosphatidylcholine (Fig. 4.21 and 4.23).  
 
The KFYI subunit binds to the B14.5b subunit. It has a very short C-terminus, 
that is practically two α-helix turns extension of the TMH and a several amino 
acids long coil on the matrix site interacting with the 42 kDa subunit (Fig. 4.21).  
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Figure 4.21 Left-IMS side view of complex I. The surface of the B9, KFYI 
and B14.5b subunits presented. 
 
The ESSS subunit tightly binds between two transmembrane helices of the ND4 
and SGDH subunits. On the IMS site, it has a short linker connecting its TMH to 
a 25 amino acids long α-helix placed in between loops and an α-helix of the 
PDSW subunit, almost perpendicularly to the membrane plane (Fig. 4.21). The 
protein ends with a coil that wraps the three helix bundle of the PDSW subunits 
and holds them together. The 38-amino acids long N-terminus of the ESSS 
subunit is not resolved well in our map but can be traced in the bovine and 
porcine maps (J. Zhu et al., 2016). It forms a coil that transverses along the 
longer axis of the membrane arm almost to the ND4L subunit. With a long 
extension on the N-terminus and α-helix/coil motif on the IMS the ESSS subunit 
spans two sides of the MD of complex I.  
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The MNLL subunit is one of the shortest complex I subunits. In the TM part it is 
attached to the ND4 subunit in between the ESSS and B14.5b subunits. The N-
terminal amphipathic α-helix is positioned on the surface of the IMM in a way 
that enables stabilization of this region. The C-terminus forms a coil that wraps 
around the SGDH and PDSW subunits (Fig. 4.22). 
 
 
Figure 4.22 IMS/side view of complex I. The surfaces of the MNLL and 
ESSS are presented.  
 
Although mass spectrometry analysis of the sample used for cryo-EM grid 
preparation confirmed the presence of the B14.7 subunit (Table S2), maps 
revealed that the region of the map where it binds is disordered. The reason for 
the B14.7 subunit instability is not entirely clear but most likely it is due to use of 
Brij-35 for the grid preparation. For that reason for initial building of this subunit 
lower resolution maps of mitochondrial respirasome were used (Letts, 
Fiedorczuk, et al., 2016). However for a more thorough analysis of this region 
the bovine or porcine complex I maps can be used (J. Zhu et al., 2016)(Wu et 
al., 2016). The B14.7 subunit is a four transmembrane helix subunit with both 
termini on the IMS side (Fig. 4.19). It interacts with complex I through TMHs I 
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and IV. Helix I is in contact with the last TM helix of the ND5 subunit and helix 
IV binds to lateral helices of the ND5 and ND2 subunits. The protein belongs to 
the Tim17 protein family, which groups mitochondrial protein translocases 
(Tim17, Tim22 and Tim23) but family members are also found in peroxisomes 
and plastids (Murcha, Wang, & Whelan, 2012). To my knowledge any 
transporting activity of the B14.7 subunit has not been shown so far. The 
protein is likely to be important for complex I assembly or supercomplex 
formation, as it interacts extensively with complex III (Letts, Fiedorczuk, et al., 
2016)(Wu et al., 2016).  
 
Lipid Molecules 
We have observed twelve lipid molecules specifically bound to complex I. Four 
of them have four alkyl carbon groups and the rest two. Molecules with four 
alkyl groups were assigned as cardiolipins (CL). Cardiolipin is one of the most 
abundant lipid types in mitochondria (Paradies et al., 2014). It constitutes 20% 
of all lipid molecules and was shown to be very important for activity of 
mitochondrial proteins (Planas-Iglesias et al., 2015). Two chain lipids were 
assigned as phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
depending on the intensity of the cryo-EM density in the lipids’ head groups. CL, 
PC and PE were identified as the most common fatty acids bound to 
mitochondrial complex I in numbers of: 16, 8 and 23 molecules per one 
molecule of the enzyme (Shinzawa-Itoh et al., 2010). Many of the identified 
lipids (including CL) occupy the cavity resulting from the evolutional loss of the 
N-terminal α-helices of the ND2 subunit. This fact indicates that either lipids 
compensate for the stability loss due to missing helices or the ND2 subunit 
evolved to accommodate specific regulatory lipids. Other cardiolipins are found 
in a large gap between the antiporter-like ND4 and ND5 subunits and at the 
“heel” of the complex interacting with the amphipathic helices of B17.2, B14.5a 
and PSST subunits. PCs and PEs were identified at the ND1/ND6 and 
ND4/ND2/B14.5b interfaces (Fig. 4.23). The tightly bound lipids presumably 
stabilize the structure, prevent potential proton leaks and possibly play 
regulatory roles. Previously, acyl chains specifically bound to complex I were 
only observed in the crystal structure of the E. coli MD (Efremov & Sazanov, 
2011). However, the density for the head groups of these molecules was 
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blurred, preventing the identification as lipids or detergent, and the binding sites 
were different.  
 
 
Figure 4.23A.Side view of complex I, with cofactors including lipids shown 
as sticks. CDL, cardiolipin; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PPT, phosphopantetheine. B. Lipids 
phosphatidylethanolamine, phosphatidylcholine and cardiolipin. Lipids are 
shown with experimental cryo-EM density carved to within 5 Å. 
  
B 
A 
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4.3 Different conformations of ovine complex I  
 
Initial data processing revealed the presence of complex I in two different 
conformations (“open” and “closed”) (Chapter 3.6.2). Extensive re-classification 
of all particles composing these two states allowed extracting three additional 
classes. The final result were five classes at resolution from 4 to 4.5Å. 
 
Class 
number 
Resolution 
(Å) 
Particles 
number 
Rotation of 
PA (o) 
Wedge-like 
motion of PA (o) 
Q cavity 
Class 5 4.4 14704 Clock wise 2o Yes 4o Blocked 
Class 4 4.2 17543 Clock wise 4o Yes 3.5o 
Poorly 
resolved 
Class 3 
(analogue 
of “open”) 
4.0 21555 Clock wise 3o Yes 3o Blocked 
Class 2 4.4 12653 Clock wise 2o No 
Poorly 
resolved 
Class 1 
(analogue 
of “closed”) 
4.5 14429 
Reference 
class 
Reference class Accessible 
 
Table 4.1 Comparison of complex I conformations after re-classification. 
Rotation angles were measured between B17.2 and SDAP-α subunits. 
Wedge-like motion degrees were measured between ND1 and B8 subunits.   
 
Re-classification of particles revealed that class 3 with ~21,5 k particles is 
almost identical to the original “open” class with ~82.9 k particles and reaches a 
similar resolution of 4.04 Å (3.9 Å class “open”). The “closed” class (4.6 Å, 
~46.3 k particles) is analogous to class 1 (4.5 Å, ~14.4 particles). This result 
clearly shows the power of the extensive 3D re-classification approach that was 
taken (Chapters 2.6.2). From the ~129.2 k particles classified originally as the 
“open” and “closed” classes only ~60.7 k was enough to obtain maps of similar 
resolution. The remaining 53% of particles were re-assigned to different 
conformations (classes 2, 4 and 5) or artefacts (Chapter 3.6.3). Such an 
approach to classification (which one might call “focus-revert-and-classify”) 
should be applicable to other cryo-EM studies, when differences between the 
conformations are relatively small globally, but significant locally and 
functionally. 
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Figure 4.24 Comparison of classes 1-4 of the new classification. A. Side 
view of complex I with rotation axis and direction of PA wedge-like 
movement. The red dashed line shows the location of the cross-section 
presented on panel B; solid line presents the rotation axis of the PA; arrows 
show direction of the rotation and movement of the PA B. Cross section of 
complex I peripheral arm. The arrow shows the direction of rotation; the 
black dot indicates the axis of rotation. C. Matrix side view of complex I. 
Arrows indicate the direction of the rotation and hinge like movement of the 
PA; point indicates axis of rotation. Structures depicted as cartoons (A. and 
C.) or ribbons (B.). Class 1 in red, class 2 in orange, class 3 in yellow, class 
4 in green. Structures aligned by the core subunits ND1 - ND4. 
 
Separated classes differ by the position of the PA over the MD. Class 1 is the 
most closed and anti clock wise rotated (matrix view) in contrast class 4 is most 
A B 
C 
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open and clock wise rotated (Table 4.1). Class 2 is very similar to class 1, it has 
a similar overall position of the peripheral arm over the membrane arm, 
however less anti clockwise rotated. Class 4 has the most open conformation 
with a strong clockwise rotation, similar to the 4 Å resolution class 3 but with a 
larger rotation. Class 5 is the most different from all other classes in regard to 
PA position. It has an intermediate rotation, similar to class 2 but very strong 
hinge-like displacement in the opening direction.  
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Figure 4.25 Comparison of classes 1, 4 and 5 of the new classification. A. 
Side view of complex I with rotation axis and direction of PA movement. 
Red dashed line shows cross-section presented on panel B; solid line 
presents rotation axis of the PA; arrows show the direction of the rotation 
and movement of the PA. B. Cross section of complex I peripheral arm. 
Arrow is showing direction of rotation; the black dot shows the axis of 
rotation. C. Matrix side view of complex I. Arrows indicate direction of the 
rotation and hinge-like movement of the PA; dot indicates axis of rotation. 
Structures depicted as cartoons (A. and C.) or ribbons (B.). Class 1 in red, 
4 in green and class 5 in blue. Structures aligned by the core subunits ND1 
- ND4. 
A B 
C 
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The new, more homogenous maps revealed correlation between the positions 
of the PD over the MD and conformation of the β1-β249-kDa loop. Although all the 
maps in the region of the Q binding contain relatively high level of noise it is 
clear that the class 3 (analogue to “open”) and class 5 (most open) have the β1-
β249-kDa loop blocking the Q site, but the class 1 (analogue to “closed”) is more 
similar to the bovine Class 2 or porcine, or T. thermophilus models in this 
region, where the N2 cluster is accessible for oxidation. Additionally, in the 
ubiquinone site an elongated density indicates that it is occupied. It is not 
possible to judge at this level of resolution what this blob belongs to. Most 
probably it is a molecule of detergent Brij-35, which has been shown to be very 
efficient Q-site inhibitor of the mammalian complex I (Chapter 3.6)(Okun et al., 
2000).  
 
Figure 4.26 Presentation of the Q site with the crucial β1-β249-kDa loop in 
different models represented as ribbons. A. Bovine class 2 in blue, 
porcine model in magenta and ovine class 1 in orange with the 
experimental density from class 1 map in grey mesh. Structures may 
represent the active state of the enzyme. Quinone in dark grey was 
modelled based on the T. thermophilus structure; note that it aligns very 
well with the extra density in the Q chamber. B. Ovine class “open” in 
cyan and ovine class 3 in yellow with the experimental density from the 
class 3map in grey mesh. Structures may represent the de-active state of 
the enzyme or different stages in the catalytic cycle. C. Ovine class 3 in 
yellow and ovine class 1 in orange superimposed with quinone in grey, 
modelled based on the T. thermophilus structure. All the models were 
aligned by 49 kDa subunit and depicted as ribbons.  
A B 
C 
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The two remaining classes, 2 and 4 have β1-β249-kDa loop map regions poorly 
resolved and the position of the β1-β249-kDa loop is difficult to judge. It may be 
caused by presence of particles in both states: with β1-β249-kDa loop inserted 
and retracted.  
 
Global changes in the PA positioning and Q chamber accessibility are clearly 
visible. Inspection of the MD also shows some changes in the position of the 
distal ND5 and surrounding subunits, however they are much less prominent 
(Fig. 4.27).  
 
 
Figure 4.27 Comparison of the membrane domain of classes 1-5 of the 
new classification. A. Side view across the membrane domain of complex I 
with change in the ND5 subunit position presented with the red lines 
connecting the corresponding point in the ND4 and ND5 subunits in classes 
1 and 4, lines form and angle of approximately 1.5o. Notice how well TMHs 
in the ND2 and ND4 subunits are aligned compared to the ND5 subunit. B. 
Matrix view of complex I membrane cross-section. Class 1 in red and class 
5 in blue. Structures aligned by the core subunits ND1-ND4. 
 
Compared to class 1, classes 2, 3 and 4 have the ND5 subunit “kinked” in the 
direction of the IMS by respectively 0.5, 1.5, 1.8 degrees. The degree of the 
ND5 subunit displacement correlates with the change in PA position. Class 4 is 
the most different form class 1 in terms of PA position (rotation and hinge-like 
movement) and have the ND5 subunit shifted to IMS by the highest degree, 
whereas class 2 is the most similar in terms of PA and ND5 subunit 
A B 
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arrangement. Class 5 is again slightly different than the other classes. It has the 
ND5 subunit rotated clockwise by ~2 degrees (looking from the IMS) rather than 
“kinked”. This is very interesting since the position of PA in this class also 
stands out comparing to the rest due to weak rotation and strong hinge-like 
opening. However two important points have to be highlighted. Firstly, due to 
very small changes, the exact direction of the ND5 subunit movement is difficult 
to evaluate unambiguously. Displacement can be caused by both rotation and 
the “kink” of the ND5 subunit. Secondly, reported degrees of the ND5 subunit 
displacement may differ depending on which amino acid residue will be used as 
a reference. Nevertheless this correlation of the ND5 subunit position change 
with overall position of the PA arm and accessibility of Q chamber is most 
intriguing. 
 
4.4 Comparison of recently published complex I structures 
 
4.4.1 Overall conformations 
Recently in addition to the ovine mitochondrial complex I, two other high 
resolution models of the enzyme, from B. Taurus at 4.2 Å resolution (J. Zhu et 
al., 2016) and S. scrofa at 3.6 Å (Wu et al., 2016) and one medium resolution 
from Ovis aries at 5.8 Å (Letts, Fiedorczuk, et al., 2016) were published. As 
expected from the sequence identity (Chapter 3.1) all the models are very 
similar. Apart from some alterations in the primary sequences, a few differences 
in amino acids tracing are likely to come mainly from lower resolution at the 
peripheries of the maps. Global changes in the position of PA, distal part of the 
MD and the position of β1-β249-kDa loop are also present (Table 4.2).  
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Class number 
Resolution 
(Å) 
Rotation of 
PA (o) 
Wedge-
like motion 
of PA (o) 
Rotation of ND5 
subunit (o) 
Q cavity 
Bovine Class 1 4.3 Clock wise 2o No 
Clock wise 
1.3 
Poorly 
resolved 
Bovine Class 2 4.4 
Anti-clock 
wise 2o 
Yes 2o 
Anti-clock wise 
2.5 
Accessible 
Bovine Class 3 5.6 Clock wise 3o Yes 3o 
Clock wise 
4o 
Poorly 
resolved 
Porcine 
respirasome 
3.6 Clock wise 3o Yes 2o 
Anti-clock wise 
1.5o 
Accessible 
Ovine 
respirasome 
(analogue to 
ovine class 2) 
5.8* Clock wise 2o No No 
Poorly 
resolved 
Ovine class 1 4.5 
Reference 
class 
Reference 
class 
Reference class Accessible 
Table 4.2 Comparison of complex I conformations from different studies. 
Rotation angles were measured between B17.2 and SDAP-α subunits. 
Hingelike motion degrees were measured between ND1 and B8 subunits 
for all the models except porcine where B8 and 49 kDa subunits were used.  
*Overall resolution reported for the supercomplex, it can be underestimated 
for the complex I region of the map.  
 
Comparison of the structures reveals distinct conformational states of the 
molecule defined by hinge and rotation like movements of the complex arms 
and displacement of ND5 (Table 4.2). It is possible that they correspond to 
active/de-active (A/D) conformations (Maklashina, Kotlyar, & Cecchini, 2003) or 
different states of the molecule during the catalytic cycle. Nevertheless this 
finding confirms the presence of global changes in the enzyme’s structure. 
Complex I from bovine and ovine mitochondria was prepared for high-resolution 
studies in Cymal-7 and Brij-35 detergents respectively. The porcine and 
medium resolution ovine structures come from the enzyme purified as 
respirasome and in case of the first one refined to high resolution focusing only 
on the complex I density of the particles.  
 
Interestingly the overall conformations presented in the bovine and porcine 
studies are somewhat different to conformations obtained from the ovine 
complex I sample (Chapter 4.2). The bovine study presents three forms of the 
enzyme. Class 1 with the position of PA over the MD and PA rotation similar to 
the ovine classes 1 and 2. Class 2 is even more closed and anti clockwise 
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rotated than ovine class 1 and Class 3 is analogous to ovine class 3. The most 
striking difference between studies is that complex I particles from the bovine 
study mostly allocate to the “closed” conformation, in contrast to the ovine 
where they are allocated more to the “open” classes. Thus most “closed” bovine 
Class 2 and most “open” ovine classes 4 and 5 are unique and do not have 
analogues (Fig. 4.28). All the classes also vary noticeably by the position of the 
distal ND5 and surrounding subunits. In this case change is more visible than in 
five ovine classes (Chapter 4.2). Anti clockwise rotation of the tip (around the 
ND5 subunit) of MD (looking from IMS) correlates with anti clockwise rotation of 
the peripheral arm (Fig. 4.28.D). 
 
 
138 
 
 
Figure 4.28 Comparison of class 1of the new classification and three 
classes published in the bovine complex I study. A. Side view of complex I 
with rotation axis and direction of PA movement. Red dashed line shows 
cross section presented on panel B; green dashed line shows cross section 
on panel D; solid line presents rotation axis of the PA; arrows show 
direction of the rotation and movement of the PA. B. Cross section of 
complex I peripheral arm. Arrow is showing direction of rotation; black dot 
shows the axis of rotation. C. Matrix side view of complex I. Arrows indicate 
direction of the rotation and wedge like movement of the PA; black dot 
indicates the axis of rotation. D. Cross section of complex I membrane 
domain showing direction of rotation of the distal part of membrane domain; 
black dot shows the axis of rotation. Structures depicted as cartoons (A. 
and C.) or ribbons (B. and D.). Class 1 in red, bovine class 1 in pale blue, 
bovine class 2 in blue and bovine class 3 in teal. Structures aligned by the 
core subunits ND1-ND4. 
 
A B 
C D 
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The porcine structure is a result of focused refinement of the complex I and III 
region in a digitonin-solubilized I1III2IV supercomplex. The enzyme displays a 
closed conformation, similar to bovine class 2 structure but is more clockwise 
rotated. Compared to the ovine maps, it is most similar to class 1 with a 
stronger clockwise rotation and moved closer to the MD (Table 4.2). 
Interestingly the rotation axis of the PA is on the opposite side comparing to all 
other structures (Fig. 4.29 B). Also the membrane domain is slightly rotated in 
the anti clockwise direction looking from the matrix side of mitochondria (Fig. 
4.29 D) 
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Figure 4.29 Comparison of class 1of the new ovine classification and 
porcine model based on mitochondrial respirasome study. A. Side view of 
complex I with rotation axis and direction of PA movement. Red dashed line 
shows cross section presented on panel B; black dashed line shows cross 
section on panel D; solid line presents rotation axis of the PA; arrows show 
direction of the rotation and movement of the PA. Note that the rotation axis 
is on the opposite side of the PA comparing to other structures (Fig. 4.28 
and 4.24-4.25) B. Cross section of complex I peripheral arm. Arrow is 
showing direction of rotation; black dot shows the axis of rotation. C. Matrix 
side view of complex I. Arrows indicate the direction of rotation and hinge-
like movement of the PA; black dot indicates the axis of rotation. D. Cross 
section of complex I membrane domain showing direction of rotation of the 
distal part of membrane domain; the black dot shows the axis of rotation. 
Structures depicted as cartoons (A. and C.) or ribbons and cartoons (B. and 
D.). Class 1 in brown, porcine model in green. Structures aligned by the 
core subunits ND1-ND4. 
 
A B 
C 
D 
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The ovine complex I model from the respirasome study is currently at the lowest 
resolution. It is most similar to moderately “closed” ovine class 2. The position of 
the PA is very close and almost no differences in the MD were observed. The 
model was build based on ~5.8 Å resolution map which allowed modelling of 
main chains only. It is possible that due to low number of particles different 
complex I conformations were difficult to separate.  
 
Importantly all the studies confirm that the global “closed” conformation of 
complex I correlates with an accessible Q site of the enzyme. The question if 
the “open” conformation is correlated with inserted β1-β249-kDa loop in species 
other than ovine remains unclear, however this theory is worthy of further 
investigation (Chapter 4.3.2). 
 
An interesting fact is that in the high resolution maps of the “closed” complex I 
conformation (ovine class 2 and porcine), the N-terminal extension of the 49 
kDa subunit followed by the β149-kDa is well ordered and possible to trace along 
the MD on the matrix side of the enzyme up to the 42 kDa subunit. In the ovine 
“open” map, this extension is disordered. Based on this observation it could be 
proposed that the N-terminus of the 49 kDa subunit may play a role in the 
open/closed transition. However it is unlikely because the following β1–249-kDa 
strands are positioned identically in all the structures, it interacts extensively 
with many other MD subunits, remains disordered in the ovine class 1 map and 
is missing in the bacterial enzyme ruling out its catalytic function. Nevertheless, 
the 49 kDa extension interacts with the TMH2-3ND3, which changes position 
upon A/D transition, thus increased flexibility of this coil cannot be ruled out (Fig 
4.29).  
 
In the TM domain the TMH5-6ND1 loop, building the ubiquinone chamber, is 
poorly resolved in the bovine and ovine studies but is better defined in porcine 
(Wu et al., 2016). That indicates a requirement for some flexibility in this region, 
possibly linked to the A/D transition (4.3.2) (J. Zhu et al., 2016). In the bovine 
and porcine models the loop is retracted, making contact with the β1–β249-kDa 
loop (4.29.A). Another crucial element linked to the A/D conversion is the α1-
α2ND3 loop (Babot & Galkin, 2013). In the bovine Class 2 (“closed”) and porcine 
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models it is relatively well resolved but is less defined (more flexible) in the O. 
aries “open” conformation. In the bovine and porcine models the loop goes in 
between the ND1, 49 kDa and PSST subunits making contacts with the β1–
β249-kDa, so that key Cys39ND3is buried in the protein interior. In the ovine model 
(“open” state) this contact is not so extensive. This cysteine becomes 
accessible to chemical modification only in the D form of the enzyme (A. Galkin 
et al., 2008), perhaps reflecting the possibility that “closed” conformations 
resemble the A form, while “open” state is closer to the D form (Fig. 4.29.B). 
 
It has been proposed that upon quinone reduction, four protons are 
translocated through four channels, one each in antiporter-like subunits ND5, 
ND4 and ND2 plus one in ND1+ND4L+ND6 subunits (Baradaran 2013). All 
characteristic features of the transmembrane part of complex I are present in all 
mammalian models. Just like in the bacterial structures (R. Baradaran et al., 
2013)(Efremov & Sazanov, 2011) TMH7 and TMH12 of ND2, ND4, ND5 contain 
a loop insertion in the middle of the membrane, while TMH8 has a π–bulge a at 
similar position. The long chain of charged and polar residues running along the 
central axis of the TM domain is well preserved as well. Maps enable modelling 
of conserved glutamates, aspartates, lysines and histidines. Those key residues 
are proposed to be crucial for the energy transduction from the Q-site to the 
very end of membrane domain. Conformational changes of chargeable residues 
may propagate through the central axis altering local pKas and accessibility of 
side chains central to proton transport (L. A. Sazanov, 2015)(R. Baradaran et 
al., 2013). In all models big cavities possibly filled with water and providing entry 
and exit points for protons are present.  
 
The main difference in the proton-pumping sites that can be found between the 
models is the position of the ND5 subunit. Its movement is correlated with the 
direction of the PA rotation (Table 4.2, Fig. 4.28-29). Comparing to ovine class 
1, looking from the matrix side PA and ND5 subunit in accord rotate in clock or 
anti clockwise directions which correlates with “closing” and “opening” of the 
complex (please note that in the porcine model it is a clockwise/anticlockwise 
relationship but the pivot point of the PA in the porcine model is on the opposite 
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side so the overall direction of the changes remains the same). Perhaps it is 
important for the catalytic mechanism of the enzyme.  
 
It will require further investigation why in the bovine and porcine models the 
distal pumping module is rotating and in the ovine classes (exception class 5) it 
“kinks”. The exact character and importance of these transitions is difficult to 
discuss due to the moderate resolution of the maps and relatively small 
changes in this region. Higher resolution models of various conformations may 
allow us in future to discern smaller conformational changes around key 
residues in other pumping modules. 
 
4.4.2 Conformational variability of complex I – possible links to the active/de-
active state transition or to the catalytic cycle. 
 
Based on our and other recently published structures, it can be proposed that 
when the ubiquinone binding site is empty, the inserted β1–β249-kDa loop covers 
the N2 cluster and key Tyr10849-kDa, possibly preventing ROS production at the 
Q-site in the presence of NADH and absence of Q. In this model, the 
“retracting” loop movement would be initiated by the approaching ubiquinone 
molecule (or any entity/inhibitor binding at this site). Accommodation of a ligand 
would bring β1–β249-kDa and TMH5-6ND1 loops together and may stabilise the 
interface between PA and MD, through the interaction mediated by the long α1-
α2ND3 loop (better ordered in the “closed” state). Stacking interactions between 
the quinine head group and His5949-kDa may shift an entire 49 kDa β1–β2 sheet 
by about 2 Å (a transition observed between ‘open’ and ‘closed’ classes). The 
initial move would facilitate “embracing” interactions of B13 and SDAP-α pair 
with the 42 kDa subunit, stabilizing complex I in the “closed” conformation. 
Upon quinol (reduced quinone) release the 49 kDa/ND1/ND3 connection is lost 
and B13/SDAP-α/42 kDa interaction is not strong enough to keep the arms 
together, which results in enzyme’s return to the initial “open” conformation. 
This is of course one of many possible mechanisms for “open”/”closed” state 
transition and more studies have to be conducted to confirm or rule it out. 
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These conformational changes may describe the transition between de-active 
and active states of the enzyme (respectively from “open” to “closed”) or reflect 
the transitions that complex I undergoes during the catalytic cycle, with the 
“open” state occurring when quinol is ejected from the cavity (possibly helped 
by β1–β249-kDa loop moving in) and “closed” state adopted once quinone is 
bound. Indeed, the A/D transitions and the catalytic cycle may follow the same 
conformational trajectories, except that in the D state conformation the enzyme 
is trapped by some protein modification (like that of Cys39ND3) requiring several 
turnovers to be released during activation (Vinogradov, 1998).  
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Fig. 4.30 A. Presentation of changes in positions of crucial loops of the 49 
kDa, ND1 and ND3 subunits between “open” and “closed” states of 
complex I. Arrows indicate hypothetical movement of the loops upon 
ubiquinone binding. Presented as ribbon with the structure of the “open” 
ovine complex I in colour and the crucial loops from the bovine Class 2 
(“closed” state)complex I in black; those loops were build very similarly in 
the porcine model. N2 cluster presented as spheres, crucial Tyr10849-kDa as 
sticks, quinone modelled based on the T. termophilus structure as sticks in 
gray. Structures were aligned by  theND3 subunit to model the TMH1-2ND3 
and TMH5-6ND1 loops and by the 49 kDa subunit to model the β1–β249-kDa 
loop. B. Presentation of the TMH1-2ND3 position in the bovine, ovine and 
porcine high-resolution models. The ND3 subunit presented as cartoon, 
ovine in light blue, bovine in blue and porcine in magenta. Arrows indicate 
position of the conserved Cys39 (Chapter 4.1.1) Subunits 30 kDa, 49 kDa, 
ND1 and PSST presented as surface and coloured.  
 
A 
B 
146 
4.5 Disease causing mutations 
 
Mitochondrial diseases are the most common group of inherited metabolic 
disorders. Mostly they are caused by isolated complex I deficiency. The defects 
result from inherited mutations in mitochondrial or nuclear genes encoding 
complex I subunits or assembly factors. Additionally, oxidative stress and 
mitochondrial division can give rise to new mutations over an individual’s 
lifetime. Dysfunction of the complex is mostly visible in organs with high-energy 
demand like the brain. Complex I has been implicated in many 
neurodegenerative disorders but also linked to cancer and ageing.  
 
4.5.1 Overview 
 
Complex I deficiencies are genetic disorders that are caused by mutations in 
genes in the nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) that encode 
mitochondrial complex I subunits or proteins involved in its assembly. About 
30% of mitochondrial diseases affecting energy metabolism can be traced to 
mutations in one of the subunits of complex I (Kirby et al., 1999). The diseases 
are characterized by defects in oxidative phosphorylation; however, symptoms 
vary widely in nature and severity from lethal to mild disorders. In general 
prognoses are poor. About 50% of patients diagnosed with complex I deficiency 
die within first two years of life and only 25% reach the age of ten (Koene et al., 
2012). The first signs are usually observed shortly after birth and affect the 
central neurological system. The most common clinical presentations are: fatal 
neonatal lactic acidosis, infantile-onset Leigh syndrome, childhood-onset 
mitochondrial encepalomyopathy, lactic acidosis and stroke like episodes 
(MELAS) syndrome, Leber hereditary optic neuropathy (LHON) (Fassone & 
Rahman, 2012).  
 
44 different proteins and a cohort of assembly factors acting in a strictly 
regulated manner are required for proper functioning of mitochondrial complex I 
(Chapter 1.4.2) (Sanchez-Caballero, Guerrero-Castillo, & Nijtmans, 2016). Thus 
even single mutations in any of these proteins can affect enzyme performance. 
To the numerous vulnerable genes directly responsible for complex I formation 
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we can also add those involved in metabolism of related co-factors and ligands 
(Shinzawa-Itoh et al., 2010).  
 
In patients suffering from complex I deficiency, mutations have been found in all 
of the core subunits and in most accessory subunits (Rodenburg, 2016). 
Diseases are caused by a wide range of mutations in nuclear or mitochondrial 
DNA, including substitutions, insertions, deletions, inversions, duplications etc. 
In this chapter I will focus only on single amino acid mutations that cause 
complex I deficiency. It is important to remember that disease causing 
mutations are placed in regions relevant but not absolutely crucial for complex I 
activity. They only cause a decrease in complex I activity. Embryos with 
mutations in amino acids crucial for complex I function are eliminated in the 
early stages of development. Single amino acid substitutions in patients 
suffering from complex I deficiency have been identified in 27 subunits (14 core 
and 13 supernumerary) (Table S5). They are mostly localized around electron 
transfer pathways and proton pumping sides. 
 
 
Figure 4.31 Overview of complex I deficiency causing mutations. 
Complex I depicted as transparent cartoon with core PA coloured in 
orange, core MD in blue, SN subunits bearing mutations in pink and 
mutations free subunits in green.  
 
A general genotype-phenotype correlation has not been clearly established so 
far (Tucker, Compton, Calvo, & Thorburn, 2011). It is not well understood how 
mutations in certain complex I related genes translate to specific clinical 
phenotypes. An oft-cited example of this ambiguity is a mutation in position 
Arg340 of the ND4 subunit. Substitution to histidine causes LHON syndrome 
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(Wallace et al., 1988) but mutation to serine results in Leigh syndrome 
(Deschauer et al., 2003). Until now a better understanding of complex I 
dysfunction caused by single substitutions has been obstructed by a lack of 
high-resolution models for mitochondrial complex I.  
 
Information about disease causing subunits in complex I were acquired from 
HGDM, ClinVar and Mitomap databases and exact references for all of them 
can be found in Table S5. Throughout this chapter amino acid numbering will 
be consistent with the sequence of the mature human proteins. Names of 
nuclear encoded human subunit homologues are in brackets in bold in headers 
of each paragraph of 4.5.2-4.5.4 next to the bovine names used throughout the 
chapter. Information about the nomenclature of subunits and ISCs can be found 
in Tables S6 and S7. 
 
4.5.2 Core Subunits Peripheral Arm 
 
75 kDa (NDUFS1) subunit 
The most frequent outcome of mutations in the 75 kDa subunit is Leigh 
syndrome (Table S5). Val48Asp, Gly143Glu, Val205Ala, Leu208Val, Arg218Trp 
are localized in the close proximity of iron-sulphur (FeS) clusters (Table S6). 
They build loops crucial for the proper binding and stability of the clusters. 
Val48 is located ~14Å (all distances are measured from the α-carbon of the 
amino acid to the edge of FeS cluster, unless indicated) away from the N3 and 
N1b clusters in a loop interacting directly with cluster-coordinating chains. 
Gly143 is also ~14Å away from the N1b cluster. It is part of a loop followed by a 
short β-sheet and a coil that binds the N1b cluster. Val205 is located in a loop 
between the N3 and N1b clusters 5.4 and 3.9Å away respectively. Leu208 also 
forms part of this loop. Arg218 is located ~11Å away from clusters N5 and N6a. 
The η-nitrogens at the side chain of Arg218 are at distances allowing direct 
interaction (~3Å) with the main chain carbonyl oxygens of cysteines binding 
these clusters (Cys10875-kDa and Cys80PSST).  
 
Interestingly, in the case of amino acids located ten or more Ångstrom away 
from FeS clusters the disease-causing mutations involve substitutions to 
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residues of a more extreme nature, involving amino acids of very different 
chemical characteristics (Val48Asp, Gly143Glu, Arg218Trp). Such alterations 
are likely to disrupt secondary structure elements. In the case of residues 
located very close (~5Å) to catalytically important centres, even a change to 
chemically similar amino acid decreases the efficiency of the enzyme 
(Val205Ala, Leu208Val).  
Other mutations such as: Asp229Gly, Arg385Cys, Gln499Lys, Thr572Ala, 
Asp596Asn, Tyr672His/Cys and Met684Val seem to cause complex I 
dysfunction due to improper complex assembly. They all are placed in the 
region of the 75 kDa subunit distal C-terminal subdomain at loops, β-strands or 
α-helices that are central for proper folding of this region. 
 
 
Figure 4.32 Examples of mutations in the 75 kDa subunit. The 75 kDa 
subunit pictured as cartoon in magenta, natural variants of amino acids as 
light pink sticks and disease causing substitutions as black sticks. Co-
factors are labelled.  
 
51 kDa (NDUFV1) subunit 
The 51 kDa subunit is one of the PA subunits with the highest number of 
reported single amino acid mutations – 17 (Table S5). Many are located around 
the FMN binding site where NADH is oxidized and electron transfer starts: 
Arg68Gly, Tyr184Cys, Cys186Gly, Ala191Val. Others like Glu357Lys, 
Pro102Leu, Glu194Lys, Arg366His/Cys, Thr403Met, affect FeS cluster binding 
150 
or like Ser36Pro, Lys91Glu, Arg127Trp, Arg179Pro, Pro232Arg, Ala321Val are 
likely to affect the stability of the whole NADH oxidizing module. Mutations that 
are not placed closely to the catalytically important centers of the subunit and 
are more likely to affect assembly are: Ser36Pro, Lys91Glu, Arg127Trp, 
Arg179Pro, Pro232Arg, Ala321Val.  
 
Arg68 is one of the amino acids building the FMN binding pocket. The nitrogen 
from its peptide bond is at hydrogen bond distance (2.65 Å away) from one of 
the terminal oxygen atoms from the ribitol group of FMN. The side chain of 
arginine, although pointing in the opposite direction, is important for the stability 
of this region due to interactions with surrounding amino acids. Tyr184 has a 
bulky side chain contributing to the FMN binding site architecture with the 
hydroxyl group of the tyrosyl only 3 Å away from the flavin ring. A substitution to 
cysteine would completely change the hydrophobic properties of this region. 
Cys186 does not interact directly with the ligand but mutation to glycine 
probably changes positions of the nearby residues, which are crucial for FMN 
and NADH binding, including Glu189. Similarly, Ala191, which does not interact 
directly with FMN or cluster N3, is located very close to FMN coordinating 
residues and interacts with Pro203 whose side chain is only 3.4Å from the N3 
cluster.  
 
Pro102 is located in a loop between FMN and cluster N1a. The function of this 
cluster is not entirely known. It has been suggested to have a role in preventing 
reactive oxygen species (ROS) production (L. A. Sazanov & Hinchliffe, 
2006)(Leonid A Sazanov, 2007)(Esterhazy et al., 2008) or purely in 
assembly/stability (Birrell et al., 2013). The side chain of Pro102 is only 3.7 Å 
away from N1a and a change to leucine may cause cluster displacement. 
Glu194 is in a short α-helix placed in between two coils, one stabilizing FMN 
and the other binding cluster N3. Change of the local charge in this case may 
lead to displacement of relevant side chains in this area. Additionally, Glu194 is 
located in the interface between the 51 kDa,24 kDa and 75 kDa subunits, 
directly interacting with Arg177 of the 75 kDa subunit. Glu357 is separated by 
only one residue from the conserved Cys359 that coordinates cluster N3. Thus, 
Glu357Lys very likely will affect positioning of the protein main chain. The same 
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explanation can be used for the substitutions in Arg366 and Thr403 situated 
right next to the N3 cluster-coordinating Cys365 and Cys405 respectively.  
 
Other substitutions in the 51 kDa subunit are playing destabilizing roles or 
perhaps affecting FMN binding and FeS cluster stability in a more indirect way. 
Lys91 is located in the periphery of the protein. Interestingly, its positively 
charged side chain is placed close to a coil followed by an α-helix stabilizing 
FMN. Change of the charge on the side chain may cause displacement of the 
coil and affect the FMN binding site. Positioning of the Lys91 side chain can 
also be disturbed by mutation in the proximate Arg127, which is additionally 
placed at the end of an α-helix central for 51 kDa subunit integrity. The same 
can be said about Pro232 and Ala321, which are located in the α-helices that 
follow or are followed by loops that come into close proximity of the FMN site. 
Mutations in Ser36 and Arg179 are positioned away from the catalytically 
important locations thus most likely have an effect on the subunit’s assembly. 
Ser36 is located in an outer α-helix of the 51 kDa subunit that makes 
interactions with the 10 kDa and C-terminal extension of the24 kDa subunit. 
Arg179 is found in a β-strand that also interacts with the 10 kDa and 24 kDa 
subunits and additionally is followed by a loop that influences stabilization of 
FMN (however the co-factor binding site is almost 10 residues away).  
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Figure 4.33 Examples of mutations in the 51 kDa subunit. The 75 kDa 
subunit pictured as cartoon in magenta, 51 kDa subunit in green, 24 kDa 
subunit in cyan, natural variants of amino acids as light pink sticks and 
disease causing substitutions as black sticks. Co-factors are labelled. 
 
49 kDa (NDUFS2) subunit 
The Arg85Gln, Arg105Gln, Ala191Val mutations possibly influence electron 
transfer from the terminal N2 cluster to ubiquinone.  
In mammalian complex I, Arg85 undergoes an unusual dimethylation (Rhein, 
Carroll, Ding, Fearnley, & Walker, 2013). The guanido group of the side chain is 
in direct contact with cluster N2. It has been proposed that it contributes to the 
relatively high reduction potential of the cluster (L. A. Sazanov & Hinchliffe, 
2006)(Hirst & Roessler, 2015). Mutation in this position will likely impact the 
redox potential of the cluster. Arg105 similarly to Arg85 is placed very close to 
N2,with one nitrogen of the side chain only 2.8 Å away from the nearest sulphur 
of the cluster and its mutations have a drastic effect on the properties of this 
redox center (Grgic, Zwicker, Kashani-Poor, Kerscher, & Brandt, 2004). 
Although Ala191 does not influence the N2 cluster directly, it is placed next to 
His190, which was proposed to be the redox-Bohr group associated with the 
cluster (Zwicker et al., 2006) and like the arginines, defines the environment for 
the N2 cluster.  
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Other mutations of the 49 kDa subunit are localized in regions important for the 
subunit’s stability or interactions with other subunits. Asp77Val is found in the 
middle of a β-strand that is part of a β-sheet interacting with the 30 kDa, PSST 
and ND1 subunits. Glu115Lys is in an α-helix located in the centre of the 49 
kDa subunit. Arg195Gln and Pro196Gln are on the interface with TYKY. 
Met259Thr is part of a short loop that interacts with the 30 kDa, TYKY, B13 and 
14.5b subunits. Arg290Gln is in a coil that probably stabilizes interactions with 
TYKY and B13. Arg300Gln is placed in the middle of an α-helix near coils of 
B16.6, TYKY and B14.5a. Ser380Pro and Ala393Ser are in a loop and β-sheet, 
forming interactions with the 30 kDa subunit. Met410Lys and Asp413Asn are in 
a loop followed by an α-helix that comes in contact with TMH5-6ND1, which in 
turn interacts with the mechanistically relevant β1-β249-kDa. 
 
 
Figure 4.34 Examples of mutations in the 49 kDa subunit. The 49 kDa 
subunit pictured as cartoon in yellow, PSST subunit in grey, natural 
variants of amino acids as light pink sticks and disease causing 
substitutions as black sticks. Co-factors are labelled. Quinone position 
modelled on T. thermophilus structure. Notice β1-β249-kDa loop clashing 
with Q head group.  
 
TYKY (NDUFS8) subunit 
The N-terminal end of the TYKY subunit is composed of two connected 
amphipathic α-helices placed on the surface of the internal mitochondrial 
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membrane (IMM), on the matrix side. One possible role of those α-helices is to 
stabilize the position of the PA with regards to the lipid bilayer (Fiedorczuk et 
al., 2016). This makes them important for the regulation of the proposed 
hinge/rotation like move of the PA (J. Zhu et al., 2016)(Fiedorczuk et al., 2016). 
The relevance of these α-helices can also be demonstrated from the analysis of 
disease causing substitutions. Arg20Trp, Glu29Gln, Arg43Trp, Pro45Leu are all 
located either in or in close proximity to these helices. Additionally, this region of 
TYKY is in contact with the B16.6, ND1, B9, B14.5a subunits and a cardiolipin 
molecule. 
 
Other mutations, Arg68His, Arg104His, Gly120Ser, Ala125Asp likely cause 
destabilization of iron-sulphur clusters. Arg68 and Arg104 are found in coils in 
direct contact with loops binding cluster N5. Gly120 and Ala125 are placed right 
next to Cys119 and Cys126, responsible for coordination of clusters N6b and 
N6a, respectively.  
 
The role of Pro51Leu and Arg60Cys mutations can be assigned to mis-
assembly of the subunits. Pro51 is at the loop localized between the B17.2 and 
PSST subunits and Arg60 can be found in a loop making the interface with the 
49 kDa subunit.  
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Figure 4.35 Examples of mutations in the TYKY subunit. The TYKY subunit 
pictured as cartoon in blue, natural variants of amino acids as light pink 
sticks and disease causing substitutions as black sticks. Co-factors 
labelled.  
 
PSST (NDUFS7) subunit 
Val84Met and Arg107His are found in two parallel β-strands that are followed 
by loops coordinating the terminal N2 cluster. This four strand β-sheet makes 
up a great part of the PSST subunit and is central for the stability of this region 
at the base of the PA.  
 
30 kDa (NDUFS3) and 24 kDa (NDUFV2) subunits 
The 30 kDa and 24 kDa subunits are the only subunits of the core peripheral 
domain that do not take part directly in electron transfer, but rather provide a 
platform for subunits assembly (Friedrich & Scheide, 2000). Identified disease 
causing mutations Thr109Ile, Arg163Trp and Pro187Leu of the 30 kDa subunit 
are located mostly at the interfaces with other subunits. Thr109 is located in the 
middle of the large 5-strand β-sheet. The sheet forms most of the 30 kDa 
subunit and is central for stability of this region. Arg163 and Pro187 are in the 
long C-terminal coil of the 30 kDa subunit that interacts with numerous 
neighbouring subunits. Arg163 is found in a loop that directly contacts the 49 
kDa and 18 kDa subunits. Pro187 is found at the end of a “hairpin-like” loop 
inserted in between the PSST, 49 kDa and B14 subunits. The single Lys177Arg 
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substitution in the 24 kDa subunit is located at the very periphery of the PA and 
its role is not clear.  
 
4.5.3 Core Subunits Membrane Domain 
 
ND1 subunit 
Mutations in this subunit cause a broad spectrum of clinical features, including 
Alzheimer and Parkinson Disease, MELAS or Leigh syndrome. Interestingly 
Ala52Thr mutation is one of the most frequently encountered mutations in 
LHON syndrome, identified in approximately 13% of cases (together with 
Ara340HisND4 [69%] and Met64ValND6 [14%] they cause almost 95% of cases). 
The broad variety of the diseases caused by substitutions in the ND1 region 
can be explained by the subunit’s involvement in several different functions. It 
contains the quinone-binding chamber, creates the proton input channel for the 
first translocation module and directly enables coupling: it links the Q-chamber 
with proton pumping modules. Disease causing mutations may affect all of 
those functions. Those that probably impact the N2 cluster accessibility to 
quinone are: Val11Met, Glu24Lys, Leu28Met, Tyr30His, Met31Val, Ala52Thr, 
Met53Ile, Glu59Lys, Tyr277Cys. The transfer of the information about quinone 
reduction/protonation from the Q to P module may be affected by: Val208Leu, 
Arg195Gln, Glu214Lys, Tyr215His. Mutations Ser110Asn, Ala112Thr, 
Glu143Lys, Gly131Ser, Ala132Thr are most likely to affect proton pumping 
activity of the first proton channel (so-called E-channel in ND1+ND4L+ND6). 
Additionally, a number of substitutions, Thr164Ala, Thr240Met, Leu285Pro, 
Leu289Met, cause dysfunction, probably by affecting the structure’s stability.  
 
Three α-helices are building the triangular entry point of the quinone channel: 
TMH1, amphipathic α-helix 2 and TMH2. Val11, Glu24, Leu28, Tyr30, Met31 
are placed in the first TM helix and Ala52, Met53 and Glu59 on the amphipathic 
α-helix 2. Mutation at any of these positions can partially obstruct access to the 
Q-site either by destabilizing secondary structure elements or introducing a side 
chain blocking it directly. Tyr277 is on one of the loops forming the Q-channel 
so substitution to cysteine will affect the architecture of the path. Additionally, 
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amphipathic α-helix 2 of the quinone entry site and the side chain of Tyr277 are 
both in contact with the amphipathic α-helix of PSST stabilizing this region. 
 
The quinone reduction site and the first proton pumping module are linked by a 
number of polar and charged residues that are proposed to link the sites via 
conformational changes of side chains (L. A. Sazanov, 2015). Val208, Arg195, 
Glu214 and Tyr215 are located in this area and mutations in these positions are 
likely to disturb conformational coupling.  
 
Mutations in positions Ser110, Gly131, Ala132, Glu143 are all localized around 
the E-channel and may affect translocation of protons. Especially important 
seems to be the conserved residue Glu143, connecting both half-channels of 
the proton translocation unit (L. A. Sazanov, 2015).  
 
Structurally important mutations in Thr164 and Thr240 are placed in the “heel” 
of complex I from the IMS. Thr164 is located in the centre of a short α-helix 
stabilizing TMHs 2-6 and Thr240 and Thr240 can be found very close to the C-
terminus of TMH6. Mutations in this region may indirectly affect quinone entry 
site or stability of ND1 and its interactions with supernumerary subunits. 
Substitutions Leu285, Leu289 are located at the C-terminal TMH of ND1 facing 
the protein interior. This is the region involved in interactions with the ND3 
subunit and mutations may influence this interaction and/or the core fold of 
ND1. 
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Figure 4.36 Examples of mutations in the ND1 subunit. The ND1 subunit 
pictured as cartoon in red, natural variants of amino acids as light pink 
sticks and disease causing substitutions as black sticks. Quinone acyl 
chain (green) modelled based on T. thermophilus structure. TMHs building 
entry site for ubiquinone and ubiquinone are labelled.  
 
ND6 subunit 
Mutations in the ND6 subunit can be classified into three groups, those affecting 
proton translocation directly: Gly36Ser, Tyr59Cys, Met63Val, Met64Ile, 
Met64Val (14% of all LHON patients), Leu60Ser; those affecting proton 
translocation indirectly: Ile26Met, Ala72Val, Ala74Val; and those likely to have 
an effect on complex I structural stability: Asn117Asp, Ser132Leu. 
 
Tyr59 is a conserved amino acid proposed to be crucial for proton translocation 
through the membrane in the IMS half-channel of the E-channel. In E. coli, 
mutations of this residue to cysteine or phenylalanine decrease complex I 
benzoquinone reduction activity by approximately 48 or 57% respectively (Kao 
et al., 2005). The function of the Tyr59 or other neighbouring key residues can 
also be affected by the mutations in the nearby Gly36, Leu60, Met64 and 
Met63. Most of these residues sit on the highly conserved TMH3, which 
contains -bulge in the middle near Tyr59, and may be directly involved in 
TMH1 
TMH2 
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propagation of conformational changes from the Q-site towards antiporter-like 
subunits.  
 
Residues Ile26, Ala72, Ala74 are located on the same or adjacent TMHs to 
TMH3 (like Tyr59), and interestingly they are all located at the very ends of 
helices on the matrix side of the membrane. They may either influence the 
nearby (and crucial for catalytic turnover), TMH1-2ND3 loop (Babot & Galkin, 
2013) or more likely, even minor disturbances to the structure of key TMH3ND6 
are detrimental to the coupling mechanism. Mutations in Asn117 and Ser132 
are in the loops in the IMS, involved in stabilization of this region. Asn117 is in a 
loop interacting with ND5, ND4L and ND4; Ser132 is placed in the centre of the 
complex I “heel” making contacts with several supernumerary subunits. 
 
 
Figure 4.37 Examples of mutations in the ND6 subunit. The ND6 subunit 
pictured as cartoon in purple, ND4L in grey and ND3 in red, natural variants 
of amino acids as light pink sticks and disease causing substitutions as 
black sticks.  
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ND3 subunit 
Most of the mutations in the ND3 subunit, Ser34Pro, Ser45Pro, Gly47Ala, 
Ile60Thr, Glu66Asn are located in putative catalytically important regions.  
Ser34, Ser45, Gly47 are all located in the long loop of ND3, that traverses the 
membrane domain on the matrix side of the mitochondria. Although none of 
these amino acids are conserved (Efremov & Sazanov, 2011) they may affect 
the catalytic turnover of complex I indirectly, since the loop plays a role in the 
A/D transition of the enzyme (Babot & Galkin, 2013) and stabilises the PA/MD 
interface. 
Glu66 is on a TMH next to key TMH3ND6 and so any disturbance in this area 
may restrict/change conformational space available to TMH3ND6 (Fiedorczuk et 
al., 2016).  
 
The role of Ile60 is difficult to predict. It is placed off the proton translocation site 
with the side chain at the interface with ND4L and ND6 subunits, thus it 
probably plays a structural role and substitution to the polar threonine may 
affect complex assembly. 
 
ND4L subunit 
Val65Ala and Cys32Arg are both located close to the sites crucial for proton 
pumping (Fiedorczuk et al., 2016). Val65 is situated next to the protuberance 
(π-bulge) of the TMH3ND6 very close to the key residues of ND4L and ND6. 
Cys32 is located next to the key Glu34 and Tyr69ND6 (Fiedorczuk et al., 2016).  
 
ND2 subunit 
Mutations of ND2: Ile57Met, Leu71Pro, Gly259Ser, Ala331Ser are most likely 
influencing protein stability.  
 
Non-conserved residues Ile57, Leu71 and Ala331 are placed at the interface 
with ND4L and B14.5b respectively. Their side chains are facing the 
neighbouring subunits and are very likely to be involved in inter-subunit 
interactions.  
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Gly259 is in the loop in the centre of broken TMH12, close to the key Lys263. 
Although this amino acid residue is not likely to be involved in the coupling 
mechanism, mutation in this position may influence the nearby relevant 
residues. 
 
ND4 subunit 
All the reported mutations of ND4: Ile165Thr, Val313Ile, Arg340Ser, Arg340His, 
Tyr409His are located on the periphery of the subunit in regions likely important 
for complex I stability, not catalysis.  
 
Ile165 is placed at the C-terminal end of the α-helix forming the main interaction 
site with ND2. Although this helix contains amino acids important for proton 
translocation (R. Baradaran et al., 2013), Ile165 is located very far from the 
crucial central axis of the membrane. Val313 can be found on TMH12 also far 
from the proton translocation site. The amino acid is not conserved (Efremov & 
Sazanov, 2011) so it is not likely to play any catalytic role. Arg340 (one of the 
three common LHON mutations) is found on the TMH12-13 loop on the matrix 
side of the membrane. The loop is in contact with the TMH10-11 loop and B15 
subunit, indicating that the mutation may have a destabilizing effect. 
Additionally, Arg340 interacts with the negatively charged C-terminus of the key 
TM7ND4, so the mutation may impede catalytically relevant movements of this 
discontinuous helix. Tyr409 interacts with subunit ASHI, and so the mutation 
may be destabilising. 
 
ND5 subunit 
Mutations Phe124Leu, Glu145Gly, Ala171Val, Ala236Thr, Met237Leu, 
Ser244Cys and Asp393Asn/Gly most likely affect catalytic function of the ND5 
subunit. Other substitutions: Tyr159His, Gln434Arg and Gly465Glu probably 
play a more structural role.  
 
Phe124 is placed in the middle of TMH4. The phenyl ring of the amino acid is 
pointing into the centre of the pumping module and is in direct contact with 
Ser250 and Thr251 of the π-bulge at TMH8, which are proposed to be crucial 
for the input half-channel of the ND5 proton-pumping module. Glu145 is one of 
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the key residues accepting protons from the matrix side of the membrane and 
passing it to the proton translocation chain (Fiedorczuk et al., 2016). Ala171 is 
located on TMH7, close to the cavity making an entry point for protons. Change 
to a larger and hydrophobic side chain may affect accessibility of the key 
residues to protons. The same would apply to Ala236 and Met237 situated 
almost opposite to Ala171 on the broken TMH8. Ser244 located on the π-bulge 
containing TMH8 is one of the amino acids linking the input and output paths of 
the ND5 translocation chain. Asp393 is placed next to the key Lys392 and 
builds the proton outlet cavity in this module. Very likely mutations in all of the 
indicated positions influence proton-pumping efficiency.  
 
Tyr159 directly interacts with ND4 residues on the matrix site of the membrane, 
so a mutation in this region probably affects stability of the protein. Gln434 is 
found on the loop that is in direct contact with B12 and B22 subunits; it is 
possible that substitution in this region may disturb its stability and influence 
interaction with complex IV in the supercomplex (Letts, Fiedorczuk, et al., 
2016). Gly465 is found in TMH13 directly opposite to the loop linking the two 
half helices of TMH12. Mutation to a bulkier and charged residue like glutamate 
most likely will strongly interfere with the role of TMH12 in proton pumping.  
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Figure 4.38 Examples of mutations in the ND5 subunit. The ND5 subunit 
pictured as cartoon in pale green, ND4 in brown, natural variants of amino 
acids as light pink sticks and disease causing substitutions as black sticks.  
 
Membrane domain – summary 
One striking observation from the review of all the disease causing point 
mutations in the MD core subunits is that they are localized mostly around the 
first (ND1, ND6) and the last (ND5) proton-pumping modules. Substitutions in 
ND2 and ND4 are much less frequent and mostly found on the periphery of the 
subunits in the regions not likely important for catalysis. The simplest 
explanation for this observation is that blocking the coupling mechanism at the 
level of ND5, ND4, ND2 will reduce complex I efficiency by 25, 50 and 75% 
respectively. However in the studies on the bacterial enzyme it has been shown 
that mutations in the most distal pumping module also affect the pumping 
efficiency of the more proximal ones (Michel, Deleon-Rangel, Zhu, Van Ree, & 
Vik, 2011). Therefore one can argue that the lower rate of observed mutations 
in ND2 and ND4 is also caused by the fact that they not only affect the proton 
pumping activity of a certain module but also cause disassembly or functional 
disconnection of the entire membrane arm translating into severe loss of 
complex I function. In ND1 and ND6 mutations are located around the E-
channel and Q-site where charged and polar residues form large clusters and in 
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the case of mutation in a single residue another one may compensate for its 
function. 
 
4.5.4 Supernumerary subunits 
 
13 kDa (NDUFS6) subunit 
The Cys87Tyr substitution is the only known single amino acid disease-causing 
mutation for this subunit. It has been previously discussed in the ovine complex 
I study (Fiedorczuk et al., 2016). The 13 kDa subunit is the only supernumerary 
complex I protein binding a metal ion, Zn2+. Zinc-binding proteins are known to 
be redox active sensors (Maret, 2005) and it has been proposed that the 13 
kDa subunit may play such a role in complex I (Fiedorczuk et al., 2016). 
Conserved Cys87 is one of the residues co-ordinating the zinc ion. It has also 
been reported that in Yarrowia lipolytica the loss of the 13 kDa subunit results in 
destabilization of the N5 cluster (Kmita et al., 2015). The structure revealed that 
the metal binding domain of the 13 kDa subunit indeed interacts with residues 
co-ordinating the N5 cluster. Additionally the protein also interacts with the 
NADPH binding 39 kDa subunit, which is also proposed to be a sensor for the 
redox state of the mitochondrial matrix. Mutation of Cys87 to another amino 
acid not only destabilizes the zinc-binding site, it also decreases electron 
transfer efficiency by disturbing the N5 cluster and affecting regulatory 
capabilities of the system (Kmita et al., 2015)(Fiedorczuk et al., 2016). 
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Figure 4.39 Mutation in the 13 kDa subunit. The 13 kDa subunit pictured 
as cartoon in pink, 75 kDa in magenta, TYKY in blue, natural variants of 
amino acids as light pink sticks and disease causing substitution as black 
sticks.  
 
18 kDa (NDUFS4) subunit 
A reported disease-causing mutation in the 18 kDa is Asp77His. This 
substitution is located in a loop anchored between the neighbouring 30 kDa, 51 
kDa, 75 kDa core subunits. The change in charge of the residue is likely to 
affect stability of the complex in this region or cause improper assembly.  
 
10 kDa (NDUFV3) subunit 
From the three mutations reported in the literature only one is in the region 
covered by the ovine model. Gly60Asp is located in a coil in the interface 
between 75 kDa, 51 kDa, 24 kDa and 18 kDa subunits and the mutation 
possibly destabilizes this region. The Lys22Asn mutation is in the disordered 
part of both the ovine and bovine models and Glu242Lys is present only in the 
long isoform of the 10 kDa subunit absent in our sample (Bridges et al., 2017). 
Mass spectrometry experiments performed on the ovine sample indicated the 
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presence only of the short (75 amino acids long) form of the protein (Letts, 
Degliesposti, et al., 2016).  
 
39 kDa (NDUFA9) subunit 
The reported mutation Arg286Pro has already been described in a previous 
ovine model study (Fiedorczuk et al., 2016). Arg286 is one of the amino acids 
coordinating the NADPH molecule bound in the centre of the 39 kDa subunit. 
Mutation to proline will cause loss of the co-factor and distortion of the whole 
subunit (van den Bosch et al., 2012), which results in decreased complex I 
activity (Abdrakhmanova et al., 2006). Very interestingly, NADPH is also 
coordinated by Arg178PSST that is located on an α-helix that extends to directly 
contact the N2 cluster. Thus loss of the NADPH molecule caused by the 
Arg286Pro mutation may influence the stability of the terminal FeS cluster. The 
direct connection between these two co-factors can possibly provide a 
mechanism of electron transfer regulation. A change in the reducing 
environment of the mitochondrial matrix may oxidize NADPH to NADP+, which 
likely results in a change in the positioning of the co-factor. This distortion may 
influence the position or potential of the N2 cluster through Arg178-α-helixPSST.  
 
 
Figure 4.40 Mutation in the 39 kDa subunit. The 39 kDa subunit pictured 
as cartoon in cyan, natural variants of amino acids as light pink sticks and 
disease causing substitution as black sticks. Co-factor is labelled. 
 
 
  167 
42 kDa (NDUFA10) and B22 (NDUFB9) subunits 
Both subunits are found on the matrix side of the membrane domain. The 42 
kDa subunit directly binds the ND2 subunit, very close to the MD-PA junction 
and B22 is in the distal part, binding to the ND5 subunit.  
The 42 kDa subunit has a nucleotide kinase fold, although to our knowledge no 
catalytic activity has been reported so far. It has been proposed that the subunit 
has an important regulatory role for complex I hinge/rotation-like arms 
movement (Fiedorczuk et al., 2016).  
 
The disease causing mutation Gly64Glu is located at the interface with the ND2 
and KFYI subunits, so it may decrease stability of the complex in this region. 
The Gln107Arg mutation is found in the central α-helix of the subunit, within the 
nucleotide kinase fold and most likely affects the structure.  
 
The B22 subunit belongs to the LYR protein family and together with the 
interacting partner SDAP-β creates part of a bulge on the distal side of the 
membrane domain. The proteins interact through the phosphopantetheine 
moiety (PNS) covalently bound to Ser44 of SDAP-β and anchored into a 
hydrophobic pocket built by the three N-terminal helices of B22 (Fiedorczuk et 
al., 2016). Two mutations of B22 are reported to cause complex I deficiency 
(Table S5). Leu63Pro occurs at the last α-helix of the bundle, accommodating 
the PNS co-factor. Mutation to proline in the middle of the helix may affect the 
structure of the PNS hydrophobic pocket. If the B22 protein is not able to bind 
PNS, the SDAP/B22 complex likely falls apart and the whole region gets 
destabilized. The hetero dimer is placed directly on the terminal antiporter-like 
ND5 module, so that these changes may affect proton pumping. The second 
mutation Tyr96Cys is located in the long coil of B22 that connects the N-
terminal bundle with the C-terminal part of the protein. The region around Tyr96 
is interacting directly with the ND5, ND4 and SGDH subunits. Thus substitution 
to a very different amino acid most likely influences subunit assembly in this 
area. 
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Figure 4.41 Mutation in the B22 subunit. The B22 subunit pictured as 
cartoon in blue, SDAP-β in magenta, natural variants of amino acids as 
light pink sticks and disease causing substitution as black sticks. PNS co-
factor and covalently bound Ser44SDAP-β are labelled. 
 
MWFE (NDUFA1), PGIV (NDUFA8), B16.6 (NDUFA13), B12 (NDUFB3) and 
15 kDa (NDUFS5) subunits 
These subunits are all located in the membrane domain of complex I on the 
IMS side. Presumably, they mostly play stabilizing roles, important for enzyme 
integrity. Disease causing mutations are mainly located on the interfaces with 
other complex I subunits.  
 
Disease causing substitutions in MWFE are: Gly8Arg, at the interface site with 
ND1; Gly32Arg and Arg37Ser, at a loop interacting with PGIV, ND1 and B16.6; 
Tyr43His, at a short helix interacting with PGIV and ND6. In each of these 
cases, mutation results in an amino acid residue of very different chemical and 
structural nature.  
 
PGIV has two single amino acid mutations reported: Glu108Lys, located at one 
of the α-helices building the heel of the complex (interestingly in sheep lysine is 
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the natural variant in this position (Letts, Degliesposti, et al., 2016)); and 
Arg134Gln, located at the start of a long coil connecting quinone and pumping 
modules.  
 
 
Figure 4.42 Mutations in the PGIV and MWFE subunits. The PGIV 
subunit pictured as cartoon in yellow, MWFE in pink, B16.6 in green, 
natural variants of amino acids as light pink sticks and disease causing 
substitution as black sticks.  
 
For each of the B16.6, B12 and 15 kDa subunits to my knowledge only one 
single point mutation has been reported in the literature so far (Table S5.). 
Lys4AsnB16.6 is located at a start of the N-terminal coil, where it binds to the 
B14.5a subunit. Pro95Ser15-kDa is at the C-terminus of the subunit, which binds 
to and locks the C-terminus of B16.6 to the complex. Trp21ArgB12 is located on 
the N-terminal coil of the subunit. The hydrophobic side chain of tryptophan is in 
contact with B22 and AGGG subunits. Mutation to arginine is likely to affect 
assembly in this area.  
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Figure 4.43 Mutation in the B12 subunit. The B12 subunit pictured as 
cartoon in green, SDAP-β in magenta, B22 in blue, natural variant of 
amino acid as light pink sticks and disease causing substitution as black 
sticks.  
 
B14 (NDUFA6) and MNLL (NDUFB1) subunits 
Mutations Ser3AsnB14 on the matrix side and Met65LeuMNLL on the IMS side are 
located in the disordered parts of the map and hence cannot be modelled. They 
are not likely to play a catalytic role and it remains to be established if they have 
any structural role.  
 
4.5.5 Complex I-related diseases treatment and drug development perspectives  
Complex I deficiencies are caused by a variety of re-arrangements in the 
nuclear or mitochondrial genome (Tucker et al., 2011). The reasons why large 
deletions, insertions or non-sense mutation in complex I subunits or assembly 
factors cause respiratory diseases are easy to understand. They usually result 
in loss or destabilization of entire functional modules or complete loss of 
complex I. In this chapter I focused exclusively on single point missense 
mutations, though it is still very challenging to unambiguously link alterations in 
the genotype with the phenotype of the patients (Table S5).  
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There is no cure for complex I related diseases. The current best treatment is to 
optimize nutrition and reduce physiologic stress. Pharmacological treatment 
includes supplementation with CoQ, riboflavin, L-creatine, L-arginine, L-
carnitine and vitamins: B1, C, E and folinic acid (reduced form of folic acid) 
(Parikh et al., 2009).  
 
4.6 Coupling mechanism of mammalian complex I 
 
The mechanism of coupling between electron transfer and proton translocation 
is still enigmatic. Conservation of key features from bacteria to mammals 
suggests that the basic mechanism is likely the same, with add-on “stabilisers” 
(disulphide - rich subunits) and “regulators” (Zn, NADPH and 
phosphopantetheine – containing subunits). The central axis of polar residues 
in the membrane probably plays a key role (Fig. 4.44). In each catalytic cycle, 
the negative charge stored either on Q or on nearby residues in the enclosed Q 
site may drive conformational changes in ND1 and the proton channel near the 
Q site, which would propagate via the central axis to channels in antiporter-like 
subunits ND2, ND4 and ND5, resulting in changes of pKa and accessibility of 
key residues. The net result would be the pumping of four protons per cycle, 
one per each channel. The observed conformation of loops in the Q site, of the 
presented ovine model built on the “Complete Map”, likely reflects the D state. 
This conformation might also occur during normal function when quinol is 
ejected from the site into the lipid bilayer, if A/D transitions are related to 
conformations encountered during the catalytic cycle (Zickermann et al., 2015). 
Supernumerary subunits implicated in A/D transitions (39 kDa, B13 and SDAP-
α/B14 pair) could also participate in catalytic conformational changes by 
interacting with the key TM1-TM2ND3 loop flanking the Q site, and possibly 
through interactions with the42 kDa subunit (Fig. 4.44). In the “closed” class, 
B13 and SDAP-α move towards 42 kDa (Chapter 4.3), hinting at such a 
possibility. Since the 42 kDa subunit is metazoan-specific (Ulrich Brandt, 2006), 
its role may be to “fine tune” movements during turnover. The traverse helix HL 
from ND5 appears to play mainly a stabilizing “stator” role (G. Belevich et al., 
2011) rather than being a moving element (Efremov et al., 2010). Rigid 
disulphide-rich supernumerary subunits traversing the IMS side of the 
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membrane domain may represent another “stator” element unique to the 
mitochondrial enzyme (Chapter 4.2.2). 
 
 
Figure 4.44 Graphic of the coupling mechanism. Core and some 
putatively regulatory supernumerary subunits are shown. Conformational 
changes, indicated by red arrows, propagate from the Q site/E-channel 
to antiporter-like subunits via the central hydrophilic axis. Shifts of 
helices near the cluster N2 (blue arrows) may help initiate the process. 
ND5 helix HL and traverse helices from four supernumerary subunits on 
the IMS side may serve as stators. Dashed line indicates the shift of 
peripheral arm in the closed conformation. The NADPH-containing 39-
kDa subunit and Zn-containing 13-kDa subunit are essential for activity 
and may serve as redox sensors. Both SDAP subunits interact with their 
LYR partners via flipped-out phosphopantetheine (black line). The net 
result of one conformational cycle, driven by 
NADH:ubiquinoneoxidoreduction, is the translocation of four protons 
across the membrane (black lines indicate possible pathways).  
  173 
5. Summary and future work 
 
 
 
Mitochondrial complex I is an entry point for electrons into the respiratory chain. 
It provides an environment for ubiquinone reduction and translocates four 
protons across the IMM per each molecule of NADH oxidized. Thus it plays a 
key role in the respiration process and its dysfunction is linked to many 
neurological disorders. X-ray crystallography studies on the bacterial enzyme 
provided great insights into the structure of the fourteen conserved core 
subunits (R. Baradaran et al., 2013). However, arrangement of the 30 
remaining supernumerary subunits of the mammalian mitochondrial complex I 
was known only from previous low resolution studies (Vinothkumar et al., 2014).  
 
This work presents the most complete and accurate reconstruction of 
mammalian mitochondrial complex I to date. Data demonstrate that the core of 
the complex is very similar to the bacterial counterpart, indicating the same 
basic mechanism. Supernumerary subunits most likely do not have a direct 
effect on the overall catalysis by the enzyme but rather stabilize and regulate its 
function. The 13 kDa and 39 kDa subunits are proposed to work as redox state 
sensors that may regulate electron flow through the peripheral arm. SDAP-
α/B14 and SDAP-β/B22 paired via a phosphopantetheine moiety provide a 
possible linker between fatty acid production and OXPHOS respiration. Several 
supernumerary subunits may have evolved to provide contacts with other 
complexes within the respirasome. Disulphide-containing intertwined subunits 
lining the IMS side of the complex provide a rigid outer shell for the enzyme in 
the oxidizing environment of the IMS. 
 
Five different conformations of the enzyme observed in this study potentially 
shed a light on different catalytic states of the enzyme. Overall they differ by the 
angle of the PA over the MD which seems to correlate with the accessibility of 
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the ubiquinone-binding site. This indicates that they may reflect the active and 
de-active states of the enzyme, or conformational states during the catalytic 
cycle. As proposed in Chapter 4.3.2, conformational changes of the crucial 
loops in the 49 kDa, ND1 and ND3 subunits in the mammalian enzyme are 
probably initiated by the binding of ubiquinone. Further large-scale 
conformational changes may require interactions of the 42 kDa, B13 and 
SDAP-α/B14 subunits. The models also give some hints about conformational 
changes in the proton pumping modules, specifically the ND5 subunit, during 
catalytic turnover.  
 
The structure allows for investigating the molecular basis of mutations causing 
complex I related diseases (Chapter 4.4). The atomic model of mitochondrial 
complex I can help to develop new drugs for a better treatment of patients 
suffering from complex I deficiency (Anderson, 2003). The structure can provide 
a starting point for structure based, in silico design and in vitro testing of new 
types of molecules that may mitigate severe mitochondrial disorders. Currently 
treatment of complex I deficiencies involves mainly nutrition optimization (Parikh 
et al., 2009). With an atomic model of the complex it is possible to design 
synthetic compounds selectively modulating ROS production at the FMN site, 
electron transfer to ubiquinone or proton translocation. That makes complex I 
an important target for next generation anti-cancer drugs or antibiotics.  
 
One of the most important questions in the field of complex I biology, how 
electron transfer is coupled to proton translocation, still remains unanswered 
(Chapter 1.4.3). It is generally accepted that coupling is triggered by Q 
reduction and requires long-distance conformational changes along the 
membrane domain but the exact mechanism remains elusive. To solve this 
puzzle, high-resolution structures of complex I in the presence of NADH and 
ubiquinone are required. Cryo-EM methods of focused refinements and 
subsequent classification presented in this dissertation may easily be adapted 
for investigation of complex I with bound NADH and ubiquinone-10 analogues. 
 
This work gives hints how future structural work performed on isolated complex 
I can be improved. Most importantly, solubilization reagent should be chosen 
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carefully. Brij-35 proved to be very useful in production of ‘good contrast’ grids 
with even particles distribution, unfortunately it acts as a complex I inhibitor and 
likely was the reason for the disorder of the B14.7 subunit in the presented 
cryo-EM maps. In the described experiments a number of detergents have 
been tested. One that performed well in cryo-EM screens was Cymal-7. The 
utility of Cymal-7 has also been shown in bovine complex I studies 
(Vinothkumar et al., 2014)(J. Zhu et al., 2016). It was also presented that a 
good alternative to detergents are some amphipathic polymers (Flotenmeyer et 
al., 2007). The commonly used Amphipol A8-35 with low concentration (0.02%) 
additives like CHAPS is a very promising solubilization reagent that can be 
used in complex I structural studies (Chapter 3.3). However, specific activity of 
the complex in amphipols yet has to be tested.  
 
Another approach would be studying complex I structure in more native 
environment, mimicking the mitochondrial lipid bilayer. That can be achieved by 
reconstituting purified complex I in nanodiscs or liposomes of desired lipid 
composition. However, using either of these systems one can face certain 
difficulties. Mitochondrial complex I has a very large MD which is at the upper 
limit of currently available membrane scaffold proteins used for nanodiscs 
formation (Hagn et al., 2013). Trapping such a big molecule can be challenging 
and there will be not much space left in the nanodisc for lipids molecules. 
Liposomes, on the other hand, can force the protein to adapt artificial ternary 
structure in the MD region due to the curvature of vesicles. This method will 
also introduce complications during data collection (low number of particles per 
image) and processing (challenging CTF correction due to the unknown Z-axis 
location of protein in thick ice). Additionally, the choice of lipid composition 
mimicking bilayers of the IMM around complex I in native mitochondria is very 
challenging. Those problems can be solved by using styrene-maleic acid (SMA) 
for membrane solubilization (Scheidelaar et al., 2015). It has the ability to 
solubilize membranes in the form of ‘nanodisks’ allowing extraction and 
purification of membrane proteins from their native environment in a single, 
detergent-free step. However, using SMA will require developing a novel 
purification protocol.  
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Once a better method for solubilization of the protein in an active state is 
developed, the sample can be incubated with NADH and ubiquinone and frozen 
to capture different conformational states of the enzyme. The idea would be to 
allow complex I to achieve full oxidoreductase activity with these substrates and 
then snap-freeze it for cryo-EM, so that different conformations can then be 
computationally sorted. Comparison of complex I states revealed by this study 
and future structures of the catalytically active enzyme are likely to give us a 
detailed catalytic mechanism of the enzyme’s action. Performing a similar 
experiment with addition of different inhibitors can add to our knowledge about 
the complex I coupling mechanism by possibly trapping the molecule in certain 
catalytic states. The biggest group of complex I inhibitors are quinone binding 
site competitors (Esposti, 1998). Other inhibitors, presumably binding close to 
the proton translocation sites, like metformin (Viollet, 2014) or bivalent ions, 
especially Zn2+ (Sharpley, 2006) may help to indicate precisely proton 
translocation paths. Although a number of these inhibitors has been known for 
years, still there is no mammalian complex I structure with inhibitor bound. For 
that reason, structural data about complex I with any of the inhibitors bound 
would be of great interest of the field.  
 
Another powerful approach is a combination of structural biology with 
mutagenesis studies. Nuclear encoded mammalian complex I proteins can be 
mutated in order to investigate the function of presumably crucial amino acids at 
FMN or ubiquinone binding sites. Mutagenesis experiments targeting the 
mitochondria-encoded part of the enzyme will probably be more challenging 
and a better model here would be a bacterial homologue. Since, very likely, 
coupling and proton pumping mechanisms are in principle identical in bacteria 
and eukaryotes, the prokaryotic model would be easier to use for studies of 
mutations in the TM core part of the protein.  
 
Complex I in mitochondria is physiologically found mostly in the form of 
supercomplexes (Schagger & Pfeiffer, 2001). This fact suggests that individual 
respiratory complexes should be studied not only in isolation but also together 
as a respirasome. Recent studies have presented moderate resolution 
structures of I1III2IV1supercomplex (Letts, Fiedorczuk, et al., 2016)(Wu et al., 
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2016) in detergent. To fully understand the OXPHOS mechanism, high-
resolution models of all IMM complexes and supercomplexesare required. 
Thanks to the recent developments, single particle cryo-EM allows achievement 
of resolutions high enough to obtain maps interpretable on the atomic scale. 
Also here, the use of respiratory complex inhibitors may be very insightful. 
Blocking one of the enzymes in the supercomplex after it achieves full 
oxidoreductase activity can help to understand processes in other enzymes and 
their interactions. For example, inhibition of cytochrome c oxidase with KCN 
may help to capture complex I, functionally located upstream, in fully reduced 
conformation.  
 
Single particle studies of supercomplexes just like isolated complex I require 
removing protein form the native lipid environment, which can cause irreversible 
damage. Again, it would be desirable to have a possibility to investigate 
proteins’ structures in the native lipid bilayer. However, because of their 
substantial size, supercomplexes are even more difficult to reconstitute in lipid 
membrane substitute systems. Bypassing this obstacle may be possible with 
cryo-electron tomography, which currently does not offer high enough 
resolution, but hopefully in a few years will develop to permit scientists to look at 
proteins in the lipid membrane at high enough resolution. 
 
Currently cryo-EM is developing very rapidly. Every month brings new 
improvements and tools enabling higher resolution structures in a faster and 
easier way. New types of data collection grids (Russo, 2015), improved 
processing software (Kimanius, 2016), detectors (http://www.gatan.com/k3-
camera) or phase plates (Danev, 2017) are only examples of current 
developments in the field. With the new EM hardware and software combined 
with biochemical methods based on mutagenesis and use of specific inhibitors, 
understanding of complex I coupling mechanism and physiological relevance of 
mitochondrial supercomplexes seems to be just a matter of time.  
 
In summary, the presented study provides insights into the structure and 
function of all mitochondrial complex I subunits and shows global changes in 
the enzyme’s structure that may be assigned to different catalytic states of the 
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molecule. It allows for better understanding of function of the supernumerary 
subunits and mutations leading to complex I deficiency. It enlarges the scope of 
our knowledge regarding one of the most basic metabolic processes – cellular 
respiration. However, more structures at higher resolution and of different 
catalytic states are required. They will improve not only our understanding of 
the very basic processes in our cells – ATP production – but in time will 
hopefully affect the life and well-being of patients suffering from mitochondrial 
illnesses.  
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Subunits: 
Human 
Nomenclature 
Bovine Ovine Porcine  
Subunits: 
Common ‘Bovine’ 
Nomenclature 
Ovine Porcine 
Core        
NDUFV1 97.5 98.0 97.5  51 kDa 99.5 98.7 
NDUFV2 98.6 98.2 97.2  24 kDa 99.5 97.7 
NDUFS1 97.4 97.3 97.2  75 kDa 99.3 96.7 
NDUFS2 95.4 95.6 95.8  49 kDa 99.8 98.6 
NDUFS3 94.7 95.2 93.9  30 kDa 97.4 95.2 
NDUFS7 92.7 92.7 92.2  PSST 100 96.1 
NDUFS8 96.0 96.01 96.0  TYKY 1001 98.3 
Average Nuclear: 96.0 96.1 95.7   99.4 97.3 
ND1 78.0 78.0 77.0  ND1 93.7 89.6 
ND2 63.1 63.1 62.0  ND2 91.9 75.8 
ND3 73.9 73.0 71.3  ND3 94.8 90.4 
ND4 74.1 75.2 73.2  ND4 92.8 86.5 
ND4L 73.5 76.5 76.5  ND4L 93.9 86.7 
ND5 69.5 69.6 69.5  ND5 90.6 81.7 
ND6 62.3 61.1 57.7  ND6 93.7 88.6 
Average Mito: 70.6 70.9 69.6   93.1 85.6 
Supernumerary       
NDUFS4 95.5 95.5 95.5  18 kDa 98.5 95.5 
NDUFS5 74.3 70.5 79.0  15 kDa 90.5 88.6 
NDUFS6 89.6 90.61 88.5  13 kDa 97.91 93.8 
NDUFV3 86.7 88.01 29.32  10 kDa 98.71 33.32 
NDUFA1 80.0 80.0 80.0  MWFE 95.7 81.4 
NDUFA2 93.9 93.9 94.9  B8 100 94.9 
NDUFA3 83.1 83.1 78.3  B9 98.8 85.5 
NDUFA5 87.0 87.0 87.8  B13 98.3 94.8 
NDUFA6 90.6 90.6 89.0  B14 98.4 92.9 
NDUFA7 88.4 87.5 90.2  B14.5a 96.4 92.0 
NDUFA8 87.7 87.1 90.6  PGIV 98.2 95.9 
NDUFA9 79.7 80.9 83.3  39 kDa 96.2 87.8 
NDUFA10 80.6 79.7 79.7  42 kDa 94.7 87.5 
NDUFA11 72.1 70.0 69.3  B14.7 95.7 90.0 
NDUFA12 89.7 89.7 89.0  B17.2 100 95.2 
NDUFA13 83.2 83.2 86.7  B16.6 95.8 93.7 
NDUFAB1 97.7 97.7 96.6  SDAP 100 98.9 
NDUFB1 82.5 77.2 82.5  MNLL 94.7 84.2 
NDUFB2 90.3 90.3 88.9  AGGG 100 95.8 
NDUFB3 82.5 83.5 84.5  B12 99.0 95.9 
NDUFB4 73.4 75.0 78.1  B15 93.8 87.5 
NDUFB5 85.3 85.5 100  SGDH 95.8 85.3 
NDUFB6 78.0 78.0 71.7  B17 97.6 86.6 
NDUFB7 86.8 85.3 85.3  B18 98.5 93.4 
NDUFB8 85.4 86.1 85.4  ASHI 98.7 93.0 
NDUFB9 91.0 89.3 91.1  B22 96.6 93.3 
NDUFB10 78.5 78.0 77.4  PDSW 97.7 93.1 
NDUFB11 85.6 85.6 83.2  ESSS 98.4 90.4 
NDUFC1 81.6 79.6 83.7  KFYI 98.0 93.9 
NDUFC2 73.3 75.0 73.3  B14.5b 93.3 85.0 
Average: 84.5 83.9 83.1   96.3 89.5 
Table S1. Comparison of sequences of core and accessory subunits between three easily available 
organisms: Sus scrofa, Bost taurus, Ovis aries and human enzyme.Sequence identity of mammalian 
complexes I relative to human (left) and bovine (right). After Letts et al (Letts, Degliesposti, et al., 2016).  
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Subunit 
Mature subunit 
size1 
Identification  
Bovine 
name 
Human 
name 
#aa 
MW 
(kDa) 
Initial 
preparation 
Improved 
preparation 
Sequence Database 
Accession Number 
51 kDa NDUFV1 445 48.6 YES YES Uniprot # W5PUX0  
24 kDa NDUFV2 217 23.8 YES YES Uniprot # W5NRY1  
75 kDa NDUFS1 704 76.9 YES YES Uniprot # W5QB34  
49 kDa NDUFS2 430 49.1 YES YES Uniprot # W5PJ73  
30 kDa NDUFS3 228 26.4 YES YES Uniprot # W5PB27  
PSST NDUFS7 179 20.1 YES YES Uniprot # W5PPP6  
TYKY NDUFS8 176 20.2 YES YES NCB Accession # 
XP_011972879.1 
ND1 ND1 318 35.9 YES YES Uniprot # O78747  
ND2 ND2 347 39.1 YES YES Uniprot # O78748  
ND3 ND3 115 13.1 NO YES Uniprot # O78753  
ND4 ND4 459 52 YES YES Uniprot # O78755  
ND4L ND4L 98 10.8 NO NO Uniprot # O787542 
ND5 ND5 606 68.4 YES YES Uniprot # O78756  
ND6 ND6 175 19.1 NO YES Uniprot # O78757  
       
18 kDa NDUFS4 133 15.3 YES YES Uniprot # W5PE07  
15 kDa NDUFS5 105 12.4 YES YES Uniprot # W5QFF9  
13 kDa NDUFS6 96 10.6 YES YES NCB Accession # 
XP_011980592.1 
10 kDa NDUFV3 75 8.4 NO YES NCB Accession # 
XP_011991231.1 
MWFE NDUFA1 70 8.2 NO YES NCB Accession # 
NP_001305903.1 
B8 NDUFA2 98 10.9 YES YES Uniprot # W5QAH8  
B9 NDUFA3 83 9.2 YES YES Uniprot # W5NYM7  
B13 NDUFA5 115 13.1 YES YES Uniprot # W5PNX7  
B14 NDUFA6 127 14.9 YES YES Uniprot # W5QC06  
B14.5a NDUFA7 112 12.4 YES YES NCB Accession # 
XP_004008614.1 
PGIV NDUFA8 171 20 YES YES Uniprot # W5PYA5  
39 kDa NDUFA9 344 39 YES YES Uniprot # W5PI58  
42 kDa NDUFA10 320 36.8 YES YES Uniprot # W5QBF5 
B14.7 NDUFA11 140 14.6 YES YES Uniprot # W5PAR2  
B17.2 NDUFA12 145 17.1 YES YES Uniprot # B9VGZ9 
B16.6 NDUFA13 143 16.6 YES YES NCB Accession # 
XP_004008450.1 
SDAP NDUFAB1 88 10.1 YES YES Uniprot # W5NQT7  
MNLL NDUFB1 57 6.9 YES YES NCB Accession # 
XP_004018002.1 
AGGG NDUFB2 72 8.5 YES YES Uniprot # W5PVD7  
B12 NDUFB3 97 11 YES YES Uniprot # W5Q5T4  
B15 NDUFB4 128 15 NO YES NCB Accession XP_004003003.1 
SGDH NDUFB5 143 16.7 YES YES Uniprot # W5QHN8  
B17 NDUFB6 127 15.4 YES YES Uniprot # W5PZE3  
B18 NDUFB7 136 16.3 YES YES Uniprot # W5P5V3  
ASHI NDUFB8 158 18.8 YES YES Uniprot # W5Q1B0  
B22 NDUFB9 178 21.6 YES YES Uniprot # W5PGA3  
PDSW NDUFB10 175 20.8 YES YES NCB Accession # 
XP_011999786.1 
ESSS NDUFB11 125 14.4 YES YES Uniprot # W5PWF1 
KFYI NDUFC1 49 5.8 NO YES NCB Accession # 
XP_004017292.1 
B14.5b NDUFC2 120 14.2 NO YES NCB Accession # 
XP_004019479.1 
Table S2. Mass spectrometry identification of complex I subunits from the initial and improved 
preparations. Note that the absence of many subunits in the initial sample is probably due to suboptimal 
performance of the experiment. Sites of mitochondrial targeting sequence removal were determined 
experimentally by peptide identification and/or by sequence alignment with the bovine subunits.   
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Figure S1A. SDS-PAGE of complex I from the initial DDM purification. Numbers represent 
bands that were cut out from the gel and analysed by tryptic peptide mass fingerprinting. 
Numbers (2a) and (2b) are side notes that should be ignored. B. Complex I subunits and 
contaminants identified by tryptic peptide mass fingerprinting. Numbers correspond to bands 
labelled on the gel Fig. S1A. In red protein contaminates.   
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Figure S2 Local resolution estimation by Resmap of A. Entire complex I B. Peripheral arm 
focused refinement map C. Membrane domain focused refinement map. Maps are coloured 
according to the shown resolution scale in Å. 
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Subunit Name 
Bovine / Human C
h
a
in
 
Total residues / 
range built 
Poly-ALA 
model 
Un-modelled 
residues 
% atomic 
model 
TMHs Cofactors / Notes 
C 
o 
r  
e 
51 kDa / NDUFV1 1 445 / 7-438 - 
1-6, 
439-445 
97.1 - 
FMN 
N3 (4Fe[51]) 
24 kDa / NDUFV2 2 217 / 3-216 - 1-2, 217 98.6 - N1a (2Fe[24]) 
75 kDa / NDUFS1 3 704 / 6-693 - 
1-5, 
694-704 
97.7 - 
N1b (2Fe[75]) 
N4 (4Fe[75]C) 
N5 (4Fe[75]H) 
49 kDa / NDUFS2 4 430 / 44-430 - 1-43 90.0 - - 
30 kDa / NDUFS3 5 228 / 7-214 - 
1-6, 
215-228 
91.2 - - 
PSST / NDUFS7 6 179 / 25-179 - 1-24 86.6 - N2 (4Fe[PS]) 
TYKY / NDUFS8 9 176 / 1-176 - - 100 - 
N6a (4Fe[TY]1) 
N6b (4Fe[TY[2) 
ND1  H 318 / 1-318 - - 100 8  
ND2   N 347 / 1-347 - - 100  11 (antiporter-like) 
ND3   A 115 / 1-115 - - 100 3  
ND4   M 459 / 1-459 - - 100  14 (antiporter-like) 
ND4L  K 98 / 1-86 - 87-98 87.8 3  
ND5  L 606 / 1-568 509-598 599-606 84.0 16 (antiporter-like) 
ND6  J 
175 / 1-108, 
123-175 
77-122 - 73.7 5 - 
S 
u 
p 
e 
r  
n 
u
m
e 
r 
a 
r 
y 
10 kDa / NDUFV3 a 75 / 34-74 - 1-33, 75 54.7 - - 
13 kDa / NDUFS6 b 96 / 1-95 - 96 99.0 - Zn2+ 
18 kDa / NDUFS4 c 133 / 11-133 - 1-10 92.5 - - 
39 kDa / NDUFA9 d 
345 / 1-252, 
277-338 
325-338 
253-276,  
339-345 
87.0 - NADPH 
B8 / NDUFA2 e 98 / 13-96 - 
1-12, 
97-98 
85.7 - Thioredoxin fold 
B13 / NDUFA5 f 115 / 4-115 - 1-3 97.4 - - 
B14 / NDUFA6 g 127 / 14-127 - 1-13 89.8 - LYR protein 
B14.5a / NDUFA7 h 
112 / 1-71, 89-
112 
- 72-88 84.8 - - 
B17.2 / NDUFA12 i 145 / 1-144 - 145 99.3 - - 
SDAP-  / NDUFAB1 j 88/ 3-87 - 1-2, 88 96.6 - 
Acyl carrier protein 
phosphopantetheine 
42 kDa / NDUFA10 k 320 / 1-320 227-320 - 70.9 - Nucleoside kinase family 
15 kDa / NDUFS5 l 105 / 1-95 - 96-105 90.5 - 
Quadruple CX9C 
2 CHCH domains 
B9 / NDUFA3 m 83 / 4-83 - 1-3 96.4 1 STMD 
B12 / NDUFB3 n 97 / 13-86 83-86 
1-12, 
87-97 
73.2 1 STMD 
B14.5b / NDUFC2 o 120 / 1-120 - - 100 2 - 
B15 / NDUFB4 p 
128 / 17-73, 
95-128 
17-27, 
74-94 
1-16 62.5 1 STMD 
B16.6 / NDUFA13 q 143 / 4-143 - 1-3 97.9 1 
Identical to  
GRIM-19, STMD 
B17 / NDUFB6 r 
127 / 1-37, 63-
118 
63-71 38-62, 119-127 66.1 1 STMD 
B18 / NDUFB7 s 136 / 5-122 5-15 
1-4, 
123-136 
78.7 - 
Double Cx9C 
CHCH domain 
B22 / NDUFB9 t 178 / 9-174 - 
1-8, 
175-178 
93.3 - LYR protein 
AGGG / NDUFB2 u 72 / 3-68 - 
1-2, 
69-72 
91.7 1 STMD 
ASHI / NDUFB8 v 
158 / 1-84, 
101-143 
1-100 144-158 27.2 1 STMD 
ESSS / NDUFB11 w 125 / 38-123 - 
1-37, 
124-125 
68.8 1 STMD 
KFYI / NDUFC1 x 49 / 1-48 - 49 98.0 1 STMD 
MNLL / NDUFB1 y 57 / 4-56 - 1-3, 57 93.0 1 STMD 
MWFE / NDUFA1 z 70 / 2-70 - 1 98.6 1 STMD 
PDSW / NDUFB10 Z 175 / 3-173 - 
1-2, 
174-175 
97.7 - - 
PGIV / NDUFA8 Y 171 / 1-171 - - 100 - 
Quadruple CX9C 
2 CHCH domains 
SDAP-  / NDUFAB1 X 88 / 1-88 - - 100 - 
Acyl carrier protein 
phosphopantetheine 
SGDH / NDUFB5 W 143 / 5-143 - 1-4 97.2 1 STMD 
B14.7 / NDUFA11 V 140 / 7-125 7-125 21 0 4 - 
 Total  8516 / 8037 518 479 88.3 78  
Table S3. Summary of the model. Figure prepared by Dr James Letts.  
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Subunit 
Surface 
area, Å2 
Buried area, 
Å2 
ΔGint 
kcal/mol 
NHB NSB 
Interacting subunits 
(Descending buried area order, core subunits in bold) 
Entire complex summary  
 297384.9 259150.4 -1838.5    
Core subunits  
51 kDa 19017.7 6988.3 -12.38 77 18 
24 kDa,75 kDa, 10 kDa, 18 kDa, B14.5a 
24 kDa 14271.6 5144.8 -34.27 43 15 51 kDa, 10 kDa, 75 kDa, 18 kDa, 13 kDa 
75 kDa 29733.9 10317.9 -23.97 102 43 
18 kDa, 51 kDa, B8, 49 kDa, 24 kDa,30 kDa, B17.2, B14, 
TYKY, 13 kDa, B14.5a, 39 kDa, 10 kDa 
49 kDa 17459.5 11703.0 -39.24 93 37 
30 kDa, TYKY, PSST, B14.5a, ND1, B16.6, 75 kDa, B13, 
ND3, 13 kDa, B14 
30 kDa 14832.7 9972.2 -40.37 79 34 
49 kDa, B13, 18 kDa, B14.5a B14 PSST, 75 kDa, 39 kDa, 
TYKY 
PSST 9483.5 6258.3 -26.86 47 31 49 kDa, ND1, TYKY, 30 kDa, 39 kDa, ND3, B17.2, B14 
TYKY 13499.4 10446.6 -47.00 87 33 
49 kDa, B17.2, PSST, B14.5a, 13 kDa, ND1, 75 kDa, B16.6, 
B9, 30 kDa, 18 kDa, 39 kDa, MWFE 
ND1 16976.8 11161.2 -98.77 61 21 
ND3, MWFE, PSST, 49 kDa, ND6, B16.6, TYKY, B9, PGIV, 
B17.2 
ND2 16531.5 9336.0 -106.34 19 1 ND4L, 42 kDa, ND4, B14.5b, 15 kDa, ND5, SGDH 
ND3 10944.8 6994.6 -81.41 15 0 ND1, ND6, ND4L, PSST, 49 kDa, B9, 39 kDa, B14, B16.6 
ND4 18758.1 11100.2 -98.26 42 3 
ND5, ESSS, ND2, B15, SGDH, MNLL, PDSW, B22, PGIV, 
B14.5b, ASHI 
ND4L 6435.4 4638.4 -64.53 7 2 ND6, ND2, 15 kDa, ND3 
ND5 26832.2 10837.8 -94.45 47 5 
ND4, AGGG, B22, PDSW, ASHI, B17, B18, B12, B15, ND2, 
SDAP- , SGDH, B14.7 
ND6 12734.4 8272.0 -95.71 19 2 ND4L, ND3, ND1, 15 kDa, B16.6, MWFE 
Supernumerary subunits 
 
10 kDa 4892.2 2471.0 -15.11 23 9 51 kDa, 24 kDa, 18 kDa, 75 kDa 
13 kDa 7651.1 2991.2 -10.11 16 6 TYKY, B17.2, 39 kDa, 75 kDa, 49 kDa, 24 kDa 
18 kDa 11083.8 5848.7 -11.52 57 20 
75 kDa, 30 kDa, B14, 51 kDa, 39 kDa, 10 kDa, TYKY, 24 kDa, 
B17.2 
39 kDa 16659.0 3814.3 -5.70 20 11 PSST, 13 kDa, 30 kDa, B14, 18 kDa, ND3, 75 kDa, TYKY 
B8 5628.2 1196.4 -2.44 13 10 75 kDa 
B13 8653.4 2370.0 -15.60 14 5 30 kDa, 49 kDa, B14.5a 
B14 9627.2 4586.9 -9.29 31 19 
SDAP- 30 kDa, 18 kDa, 75 kDa, 39 kDa, ND3, 49 kDa, 
PSST 
B14.5a 11473.6 5753.0 -40.33 49 17 49 kDa, 30 kDa, TYKY, 75 kDa, B17.2, B13, B16.6, 51 kDa 
B17.2 12313.0 4593.5 -25.36 40 9 TYKY, 13 kDa, 75 kDa, B14.5a, PSST, ND1, 18 kDa 
SDAP-  5667.7 731.3 -3.93 7 12 B14 
SDAP-  6074.4 2554.8 -9.23 22 26 B22, B17, B12, ND5, AGGG 
42 kDa 16761.9 1942.1 -19.89 2 0 ND2, KFYI, B14.5b 
15 kDa 9228.8 5236.4 -29.49 27 9 SGDH, B16.6, ND2, ND6, ND4L, PGIV, B14.5b 
B9 8142.1 3420.4 -27.55 19 8 PGIV, ND1, B16.6, TYKY, ND3, SGDH 
B12 7188.3 2427.6 -13.38 14 7 ND5, AGGG, SDAP- , B22 
B14.5b 10935.4 5873.6 -39.62 31 8 
ND2, KFYI, PDSW, SGDH, PGIV, ND4, 15 kDa, ESSS, 42 
kDa, B15 
B15 10929.5 3772.9 -15.63 16 0 ND4, ASHI, B22, ND5, PDSW, B14.5b 
B16.6 14451.0 7839.8 -51.27 42 12 
PGIV, 15 kDa, ND1, 49 kDa, ND6, MWFE, B9, TYKY, B14.5a, 
ND3, SGDH 
B17 10137.0 4528.8 -24.39 29 6 B22, PDSW, ND5, B18, SDAP- , SGDH 
B18 9860.6 3512.3 -6.33 24 6 ND5, AGGG, ASHI, B17, PDSW 
B22 14868.0 5662.9 -32.67 25 15 ND5, B17, SDAP- , B15, SGDH, B12, ND4, ASHI 
AGGG 7273.2 3125.3 -26.86 17 7 ND5, B18, B12, SDAP- , ASHI 
ASHI 11797.4 2971.5 -22.74 10 1 B15, ND5, B18, ND4, AGGG, B22 
ESSS 8835.5 4764.1 -39.36 21 5 ND4, PDSW, SGDH, B14.5b 
KFYI 5365.5 1349.6 -12.98 0 2 B14.5b, 42 kDa 
MNLL 5714.8 1719.4 -14.42 9 5 ND4, SGDH, PDSW 
MWFE 6638.2 3788.4 -29.68 29 4 ND1, PGIV, B16.6, ND6, TYKY 
PDSW 15770.6 7444.1 -35.07 54 8 ESSS, SGDH, ND5, B17, B14.5b, ND4, B18, B15, MNLL 
PGIV 14545.4 6552.6 -38.16 49 28 B16.6, B9, MWFE, SGDH, B14.5b, 15 kDa, ND4, ND1 
SGDH 14101.4 8031.0 -55.12 40 10 
ND4, PDSW, 15 kDa, ESSS, B14.5b, MNLL, PGIV, B22, ND2, 
B17, ND5, B16.6, B9 
Table S4 Summary of interactions between subunits of ovine complex I. Analysis was performed 
using the PISA server (www.ebi.ac.uk/pdbe/pisa/). ΔGint indicates the solvation free energy gain 
upon formation of the assembly, NHB – number of hydrogen bonds at the interface and NSB – 
number of salt bridges at the interface 
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Subunit name 
Location 
Most 
frequently 
reported 
clinical feature 
Mutation 
Proposed 
reason for 
complex I 
disfunction 
Reference 
Human Bovine 
NDUFS1 
75 
kDa 
Peripheral 
domain/core 
Leigh 
syndrome 
Val48Asp DE 
(Haack, Madignier, 
et al., 2012) 
Gly143Glu DE 
(Danhauser et al., 
2011) 
Val205Ala DE 
(Pagniez-Mammeri 
et al., 2009) 
Leu208Val DE (Martin et al., 2005) 
Arg218Trp DA (Benit et al., 2001) 
Asp229Gly DA (Benit et al., 2001) 
Arg385Cys DA (Hoefs et al., 2010) 
Gln499Lys DA (Bugiani et al., 2004) 
Thr572Ala DA 
(Ferreira et al., 
2011) 
Asp596Asn DA (Visch et al., 2004) 
Tyr672His DA 
(Haack, Madignier, 
et al., 2012) 
Tyr672Cys DA 
(Haack, Madignier, 
et al., 2012) 
Met684Val DA (Benit et al., 2001) 
NDUFV1 
51 
kDa 
Peripheral 
domain/core 
Leigh 
syndrome 
Ser36Pro DA (Koene et al., 2012) 
Arg68Gly DE (Marin et al., 2013) 
*Lys91Glu DA (Calvo et al., 2010) 
Pro102Leu DE (Lieber et al., 2013) 
*Arg127Trp DA (Calvo et al., 2010) 
Arg179Pro DA (Marin et al., 2013) 
Tyr184Cys DE (Benit et al., 2001) 
Cys186Gly DA,DE (Benit et al., 2001) 
Ala191Val DA,DE 
(Schuelke et al., 
2002) 
Glu194Lys DA,DE (Benit et al., 2001) 
*Pro232Arg DA (Calvo et al., 2010) 
Ala321Val DA 
(Schuelke et al., 
1999) 
*Glu357Lys DA,DE (Calvo et al., 2010) 
*Arg366His DE (Calvo et al., 2010) 
Arg366Cys DE 
(Breningstall, 
Shoffner, & 
Patterson, 2008) 
Thr403Met DE 
(Schuelke et al., 
1999) 
Ala412Pro DE (Benit et al., 2001) 
NDUFS2 
49 
kDa 
Peripheral 
domain/core 
Leigh 
syndrome, 
hypertrophic 
cardiomyopaty 
Asp77Val DA 
(Haack, 
Haberberger, et al., 
2012) 
Arg85Gln DA,DE 
(Tuppen et al., 
2010) 
Arg105Gln DA,DE 
(Tuppen et al., 
2010) 
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Glu115Lys DA 
(Tuppen et al., 
2010) 
Ala191Val DA,DE (Bugiani et al., 2004) 
Arg195Gln DA (Loeffen et al., 2001) 
Pro196Gln DA (Loeffen et al., 2001) 
Met259Thr DA 
(McFarland et al., 
2009) 
Arg290Gln DA 
(Haack, 
Haberberger, et al., 
2012) 
Arg300Gln DA 
(Tuppen et al., 
2010) 
Ser380Pro DA (Loeffen et al., 2001) 
*Ala393Ser DA (Calvo et al., 2010) 
Met410Lys DA 
(Tuppen et al., 
2010) 
Asp413Asn DA 
(Distelmaier et al., 
2009) 
NDUFS3 
30 
kDa 
Peripheral 
domain/core 
Leigh 
syndrome 
Thr109Ile DA (Benit et al., 2004) 
Arg163Trp DA (Benit et al., 2004) 
Pro187Leu DA 
(Pagniez-Mammeri 
et al., 2009) 
NDUFV2 
24 
kDa 
Peripheral 
domain/core 
Hypertrophic 
cardiomyopaty 
Lys177Arg DA 
(Nishioka et al., 
2010) 
NDUFS8 TYKY 
Peripheral 
domain/core 
Leigh 
syndrome, 
hypertrophic 
cardiomyopaty 
Arg20Trp DA (Marina et al., 2013) 
Glu29Gln DA 
(Haack, 
Haberberger, et al., 
2012) 
Arg43Trp DA 
(Haack, 
Haberberger, et al., 
2012) 
Pro45Leu DA (Loeffen et al., 1998) 
Pro51Leu DA 
(Procaccio & 
Wallace, 2004) 
Arg60Cys DA (Visch et al., 2006) 
Arg68His DE (Loeffen et al., 1998) 
Arg104His DA,DE 
(Procaccio & 
Wallace, 2004) 
*Gly120Ser DE (Calvo et al., 2010) 
Ala125Asp DE 
(Haack, 
Haberberger, et al., 
2012) 
NDUFS7 PSST 
Peripheral 
domain/core 
Leigh 
syndrome 
Val84Met DE (Loeffen et al., 1998) 
Arg107His DA,DE (Lebon et al., 2007) 
MT-ND6 ND6 
Membrane 
domain/ core 
Broad 
spectrum 
Ser132Leu DA, DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Asn117Asp DA, DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Ala72Val DP (Ravn et al., 2001) 
Ala74Val DP 
(Jun, Brown, & 
Wallace, 1994) 
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Met64Ile DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Tyr59Cys DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Leu60Ser DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Gly36Ser DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Ile26Met 
DA, 
catalysis 
(Yu-Wai-Man & 
Chinnery, 1993) 
Met64Val DP 
(Macmillan, Johns, 
Fu, & Shoubridge, 
2000) 
MT-ND5 ND5 
Membrane 
domain/ core 
Broad 
spectrum 
Phe124Leu DP 
(Taylor, Morris, 
Hutchinson, & 
Turnbull, 2002) 
Glu145Gly DP 
(Liolitsa, Rahman, 
Benton, Carr, & 
Hanna, 2003) 
Tyr159His DA 
(Yu-Wai-Man & 
Chinnery, 1993) 
Ala171Val DP 
(Mayorov, Biousse, 
Newman, & Brown, 
2005) 
Ala236Thr DP (Naini et al., 2005) 
Met237Leu DP (Liolitsa et al., 2003) 
Ser244Cys DP (Crimi et al., 2003) 
Asp393Asn DP 
(Sudo, Honzawa, 
Nonaka, & Goto, 
2004) 
Asp393Gly DP (Bugiani et al., 2004) 
Gln434Arg DA 
(Yu-Wai-Man & 
Chinnery, 1993) 
Gly465Glu DA 
(Howell, Halvorson, 
Burns, McCullough, 
& Paulton, 1993) 
Ser250Cys DP (Crimi et al., 2003) 
MT-ND4L ND4L 
Membrane 
domain/ core 
Leber optic 
atrophy 
Val65Ala DP (Brown et al., 2002) 
Cys32Arg DP (Polyak et al., 1998) 
MT-ND4 ND4 
Membrane 
domain/ core 
Broad 
spectrum 
Ile165Thr DA 
(Leo-Kottler, 
Luberichs, Besch, 
Christ-Adler, & 
Fauser, 2002) 
Val313Ile DA 
(Yu-Wai-Man & 
Chinnery, 1993) 
Arg340Ser DA 
(Q. Wang et al., 
2005) 
Arg340His DA 
(Wallace et al., 
1988) 
Tyr409His DA 
(Vanniarajan et al., 
2006) 
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MT-ND3 ND3 
Membrane 
domain/ core 
Leigh 
syndrome, 
leber optic 
atrophy 
Ser34Pro DP 
(McFarland et al., 
2004) 
Ser45Pro DP 
(McFarland et al., 
2004) 
Gly47Ala DP (Sarzi et al., 2007) 
Ile60Thr DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Glu66Asn DP 
(Leshinsky-Silver et 
al., 2010) 
MT-ND2 ND2 
Membrane 
domain/ core 
Broad 
spectrum 
Ile57Met DA (Brown et al., 2001) 
Leu71Pro DA 
(Hinttala et al., 
2006) 
Gly259Ser DA (Brown et al., 1992) 
Ala331Ser DA 
(Q. Wang et al., 
2005) 
MT-ND1 ND1 
Membrane 
domain/ core 
Broad 
spectrum 
Val11Met DE (Blakely et al., 2005) 
Leu28Met DE 
(Gutierrez Cortes et 
al., 2012) 
Tyr30His DE 
(Obayashi et al., 
1992) 
Met31Val DE 
(Hutchin & 
Cortopassi, 1995) 
Met53Ile DE (Funalot et al., 2002) 
Glu59Lys DE 
(Moslemi et al., 
2008) 
Ser110Asn DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Gly131Ser DP (Kirby et al., 2004) 
Ala132Thr DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Glu143Lys DP 
(Yu-Wai-Man & 
Chinnery, 1993) 
Thr164Ala DA (Simon et al., 2003) 
Arg195Gln coupling 
(Moslemi et al., 
2008) 
Val208Leu coupling (Wray et al., 2013) 
Glu214Lys coupling (Kirby et al., 2004) 
Tyr215His coupling (Kirby et al., 2004) 
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Thr240Met DA 
(Yu-Wai-Man & 
Chinnery, 1993) 
Tyr277Cys DP (Howell et al., 1991) 
Leu285Pro DA (Howell et al., 1991) 
Leu289Met DA 
(Yu-Wai-Man & 
Chinnery, 1993) 
Glu24Lys DP (Blakely et al., 2005) 
Ala52Thr DP (Howell et al., 1991) 
Ala112Thr DP 
(Q. Wang et al., 
2005) 
NDUFS4 
18 
kDa 
Peripheral 
domain/ 
supernumerary 
Leigh 
syndrome, 
hypertrophic 
cardiomyopaty 
Asp77His DA 
(Leshinsky-Silver et 
al., 2009) 
NDUFS6 
13 
kDa 
Peripheral 
domain/ 
supernumerary 
Fatal lactic 
acidosis 
Cys87Tyr DA (Spiegel et al., 2009) 
NDUFV3 
10 
kDa 
Peripheral 
domain/ 
supernumerary 
Complex I 
deficiency 
*Lys22Asn not modelled (Calvo et al., 2010) 
*Gly69Asp DA (Calvo et al., 2010) 
*Glu242Lys not modelled (Calvo et al., 2010) 
NDUFA9 
39 
kDa 
Peripheral 
domain/ 
supernumerary 
Leigh 
syndrome 
Arg286Pro 
DA, 
catalysis 
(van den Bosch et 
al., 2012) 
NDUFA6 B14 
Peripheral 
domain/ 
supernumerary 
Complex I 
deficiency 
*Ser3Asn not modelled (Calvo et al., 2010) 
NDUFA1 MWFE 
Membrane 
domain/ 
supernumerary 
Leigh 
syndrome 
Gly8Arg DA 
(Fernandez-Moreira 
et al., 2007) 
Gly32Arg DA (Potluri et al., 2009) 
Arg37Ser DA 
(Fernandez-Moreira 
et al., 2007) 
Tyr43His DA 
 
NDUFA8 PGIV 
Membrane 
domain/ 
supernumerary 
Complex I 
deficiency 
Glu108Lys DA (Bugiani et al., 2004) 
*Arg134Gln DA (Calvo et al., 2010) 
NDUFA10 
42 
kDa 
Membrane 
domain/ 
supernumerary 
Complex I 
deficiency 
Gly64Glu DA 
(Haack, 
Haberberger, et al., 
2012) 
Gln107Arg DA (Hoefs et al., 2011) 
NDUFA13 B16.6 
Membrane 
domain/ 
supernumerary 
Encephalopat
hy 
Lys4Asn DA 
(Maximo et al., 
2005) 
NDUFS5 
15 
kDa 
Membrane 
domain/ 
supernumerary 
Complex I 
deficiency 
*Pro95Ser DA (Calvo et al., 2010) 
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NDUFB1 MNLL 
Membrane 
domain/ 
supernumerary 
Complex I 
deficiency 
*Met65Leu not modelled (Calvo et al., 2010) 
NDUFB3 B12 
Membrane 
domain/ 
supernumerary 
Encephalomyo
pathy, lactic 
acidosis 
*Trp21Arg DA (Calvo et al., 2010) 
NDUFB9 B22 
Membrane 
domain/ 
supernumerary 
Encephalomyo
pathy 
Leu63Pro DA 
(Haack, 
Haberberger, et al., 
2012) 
*Tyr96Cys DA (Calvo et al., 2010) 
 
Table S5 Summary of the single amino acid substitutions in complex I subunits leading to 
complex I deficiencies. DA – disassembly, DE – disruption to electron transfer, DP – 
disruption to proton translocation, * - likely pathogenic. 
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Table S6. Core subunits of complex I. Table modified from prepared by Dr James. 
1Homo sapiens core subunit names are shown for reference, no structures of human Complex I have 
been elucidated 
2 The traditional nomenclature for Fe-S clusters (Nx, derived from initially described electron 
paramagnetic resonance (EPR) signatures), as well as the nomenclature proposed recently on the basis 
of re-assignment of EPR signals to structurally observed clusters, is shown. In the new nomenclature, 
clusters are named according to their nuclearity (2Fe or 4Fe), their subunit location (using bovine 
nomenclature) and when necessary, as ligated by four Cys (C) or three Cys and one His (H).  
3 Number of amino acids in the mature subunit 
4 MW of the mature subunit in kilo-Daltons 
5 Cluster N7 is present only in some bacteria (for example, E. coli and T. thermophilus) 
6 Subunits NuoC and NuoD are fused in E. coli and some other bacteria 
7 Number of transmembrane helices 
  
Module Escherichia 
coli 
Thermus 
thermophilus 
Yarrowia 
lipolytica 
Bos taurus 
(Bovine) 
Homo 
sapiens1 
 
Peripheral arm    Cofactors2 
Dehydrogenase 
(N) 
NuoF Nqo1 NUBM 51 kDa NDUFV1 
FMN 
N3 (4Fe[51]) 
4453 
 
49.34 
 
438 
 
48.6 
 
470 
 
51.6 
 
444 
 
48.5 
 
NuoE Nqo2 NUHM 24 kDa NDUFV2 
N1a (2Fe[24]) 166 
 
18.6 
 
180 
 
20.2 
 
215 
 
24.1 
 
217 
 
23.8 
 
NuoG Nqo3 NUAM 75 kDa NDUFS1 N1b (2Fe[75]) 
N4 (4Fe[75]C) 
N5 (4Fe[75]H) 
(N7)5 
907 
 
100.2 
 
783 
 
86.5 
 
694 
 
75.2 
 
704 
 
77.0 
 
Connecting  
(Q) 
NuoD (NuoCD)6 Nqo4 NUCM 49 kDa NDUFS2 
No cofactor 595 
 
68.1 
 
409 
 
46.4 
 
444 
 
49.9 
 
430 
 
49.1 
 
NuoC Nqo5 NUGM 30 kDa NDUFS3 
No cofactor 
see above 
207 
 
23.4 
 
251 
 
29.2 
 
228 
 
26.4 
 
NuoI Nqo9 NUIM TYKY NDUFS8 N6a 
(4Fe{TY]1) 
N6b 
(4Fe[TY]2) 
180 
 
20.5 
 
182 
 
20.1 
 
198 
 
22.3 
 
176 
 
20.2 
 
NuoB Nqo6 NUKM PSST NDUFS7 
N2 (4Fe[PS]) 
 
220 
 
25.1 
 
180 
 
20.1 
 
183 
 
20.4 
 
179 
 
20.1 
 
Membrane arm    TMH7 
- 
NuoH Nqo8 NU1M ND1 ND1 
8-9 325 
 
36.2 
 
365 
 
41.0 
 
341 
 
38.3 
 
318 
 
35.7 
 
Pumping  
(P) 
NuoA Nqo7 NU3M ND3 ND3 
3 147 
 
16.5 
 
119 
 
13.1 
 
128 
 
14.5 
 
115 
 
13.1 
 
NuoJ Nqo10 NU6M ND6 ND6 
5 184 
 
19.9 
 
176 
 
18.6 
 
185 
 
20.8 
 
175 
 
19.1 
 
NuoK Nqo11 NULM ND4L ND4L 
3 100 
 
10.8 
 
95 
 
10.0 
 
89 
 
9.8 
 
98 
 
10.8 
 
NuoN Nqo14 NU2M ND2 ND2 
11-14 485 
 
52.0 
 
427 
 
44.4 
 
469 
 
53.3 
 
347 
 
39.3 
 
NuoM Nqo13 NU4M ND4 ND4 
14 509 
 
56.5 
 
469 
 
49.2 
 
486 
 
54.5 
 
459 
 
52.1 
 
NuoL Nqo12 NU5M ND5 ND5 
16-17 613 
 
66.5 
 
606 
 
65.1 
 
655 
 
73.7 
 
606 
 
68.3 
 
Total Core 
4876 
 
540 
 
4636 
 
507 
 
4808 
 
538 
 
4496 
 
503.5 
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Module Bos taurus 
Homo 
sapiens 
Number 
of TMHs 
Notes 
N 
 
51 kDa 
24 kDa 
75 kDa 
18 kDa 
NDUFS4 
  1332 15.33 
13 kDa 
NDUFS6 
 
Zn2+ binding 
96 10.5 
10 kDa 
NDUFV3 
  75 8.4 
B17.2 
NDUFA12 
 
Homologous to assembly factor B17.2L 
145 17.1 
B8 
NDUFA2 
 
Thioredoxin fold 
98 10.9 
Q 
 
49 kDa 
30 kDa 
PSST 
TYKY 
B14.5a 
NDUFA7 
  
112 12.5 
SDAP-α 
NDUFAB1 
 
Acyl carrier protein 
88 10.1 
39 kDa 
NDUFA9 
 
NADPH-binding short-chain dehydrogenase/ 
reductase family 
345 39.1 
B13 
NDUFA5 
  115 13.2 
B14 
NDUFA6 
 
LYR protein 
127 14.9 
ND1 
MWFE 
NDUFA1 
  70 8.1 
B16.6 
NDUFA13 
 
Identical to GRIM-19 in humans and cows 
143 16.5 
B9 
NDUFA3 1 
 83 9.2 
PGIV 
NDUFA8 
 
Quadruple CX9C, 2 CHCH domains 
171 20 
P 
 
ND2 
ND3 
ND4L 
ND4 
ND5 
ND6 
B14.7 
NDUFA11 4 Related to TIM 17, 22, 23 
140 14.6 
B17 
NDUFB6 1 
 127 15.4 
42 kDa 
NDUFA10 
 
Nucleoside kinase family 
320 36.7 
KFYI 
NDUFC1 1 
 49 5.8 
15 kDa 
NDUFS5 
 
Double CX9C 
105 12.5 
ASHI 
NDUFB8 1 
 
158 18.7 
B14.5b 
NDUFC2 2 
 120 14.1 
AGGG NDUFB2 1 
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72 8.5 
MNLL 
NDUFB1 1 
 57 6.7 
SGDH 
NDUFB5 1 
 143 16.7 
B22 
NDUFB9 
 
LYR protein 
178 21 
B18 
NDUFB7 
 
Double CX9C 
136 16.3 
SDAP-β 
NDUFAB1 
 
Acyl carrier protein 
88 10.1 
PDSW 
NDUFB10 
  176 21 
B15 
NDUFB4 1 
 128 15.1 
ESSS 
NDUFB11 1 
 125 14.5 
B12 
NDUFB3 1  
97 11 
 
Table S7 Supernumerary subunits of mitochondrial complex I. Table modified form prepared 
by Dr James Letts 
1 Assembly intermediate 
2Number of amino acids in the mature subunit 
3MW of the mature subunit in kilo-Daltons 
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Subunit 1 Residue Subunit 2 Residue Cross - linker 
Euclidian 
Distance 
(Å) 
SAS 
(Å) 
Number 
of times 
observed 
Best 
Score 
51 kDa_NDUFV1 Lys8 10 kDa_NDUFV3 Lys6 DSS - - 1 39.92 
51 kDa_NDUFV1 Lys8 10 kDa_NDUFV3 Lys17 DSS - - 1 32.05 
51 kDa_NDUFV1 Lys34 10 kDa_NDUFV3 Lys6 DSS - - 2 40.70 
51 kDa_NDUFV1 Lys34 10 kDa_NDUFV3 Lys17 DSS - - 2 37.83 
51 kDa_NDUFV1 Lys34 10 kDa_NDUFV3 Lys22 DSS - - 2 30.38 
51 kDa_NDUFV1 Lys34 10 kDa_NDUFV3 Lys23 DSS - - 3 39.59 
51 kDa_NDUFV1 Glu158 10 kDa_NDUFV3 Glu31 SDH - - 1 28.79 
51 kDa_NDUFV1 Lys397 75 kDa_NDUFS1 Lys87 DSS 20.8 29.0 2 31.34 
51 kDa_NDUFV1 Lys397 75 kDa_NDUFS1 Lys88 DSS 10.1 12.3 1 31.68 
24 kDa_NDUFV2 Lys180 10 kDa_NDUFV3 Lys17 DSS - - 1 36.92 
24 kDa_NDUFV2 Lys183 10 kDa_NDUFV3 Lys23 DSS - - 1 28.87 
75 kDa_NDUFS1 Lys61 30 kDa_NDUFS3 Lys223 DSS - - 3 40.12 
75 kDa_NDUFS1 Lys61 B14.5a_NDUFA7 Lys79 DSS - - 2 35.52 
75 kDa_NDUFS1 Glu297 B14_NDUFA6 Asp116 ADH 11.8 15.4 1 30.51 
75 kDa_NDUFS1 Glu297 39 kDa_NDUFA9 Asp220 SDH 10.6 11.8 1 27.55 
75 kDa_NDUFS1 Asp486 B8_NDUFA2 Glu37 SDH 13.8 15.3 1 27.03 
75 kDa_NDUFS1 Asp504 B8_NDUFA2 Asp49 SDH/ADH 20.8 - 2 26.73 
75 kDa_NDUFS1 Lys516 B8_NDUFA2 Lys12 DSS - - 1 30.00 
75 kDa_NDUFS1 Lys598 B14_NDUFA6 Lys115 DSS 16.5 19.3 1 29.43 
75 kDa_NDUFS1 Glu624 B8_NDUFA2 Asp59 SDH/ADH 9.2 12.3 2 43.52 
75 kDa_NDUFS1 Lys650 B8_NDUFA2 Lys45 DSS 13.1 15.1 1 29.43 
49 kDa_NDUFS2 Lys334 B16.6_NDUFA13 Lys6 DSS 11.0 17.3 1 31.00 
49 kDa_NDUFS2 Lys334 B14.5a_NDUFA7 Lys39 DSS/BS3/DSA 9.8 9.9 7 33.87 
49 kDa_NDUFS2 Lys404 B14.5a_NDUFA7 Lys79 DSS - - 1 25.63 
30 kDa_NDUFS3 Lys20 B14.5a_NDUFA7 Lys79 BS3 - - 1 37.58 
30 kDa_NDUFS3 Lys20 B14.5a_NDUFA7 Lys92 DSS/BS3 13.7 16.3 5 45.74 
30 kDa_NDUFS3 Glu158 B14_NDUFA6 Glu108 ADH 18.4 24.0 1 28.42 
30 kDa_NDUFS3 Glu158 B14_NDUFA6 Glu110 SDH/ADH 12.0 12.1 1 30.63 
30 kDa_NDUFS3 Asp178 PSST_NDUFS7 Glu109 SDH 12.6 14.4 1 34.49 
30 kDa_NDUFS3 Glu189 B14_NDUFA6 Glu108 SDH 22.0 35.4 2 35.35 
30 kDa_NDUFS3 Lys196 18 kDa_NDUFS4 Lys56 DSS 9.0 10.4 1 31.17 
30 kDa_NDUFS3 Lys223 B13_NDUFA5 Lys45 DSS - - 1 29.47 
30 kDa_NDUFS3 Lys223 18 kDa_NDUFS4 Lys53 DSS - - 1 31.96 
30 kDa_NDUFS3 Lys223 B14.5a_NDUFA7 Lys79 DSS - - 3 33.18 
30 kDa_NDUFS3 Lys224 18 kDa_NDUFS4 Lys53 DSS - - 2 31.17 
30 kDa_NDUFS3 Lys224 18 kDa_NDUFS4 Lys112 DSS - - 2 29.62 
PSST_NDUFS7 Lys17 39 kDa_NDUFA9 Lys78 DSS - - 2 30.05 
PSST_NDUFS7 Lys17 39 kDa_NDUFA9 Lys144 DSS - - 2 33.47 
TYKY_NDUFS8 Lys15 B9_NDUFA3 Lys9 DSS 11.1 15.4 1 30.62 
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TYKY_NDUFS8 Lys54 B17.2_NDUFA12 Lys43 DSS 19.4 19.9 1 29.83 
18 kDa_NDUFS4 Lys31 B14_NDUFA6 Lys68 DSS 11.1 13.0 1 27.97 
18 kDa_NDUFS4 Lys31 B14_NDUFA6 Lys120 DSS 12.1 12.9 1 33.32 
15 kDa_NDUFS5 Lys53 SGDH_NDUFB5 Lys117 DSS 8.9 10.9 1 30.45 
15 kDa_NDUFS5 Glu101 B16.6_NDUFA13 Glu91 SDH/ADH - - 2 25.99 
15 kDa_NDUFS5 Asp102 B16.6_NDUFA13 Glu88 SDH - - 1 29.29 
15 kDa_NDUFS5 Asp102 B16.6_NDUFA13 Glu91 SDH - - 1 28.28 
13 kDa_NDUFS6 Asp22 39 kDa_NDUFA9 Glu162 ADH 23.6 27.4 1 32.67 
MWFE_NDUFA1 Lys64 PGIV_NDUFA8 Lys18 DSS/BS3/DSA 7.9 11.9 6 35.25 
B13_NDUFA5 Lys39 B14.5a_NDUFA7 Lys79 DSS - - 2 37.96 
B13_NDUFA5 Lys45 B14.5a_NDUFA7 Lys79 DSS/BS3/DSA - - 7 44.62 
B13_NDUFA5 Lys45 B14.5a_NDUFA7 Lys91 DSS 10.5 11.2 2 48.38 
B13_NDUFA5 Lys45 B14.5a_NDUFA7 Lys92 DSS/BS3/DSA 14.7 21.2 7 45.83 
B13_NDUFA5 Lys65 B14.5a_NDUFA7 Lys101 DSS 16.8 18.0 1 29.78 
B14.5a_NDUFA7 Lys22 B17.2_NDUFA12 Lys53 DSS 16.3 19.2 1 43.39 
B14.5a_NDUFA7 Lys32 B17.2_NDUFA12 Lys101 DSS 11.9 13.0 1 26.08 
B14.5a_NDUFA7 Lys32 B17.2_NDUFA12 Lys43 DSS 19.3 25.5 3 37.85 
B14.5a_NDUFA7 Lys32 B17.2_NDUFA12 Lys53 DSS 7.0 8.2 1 36.39 
B14.5a_NDUFA7 Lys39 B16.6_NDUFA13 Lys6 DSS 10.9 13.3 1 42.73 
PGIV_NDUFA8 Glu5 B16.6_NDUFA13 Glu91 ADH 15.8 18.3 1 30.86 
PGIV_NDUFA8 Glu10 B16.6_NDUFA13 Glu91 ADH 10.8 12.6 1 34.43 
PGIV_NDUFA8 Lys18 B16.6_NDUFA13 Lys78 DSS 19.4 24.9 1 35.3 
PGIV_NDUFA8 Glu148 B14.5b_NDUFC2 Asp16 SDH/ADH 18.5 24.5 2 39.9 
PGIV_NDUFA8 Glu148 B14.5b_NDUFC2 Glu99 ADH 14.4 16.1 1 32.81 
PGIV_NDUFA8 Glu152 B14.5b_NDUFC2 Glu17 SDH/ADH 11.1 12.6 2 36.13 
PGIV_NDUFA8 Glu152 B14.5b_NDUFC2 Asp100 SDH/ADH 21.7 29.4 2 36.24 
PGIV_NDUFA8 Asp156 B14.5b_NDUFC2 Glu17 SDH/ADH 7.0 7.2 2 34.99 
PGIV_NDUFA8 Lys158 B14.5b_NDUFC2 Lys95 DSS 12.7 13.5 3 44.15 
PGIV_NDUFA8 Lys158 B14.5b_NDUFC2 Lys104 DSS 27.5 29.5 1 38.98 
PGIV_NDUFA8 Lys158 SGDH_NDUFB5 Lys106 DSS 13.6 13.9 5 46.33 
42 kDa_NDUFA10 Lys87 ESSS_NDUFB11 Lys17 DSS - - 3 33.42 
MNLL_NDUFB1 Lys29 B14.5b_NDUFC2 Lys25 DSS 11.9 12.2 1 23.68 
B12_NDUFB3 Lys12 SDAP_NDUFAB1 Lys20 DSS - - 2 32.79 
B12_NDUFB3 Lys19 SDAP_NDUFAB1 Lys20 DSS 6.4 6.9 1 36.87 
B15_NDUFB4 Lys30 ASHI_NDUFB8 Lys25 DSS/BS3/DSA 22.7 26.5 6 39.21 
B15_NDUFB4 Lys119 PDSW_NDUFB10 Lys170 DSS/BS3/DSA 26.7 30.7 7 38.09 
SGDH_NDUFB5 Lys106 B14.5b_NDUFC2 Lys95 DSS 12.6 14.6 3 37.89 
SGDH_NDUFB5 Lys106 B14.5b_NDUFC2 Lys104 DSS 14.3 15.8 8 44.04 
SGDH_NDUFB5 Lys106 B14.5b_NDUFC2 Lys106 DSS 11.4 12.1 2 39.56 
SGDH_NDUFB5 Lys106 B14.5b_NDUFC2 Lys107 DSS 19 21.1 2 33.65 
B17_NDUFB6 Lys23 B22_NDUFB9 Lys120 DSS 10.6 13.3 1 31.11 
ASHI_NDUFB8 Lys25 ESSS_NDUFB11 Lys17 DSS - - 6 34.91 
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ASHI_NDUFB8 Lys49 ESSS_NDUFB11 Lys17 DSS/BS3/DSA - - 1 27.74 
ASHI_NDUFB8 Lys148 PDSW_NDUFB10 Lys126 DSS - - 1 31.02 
ASHI_NDUFB8 Lys148 PDSW_NDUFB10 Lys167 DSS - - 1 29.02 
ASHI_NDUFB8 Lys148 PDSW_NDUFB10 Lys170 DSS - - 2 32.55 
B22_NDUFB9 Lys137 ESSS_NDUFB11 Lys17 DSS/BS3/DSA - - 6 36.24 
PDSW_NDUFB10 Glu165 ESSS_NDUFB11 Glu109 SDH 17.1 19.1 1 32.16 
Table S8 Inter-subunit cross - links. Residues in red are not modelled in the structure. Solvent accessible 
surface distances (SAS) calculated using Xwalk are shown. If the SAS distance is less than 8 Å over the 
approximate maximum cross - link length the distance is shown in red. These are considered true cross - 
links because of the flexibility of the side chains and were each checked manually in the structure. False 
positive cross - links are too far apart in the structure and likely result from inter-complex cross - 
linking.Table modified form prepared by Dr James Letts. 
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Subunit 1 Residue Subunit 2 Residue Cross - linker 
Euclidian 
Distance (Å) 
SAS 
(Å) 
Number of 
times 
observed 
Best 
Score 
51 kDa_NDUFV1 Lys16 51 kDa_NDUFV1 Lys8 DSS 8.7 10.5 2 38.06 
51 kDa_NDUFV1 Lys61 51 kDa_NDUFV1 Lys78 DSS 13.6 24.7 1 30.07 
51 kDa_NDUFV1 Lys61 51 kDa_NDUFV1 Lys84 DSS 15.0 17.9 4 46.78 
24 kDa_NDUFV2 Lys29 24 kDa_NDUFV2 Lys36 DSS 6.7 7.7 2 35.59 
24 kDa_NDUFV2 Glu40 24 kDa_NDUFV2 Glu32 SDH 11.8 11.8 1 38.17 
24 kDa_NDUFV2 Lys122 24 kDa_NDUFV2 Lys167 DSS 17.2 21.9 1 28.76 
75 kDa_NDUFS1 Lys61 75 kDa_NDUFS1 Lys75 DSS 17.5 19.7 3 32.37 
75 kDa_NDUFS1 Lys61 75 kDa_NDUFS1 Lys85 DSS 11.4 11.6 1 35.52 
75 kDa_NDUFS1 Lys64 75 kDa_NDUFS1 Lys85 DSS 12.0 18.9 1 32.99 
75 kDa_NDUFS1 Lys275 75 kDa_NDUFS1 Lys686 DSS 12.9 13.1 1 27.89 
75 kDa_NDUFS1 Lys508 75 kDa_NDUFS1 Lys516 DSS 8.1 8.1 7 38.03 
49 kDa_NDUFS2 Glu302 49 kDa_NDUFS2 Glu227 ADH 16.6 24.4 1 32.51 
30 kDa_NDUFS3 Asp178 30 kDa_NDUFS3 Glu189 SDH/ADH 22.8 - 1 30.87 
30 kDa_NDUFS3 Glu179 30 kDa_NDUFS3 Glu189 SDH 17.9 32.3 1 29.17 
30 kDa_NDUFS3 Lys217 30 kDa_NDUFS3 Lys223 DSS - - 2 42.78 
PSST_NDUFS7 Lys17 PSST_NDUFS7 Lys32 DSS 12.1 18.2 2 36.22 
PSST_NDUFS7 Lys17 PSST_NDUFS7 Lys102 DSS - - 1 25.57 
10 kDa_NDUFV3 Lys6 10 kDa_NDUFV3 Lys17 DSS - - 2 34.46 
10 kDa_NDUFV3 Lys6 10 kDa_NDUFV3 Lys23 DSS - - 1 25.17 
10 kDa_NDUFV3 Lys16 10 kDa_NDUFV3 Lys23 DSS - - 1 26.12 
18 kDa_NDUFS4 Glu15 18 kDa_NDUFS4 Asp91 ADH 23.5 26.1 1 35.81 
18 kDa_NDUFS4 Lys53 18 kDa_NDUFS4 Lys109 DSS 18.7 27.4 1 38.56 
18 kDa_NDUFS4 Lys112 18 kDa_NDUFS4 Lys126 DSS 17.0 18.4 1 33.81 
18 kDa_NDUFS4 Lys114 18 kDa_NDUFS4 Lys126 DSS 16.9 19.5 2 31.85 
15 kDa_NDUFS5 Lys79 15 kDa_NDUFS5 Lys84 DSS 15.6 25.3 1 32.98 
15 kDa_NDUFS5 Lys79 15 kDa_NDUFS5 Lys87 DSS 19.3 23.1 3 40.95 
15 kDa_NDUFS5 Lys79 15 kDa_NDUFS5 Lys90 DSS 22.9 30.0 1 37.70 
13 kDa_NDUFS6 Glu9 13 kDa_NDUFS6 Asp19 ADH 10.5 26.9 1 24.92 
13 kDa_NDUFS6 Lys10 13 kDa_NDUFS6 Lys33 DSS 6.5 7.4 1 28.36 
B8_NDUFA2 Lys12 B8_NDUFA2 Lys74 DSS/BS3 - - 3 38.11 
B8_NDUFA2 Lys12 B8_NDUFA2 Lys97 DSS/BS3/DSA - - 5 32.69 
B8_NDUFA2 Lys38 B8_NDUFA2 Lys45 DSS/BS3 15.2 15.7 5 42.23 
B8_NDUFA2 Glu42 B8_NDUFA2 Glu91 SDH/ADH 10.1 11.4 2 36.53 
B8_NDUFA2 Lys74 B8_NDUFA2 Lys97 DSS/BS3 - - 8 42.40 
B13_NDUFA5 Lys6 B13_NDUFA5 Lys65 DSS 11.6 13.2 2 30.26 
B13_NDUFA5 Lys24 B13_NDUFA5 Lys59 DSS/BS3/DSA 5.4 5.4 9 44.79 
B13_NDUFA5 Lys39 B13_NDUFA5 Lys45 DSS 6.7 7.1 3 34.82 
B14_NDUFA6 Lys56 B14_NDUFA6 Lys68 DSS 20.7 25.2 1 35.17 
B14_NDUFA6 Lys67 B14_NDUFA6 Lys84 DSS 21.0 26.5 1 29.51 
B14_NDUFA6 Lys68 B14_NDUFA6 Lys84 DSS 10.6 11.6 1 30.39 
B14_NDUFA6 Lys84 B14_NDUFA6 Lys120 DSS 26.7 31.2 1 28.85 
B14.5a_NDUFA7 Lys22 B14.5a_NDUFA7 Lys32 DSS/BS3/DSA 20.2 23.0 6 34.86 
B14.5a_NDUFA7 Lys32 B14.5a_NDUFA7 Lys39 DSS 23.6 26.6 3 34.08 
B14.5a_NDUFA7 Lys79 B14.5a_NDUFA7 Lys92 DSS - - 1 39.81 
PGIV_NDUFA8 Lys40 PGIV_NDUFA8 Lys50 DSS 17.7 - 1 29.26 
PGIV_NDUFA8 Lys40 PGIV_NDUFA8 Lys131 DSS 12.8 - 1 32.48 
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PGIV_NDUFA8 Glu138 PGIV_NDUFA8 Glu152 ADH 26.2 28.1 1 42.97 
39 kDa_NDUFA9 Lys78 39 kDa_NDUFA9 Lys122 DSS 11.3 24.9 2 38.48 
39 kDa_NDUFA9 Asp79 39 kDa_NDUFA9 Glu86 SDH 12.6 15.5 1 34.29 
39 kDa_NDUFA9 Lys140 39 kDa_NDUFA9 Lys149 DSS 16.5 - 1 31.25 
39 kDa_NDUFA9 Lys140 39 kDa_NDUFA9 Lys154 DSS/BS3 11.0 13.5 8 38.22 
39 kDa_NDUFA9 Lys144 39 kDa_NDUFA9 Lys149 DSS 13.8 - 3 38.39 
39 kDa_NDUFA9 Lys149 39 kDa_NDUFA9 Lys283 BS3 14.2 20.7 1 41.33 
42 kDa_NDUFA10 Lys35 42 kDa_NDUFA10 Lys185 DSS 20.2 25.5 1 34.62 
42 kDa_NDUFA10 Lys35 42 kDa_NDUFA10 Lys186 DSS 14.3 16.1 1 41.18 
42 kDa_NDUFA10 Lys37 42 kDa_NDUFA10 Lys45 DSS 16.2 19.8 2 36.39 
42 kDa_NDUFA10 Lys37 42 kDa_NDUFA10 Lys185 DSS 14.4 15.8 1 28.54 
42 kDa_NDUFA10 Lys37 42 kDa_NDUFA10 Lys186 DSS 10.4 11.4 3 37.80 
42 kDa_NDUFA10 Lys40 42 kDa_NDUFA10 Lys49 DSS 12.9 16.9 2 37.25 
42 kDa_NDUFA10 Lys40 42 kDa_NDUFA10 Lys186 DSS/BS3 16.8 18.9 7 43.10 
42 kDa_NDUFA10 Lys87 42 kDa_NDUFA10 Lys193 DSS 18.1 21.0 1 40.29 
42 kDa_NDUFA10 Lys245 42 kDa_NDUFA10 Lys255 DSS 20.4 - 1 25.53 
B15_NDUFB4 Lys113 B15_NDUFB4 Lys119 DSS 18.6 22.9 2 31.92 
B18_NDUFB7 Lys111 B18_NDUFB7 Lys123 DSS - - 1 25.82 
B18_NDUFB7 Lys112 B18_NDUFB7 Lys123 DSS - - 1 27.64 
ASHI_NDUFB8 Lys6 ASHI_NDUFB8 Lys25 DSS 19.9 35.5 5 34.09 
ASHI_NDUFB8 Lys6 ASHI_NDUFB8 Lys26 DSS 16.0 20.5 1 31.32 
B22_NDUFB9 Lys51 B22_NDUFB9 Lys58 DSS 19.1 26.3 1 38.30 
PDSW_NDUFB10 Lys6 PDSW_NDUFB10 Lys126 DSS 15.8 18.5 1 32.69 
B17.2_NDUFA12 Lys43 B17.2_NDUFA12 Lys101 DSS 13.5 22.6 1 32.59 
B17.2_NDUFA12 Lys43 B17.2_NDUFA12 Lys107 DSS 22.5 25.9 1 30.15 
SDAP_NDUFAB1 Lys12 SDAP_NDUFAB1 Lys20 DSS 11.7 11.7 1 37.22 
B14.5b_NDUFC2 Lys104 B14.5b_NDUFC2 Lys107 DSS 6.2 7.6 1 26.21 
Table S9 Intra-subunit cross - links. Residues in red are not modelled in the structure. Solvent 
accessible surface distances (SAS) calculated using Xwalk are shown. If the SAS distance is 
less than 8 Å over the approximate maximum cross - link length the distance is shown in red. 
These are considered true cross - links because of the flexibility of the side chains and were 
each checked manually in the structure. False positive cross - links are too far apart in the 
structure and likely result from inter-complex cross - linking.Table modified form prepared by 
Dr James Letts 
  
200 
References 
 
 
 
Abdrakhmanova, A., Zickermann, V., Bostina, M., Radermacher, M., Schagger, H., 
Kerscher, S., & Brandt, U. (2004). Subunit composition of mitochondrial 
complex I from the yeast Yarrowia lipolytica. Biochim Biophys Acta, 1658(1-
2), 148-156 
Abdrakhmanova, A., Zwicker, K., Kerscher, S., Zickermann, V., & Brandt, U. (2006). 
Tight binding of NADPH to the 39-kDa subunit of complex I is not required 
for catalytic activity but stabilizes the multiprotein complex. Biochim 
Biophys Acta, 1757(12), 1676-1682 
Abrahams, J. P., Leslie, A. G., Lutter, R., & Walker, J. E. (1994). Structure at 2.8 A 
resolution of F1-ATPase from bovine heart mitochondria. Nature, 
370(6491), 621-628 
Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, N., . . . 
Zwart, P. H. (2010). PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta crystallogr. D, 66(Pt 2), 213-221 
Adrian, M., Dubochet, J., Lepault, J., & McDowall, A. W. (1984). Cryo-electron 
microscopy of viruses. Nature, 308(5954), 32-36.  
Akram, M. (2014). Citric acid cycle and role of its intermediates in metabolism. Cell 
Biochem Biophys, 68(3), 475-478. doi:10.1007/s12013-013-9750-1 
Alberts, B. (2015). Molecular biology of the cell (6th edition). 2015. 
Allegretti, M., Mills, D. J., McMullan, G., Kuhlbrandt, W., & Vonck, J. (2014). Atomic 
model of the F420-reducing [NiFe] hydrogenase by electron cryo-
microscopy using a direct electron detector. eLife, 3, e01963 
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local 
alignment search tool. J Mol Biol, 215(3), 403-410 
Anderson, A. C. (2003). The process of structure-based drug design. Chem Biol, 
10(9), 787-797.  
Anesti, V., & Scorrano, L. (2006). The relationship between mitochondrial shape 
and function and the cytoskeleton. Biochim Biophys Acta, 1757(5-6), 692-
699 
Angerer, H. (2015). Eukaryotic LYR Proteins Interact with Mitochondrial Protein 
Complexes. Biology (Basel), 4(1), 133-150. doi:10.3390/biology4010133 
Angerer, H., Radermacher, M., Mankowska, M., Steger, M., Zwicker, K., Heide, H., . . . 
Zickermann, V. (2014). The LYR protein subunit NB4M/NDUFA6 of 
mitochondrial complex I anchors an acyl carrier protein and is essential for 
catalytic activity. Proc Natl Acad Sci U S A, 111(14), 5207-5212 
Arteni, A. A., Zhang, P., Battchikova, N., Ogawa, T., Aro, E. M., & Boekema, E. J. 
(2006). Structural characterization of NDH-1 complexes of 
Thermosynechococcus elongatus by single particle electron microscopy. 
Biochim. Biophys. Acta, 1757(11), 1469-1475 
  201 
Babot, M., & Galkin, A. (2013). Molecular mechanism and physiological role of 
active-deactive transition of mitochondrial complex I. Biochem Soc Trans, 
41(5), 1325-1330 
Bai, X. C., Rajendra, E., Yang, G., Shi, Y., & Scheres, S. H. (2015). Sampling the 
conformational space of the catalytic subunit of human gamma-secretase. 
eLife, 4. doi:10.7554/eLife.11182 
Barad, B. A., Echols, N., Wang, R. Y.-R., Cheng, Y., DiMaio, F., Adams, P. D., & Fraser, J. 
S. (2015). Side-chain-directed model and map validation for 3D Electron 
Cryomicroscopy. bioRxiv 
Baradaran, R. (2009). Purification, characterisation and crystallisation of intact 
complex I from Thermus thermophilus. (Doctor of Philosphy), University of 
Cambridge, Cambridge. 
Baradaran, R., Berrisford, J. M., Minhas, G. S., & Sazanov, L. A. (2013). Crystal 
structure of the entire respiratory complex I. Nature, 494(7438), 443-448.  
Baranova, E. A., Holt, P. J., & Sazanov, L. A. (2007). Projection structure of the 
membrane domain of Escherichia coli respiratory complex I at 8 A 
resolution. J Mol Biol, 366(1), 140-154 
Belevich, G., Knuuti, J., Verkhovsky, M. I., Wikstrom, M., & Verkhovskaya, M. (2011). 
Probing the mechanistic role of the long alpha-helix in subunit L of 
respiratory Complex I from Escherichia coli by site-directed mutagenesis. 
Molecular microbiology, 82(5), 1086-1095 
Belevich, I., Verkhovsky, M. I., & Wikstrom, M. (2006). Proton-coupled electron 
transfer drives the proton pump of cytochrome c oxidase. Nature, 
440(7085), 829-832.  
Benit, P., Chretien, D., Kadhom, N., de Lonlay-Debeney, P., Cormier-Daire, V., Cabral, 
A., . . . Rotig, A. (2001). Large-scale deletion and point mutations of the 
nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. 
Am. J. Hum. Genet., 68(6), 1344-1352.  
Benit, P., Slama, A., Cartault, F., Giurgea, I., Chretien, D., Lebon, S., . . . Rustin, P. 
(2004). Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh 
syndrome. J Med Genet, 41(1), 14-17.  
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2002). Biochemistry, Fifth Edition: W. H. 
Freeman. 
Berrisford, J. M., & Sazanov, L. A. (2009). Structural basis for the mechanism of 
respiratory complex I. J Biol Chem, 284(43), 29773-29783 
Bertsova, Y. V., & Bogachev, A. V. (2004). The origin of the sodium-dependent 
NADH oxidation by the respiratory chain of Klebsiella pneumoniae. FEBS 
Lett, 563(1-3), 207-212 
Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., . . . 
Schwede, T. (2014). SWISS-MODEL: modelling protein tertiary and 
quaternary structure using evolutionary information. Nucleic Acids Res., 
42(Web Server issue), W252-258 
Birrell, J. A., Morina, K., Bridges, H. R., Friedrich, T., & Hirst, J. (2013). Investigating 
the function of [2Fe-2S] cluster N1a, the off-pathway cluster in complex I, 
by manipulating its reduction potential. Biochem J, 456(1), 139-146 
Blakely, E. L., de Silva, R., King, A., Schwarzer, V., Harrower, T., Dawidek, G., . . . 
Taylor, R. W. (2005). LHON/MELAS overlap syndrome associated with a 
mitochondrial MTND1 gene mutation. European journal of human genetics : 
EJHG, 13(5), 623-627 
202 
Böttcher, B., Scheide, D., Hesterberg, M., Nagel-Steger, L., & Friedrich, T. (2002). A 
novel, enzymatically active conformation of the Escherichia coli 
NADH:ubiquinone oxidoreductase (complex I). J Biol Chem, 277(20), 17970-
17977 
Brandt, U. (2006). Energy converting NADH:quinone oxidoreductase (complex I). 
Annu Rev Biochem, 75, 69-92.  
Brandt, U. (2011). A two-state stabilization-change mechanism for proton-
pumping complex I. Biochim Biophys Acta, 1807(10), 1364-1369 
Breningstall, G. N., Shoffner, J., & Patterson, R. J. (2008). Siblings with 
leukoencephalopathy. Semin Pediatr Neurol, 15(4), 212-215 
Bridges, H. R., Bill, E., & Hirst, J. (2012). Mossbauer spectroscopy on respiratory 
complex I: the iron-sulfur cluster ensemble in the NADH-reduced enzyme is 
partially oxidized. Biochemistry, 51(1), 149-158 
Bridges, H. R., Fearnley, I. M., & Hirst, J. (2010). The subunit composition of 
mitochondrial NADH:ubiquinone oxidoreductase (complex I) from Pichia 
pastoris. Molecular & cellular proteomics : MCP, 9(10), 2318-2326 
Bridges, H. R., Mohammed, K., Harbour, M. E., & Hirst, J. (2017). Subunit NDUFV3 is 
present in two distinct isoforms in mammalian complex I. Biochim Biophys 
Acta, 1858(3), 197-207 
Brockmann, C., Diehl, A., Rehbein, K., Strauss, H., Schmieder, P., Korn, B., . . . 
Oschkinat, H. (2004). The oxidized subunit B8 from human complex I 
adopts a thioredoxin fold. Structure, 12(9), 1645-1654 
Brown, M. D., Starikovskaya, E., Derbeneva, O., Hosseini, S., Allen, J. C., 
Mikhailovskaya, I. E., . . . Wallace, D. C. (2002). The role of mtDNA 
background in disease expression: a new primary LHON mutation 
associated with Western Eurasian haplogroup J. Hum Genet, 110(2), 130-
138 
Brown, M. D., Voljavec, A. S., Lott, M. T., Torroni, A., Yang, C. C., & Wallace, D. C. 
(1992). Mitochondrial DNA complex I and III mutations associated with 
Leber's hereditary optic neuropathy. Genetics, 130(1), 163-173.  
Brown, M. D., Zhadanov, S., Allen, J. C., Hosseini, S., Newman, N. J., Atamonov, V. V., . 
. . Wallace, D. C. (2001). Novel mtDNA mutations and oxidative 
phosphorylation dysfunction in Russian LHON families. Hum Genet, 109(1), 
33-39.  
Brzoska, K., Meczynska, S., & Kruszewski, M. (2006). Iron-sulfur cluster proteins: 
electron transfer and beyond. Acta Biochim Pol, 53(4), 685-691.  
Bugiani, M., Invernizzi, F., Alberio, S., Briem, E., Lamantea, E., Carrara, F., . . . Zeviani, 
M. (2004). Clinical and molecular findings in children with complex I 
deficiency. Biochim Biophys Acta, 1659(2-3), 136-147 
Byers, D. M., & Gong, H. (2007). Acyl carrier protein: structure-function 
relationships in a conserved multifunctional protein family. Biochem Cell 
Biol, 85(6), 649-662 
Calvo, S. E., Tucker, E. J., Compton, A. G., Kirby, D. M., Crawford, G., Burtt, N. P., . . . 
Mootha, V. K. (2010). High-throughput, pooled sequencing identifies 
mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat 
Genet, 42(10), 851-858 
Campello, S., & Scorrano, L. (2010). Mitochondrial shape changes: orchestrating 
cell pathophysiology. EMBO Rep, 11(9), 678-684 
  203 
Carroll, J., Ding, S., Fearnley, I. M., & Walker, J. E. (2013). Post-translational 
modifications near the quinone binding site of mammalian complex I. J Biol 
Chem, 288(34), 24799-24808 
Carroll, J., Fearnley, I. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2003). Analysis of 
the subunit composition of complex I from bovine heart mitochondria. 
Molecular & cellular proteomics : MCP, 2(2), 117-12 
Carroll, J., Fearnley, I. M., Skehel, J. M., Runswick, M. J., Shannon, R. J., Hirst, J., & 
Walker, J. E. (2005). The post-translational modifications of the nuclear 
encoded subunits of complex I from bovine heart mitochondria. Molecular & 
cellular proteomics : MCP, 4(5), 693-699 
Carroll, J., Fearnley, I. M., Skehel, J. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2006). 
Bovine complex I is a complex of 45 different subunits. J. Biol. Chem., 
281(43), 32724-32727  
Cheng, Y., Grigorieff, N., Penczek, P. A., & Walz, T. (2015). A primer to single-
particle cryo-electron microscopy. Cell, 161(3), 438-449 
Conrad, M., Jakupoglu, C., Moreno, S. G., Lippl, S., Banjac, A., Schneider, M., . . . 
Brielmeier, M. (2004). Essential role for mitochondrial thioredoxin 
reductase in hematopoiesis, heart development, and heart function. Mol Cell 
Biol, 24(21), 9414-9423 
Crimi, M., Galbiati, S., Moroni, I., Bordoni, A., Perini, M. P., Lamantea, E., . . . Comi, G. 
P. (2003). A missense mutation in the mitochondrial ND5 gene associated 
with a Leigh-MELAS overlap syndrome. Neurology, 60(11), 1857-1861 
Crofts, A. R. (2004). The cytochrome bc1 complex: function in the context of 
structure. Annu Rev Physiol, 66, 689-733 
Danev, R., Tegunov, D., & Baumeister, W. (2017). Using the Volta phase plate with 
defocus for cryo-EM single particle analysis. eLife,6, e23006.  
Danhauser, K., Iuso, A., Haack, T. B., Freisinger, P., Brockmann, K., Mayr, J. A., . . . 
Prokisch, H. (2011). Cellular rescue-assay aids verification of causative 
DNA-variants in mitochondrial complex I deficiency. Molecular genetics and 
metabolism, 103(2), 161-166 
Deschauer, M., Bamberg, C., Claus, D., Zierz, S., Turnbull, D. M., & Taylor, R. W. 
(2003). Late-onset encephalopathy associated with a C11777A mutation of 
mitochondrial DNA. Neurology, 60(8), 1357-1359  
DiMaio, F., Song, Y., Li, X., Brunner, M. J., Xu, C., Conticello, V., . . . Baker, D. (2015). 
Atomic-accuracy models from 4.5-A cryo-electron microscopy data with 
density-guided iterative local refinement. Nature methods, 12(4), 361-365 
Distelmaier, F., Koopman, W. J., van den Heuvel, L. P., Rodenburg, R. J., Mayatepek, 
E., Willems, P. H., & Smeitink, J. A. (2009). Mitochondrial complex I 
deficiency: from organelle dysfunction to clinical disease. Brain : a journal of 
neurology, 132(Pt 4), 833-842 
Djafarzadeh, R., Kerscher, S., Zwicker, K., Radermacher, M., Lindahl, M., Schagger, 
H., & Brandt, U. (2000). Biophysical and structural characterization of 
proton-translocating NADH-dehydrogenase (complex I) from the strictly 
aerobic yeast Yarrowia lipolytica. Biochim. Biophys. Acta, 1459(1), 230-238.  
Dudkina, N. V., Heinemeyer, J., Sunderhaus, S., Boekema, E. J., & Braun, H. P. (2006). 
Respiratory chain supercomplexes in the plant mitochondrial membrane. 
Trends Plant Sci, 11(5), 232-240 
204 
Dudkina, N. V., Kudryashev, M., Stahlberg, H., & Boekema, E. J. (2011). Interaction 
of complexes I, III, and IV within the bovine respirasome by single particle 
cryoelectron tomography. Proc Natl Acad Sci U S A, 108(37), 15196-15200 
Dyall, S. D., Brown, M. T., & Johnson, P. J. (2004). Ancient invasions: from 
endosymbionts to organelles. Science, 304(5668), 253-257 
Efremov, R. G., Baradaran, R., & Sazanov, L. A. (2010). The architecture of 
respiratory complex I. Nature, 465(7297), 441-445 
Efremov, R. G., & Sazanov, L. A. (2011). Structure of the membrane domain of 
respiratory complex I. Nature, 476(7361), 414-420 
Efremov, R. G., & Sazanov, L. A. (2012). The coupling mechanism of respiratory 
complex I - A structural and evolutionary perspective. Biochim Biophys Acta 
Egerton, R. F. (2007). Physical principles of electron microscopy : an introduction to 
TEM, SEM, and AEM. New York: Springer Science+Business Media. 
Emelyanov, V. V. (2001). Evolutionary relationship of Rickettsiae and 
mitochondria. FEBS Lett, 501(1), 11-18.  
Emsley, P., & Cowtan, K. (2004). Coot: model-building tools for molecular graphics. 
Acta crystallogr. D, 60(Pt 12 Pt 1), 2126-2132 
Esposti, D. (1998). Inhibitors of NADH-ubiquinone reductase: an overview. 
Biochim Biophys Acta, 1364(2):222-35 
Esterhazy, D., King, M. S., Yakovlev, G., & Hirst, J. (2008). Production of reactive 
oxygen species by complex I (NADH:ubiquinone oxidoreductase) from 
Escherichia coli and comparison to the enzyme from mitochondria. 
Biochemistry, 47(12), 3964-3971.  
Fassone, E., & Rahman, S. (2012). Complex I deficiency: clinical features, 
biochemistry and molecular genetics. J Med Genet, 49(9), 578-590. 
doi:10.1136/jmedgenet-2012-101159 
Fearnley, I. M., & Walker, J. E. (1992). Conservation of sequences of subunits of 
mitochondrial complex I and their relationships with other proteins. 
Biochim. Biophys. Acta, 1140(2), 105-134.  
Fernandez-Moreira, D., Ugalde, C., Smeets, R., Rodenburg, R. J., Lopez-Laso, E., Ruiz-
Falco, M. L., . . . Arenas, J. (2007). X-linked NDUFA1 gene mutations 
associated with mitochondrial encephalomyopathy. Ann Neurol, 61(1), 73-
83 
Ferreira, M., Torraco, A., Rizza, T., Fattori, F., Meschini, M. C., Castana, C., . . . Bertini, 
E. (2011). Progressive cavitating leukoencephalopathy associated with 
respiratory chain complex I deficiency and a novel mutation in NDUFS1. 
Neurogenetics, 12(1), 9-17 
Fiedorczuk, K., Letts, J. A., Degliesposti, G., Kaszuba, K., Skehel, M., & Sazanov, L. A. 
(2016). Atomic structure of the entire mammalian mitochondrial complex I. 
Nature, 538(7625), 406-410 
Finel, M. (1998). Does NADH play a central role in energy metabolism in 
Helicobacter pylori? Trends Biochem. Sci., 23(11), 412-413.  
Finel, M., Majander, A. S., Tyynela, J., De Jong, A. M., Albracht, S. P., & Wikstrom, M. 
(1994). Isolation and characterisation of subcomplexes of the 
mitochondrial NADH:ubiquinone oxidoreductase (complex I). Eur. J. 
Biochem., 226(1), 237-242  
Flotenmeyer, M., Weiss, H., Tribet, C., Popot, J. L., & Leonard, K. (2007). The use of 
amphipathic polymers for cryo electron microscopy of NADH:ubiquinone 
oxidoreductase (complex I). J Microsc, 227(Pt 3), 229-235 
  205 
Friedman, J. R., & Nunnari, J. (2014). Mitochondrial form and function. Nature, 
505(7483), 335-343 
Friedrich, T., & Scheide, D. (2000). The respiratory complex I of bacteria, archaea 
and eukarya and its module common with membrane-bound multisubunit 
hydrogenases. FEBS Lett., 479(1-2), 1-5  
Friedrich, T., Steinmuller, K., & Weiss, H. (1995). The proton-pumping respiratory 
complex I of bacteria and mitochondria and its homologue in chloroplasts. 
FEBS Lett., 367(2), 107-111 
Fujimoto, M., & Hayashi, T. (2011). New insights into the role of mitochondria-
associated endoplasmic reticulum membrane. Int Rev Cell Mol Biol, 292, 73-
117 
Funalot, B., Reynier, P., Vighetto, A., Ranoux, D., Bonnefont, J. P., Godinot, C., . . . Mas, 
J. L. (2002). Leigh-like encephalopathy complicating Leber's hereditary 
optic neuropathy. Ann Neurol, 52(3), 374-377 
Gabaldon, T., Rainey, D., & Huynen, M. A. (2005). Tracing the evolution of a large 
protein complex in the eukaryotes, NADH:ubiquinone oxidoreductase 
(Complex I). J. Mol. Biol., 348(4), 857-870 
Galkin, A., Dröse, S., & Brandt, U. (2006). The proton pumping stoichiometry of 
purified mitochondrial complex I reconstituted into proteoliposomes. 
Biochim Biophys Acta, 1757(12), 1575-1581 
Galkin, A., Meyer, B., Wittig, I., Karas, M., Schagger, H., Vinogradov, A., & Brandt, U. 
(2008). Identification of the mitochondrial ND3 subunit as a structural 
component involved in the active/deactive enzyme transition of respiratory 
complex I. J. Biol. Chem., 283(30), 20907-20913 
Gemperli, A. C., Dimroth, P., & Steuber, J. (2002). The respiratory complex I (NDH I) 
from Klebsiella pneumoniae, a sodium pump. J Biol Chem, 277(37), 33811-
33817 
Ghayee, H. K., & Auchus, R. J. (2007). Basic concepts and recent developments in 
human steroid hormone biosynthesis. Rev Endocr Metab Disord, 8(4), 289-
300 
Glaeser, R. M., Han, B. G., Csencsits, R., Killilea, A., Pulk, A., & Cate, J. H. (2016). 
Factors that Influence the Formation and Stability of Thin, Cryo - EM 
Specimens. Biophysical Journal, 110(4), 749-755 
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., . . . 
Turnbull, D. M. (2016). Mitochondrial diseases. Nat Rev Dis Primers, 2, 
16080 
Gray, M. W., Burger, G., & Lang, B. F. (1999). Mitochondrial evolution. Science, 
283(5407)  
Grgic, L., Zwicker, K., Kashani-Poor, N., Kerscher, S., & Brandt, U. (2004). Functional 
significance of conserved histidines and arginines in the 49-kDa subunit of 
mitochondrial complex I. J. Biol. Chem., 279(20), 21193-21199  
Grigorieff, N. (1998). Three-dimensional structure of bovine NADH:ubiquinone 
oxidoreductase (complex I) at 22 A in ice. J. Mol. Biol., 277(5), 1033-1046.  
Grigorieff, N., & Harrison, S. C. (2011). Near-atomic resolution reconstructions of 
icosahedral viruses from electron cryo-microscopy. Curr Opin Struct Biol, 
21(2), 265-273 
Gu, J., Wu, M., Guo, R., Yan, K., Lei, J., Gao, N., & Yang, M. (2016). The architecture of 
the mammalian respirasome. Nature, 537(7622), 639-643 
206 
Guenebaut, V., Schlitt, A., Weiss, H., Leonard, K., & Friedrich, T. (1998). Consistent 
structure between bacterial and mitochondrial NADH:ubiquinone 
oxidoreductase (complex I). J. Mol. Biol., 276(1), 105-112  
Guenebaut, V., Vincentelli, R., Mills, D., Weiss, H., & Leonard, K. R. (1997). Three-
dimensional structure of NADH-dehydrogenase from Neurospora crassa by 
electron microscopy and conical tilt reconstruction. J. Mol. Biol., 265(4), 
409-418  
Guerrero-Castillo, S., Baertling, F., Kownatzki, D., Wessels, H. J., Arnold, S., Brandt, 
U., & Nijtmans, L. (2017). The Assembly Pathway of Mitochondrial 
Respiratory Chain Complex I. Cell metab., 25(1), 128-139 
Gutierrez Cortes, N., Pertuiset, C., Dumon, E., Borlin, M., Hebert-Chatelain, E., 
Pierron, D., . . . Rocher, C. (2012). Novel mitochondrial DNA mutations 
responsible for maternally inherited nonsyndromic hearing loss. Hum 
Mutat, 33(4), 681-689 
Haack, T. B., Haberberger, B., Frisch, E. M., Wieland, T., Iuso, A., Gorza, M., . . . 
Prokisch, H. (2012). Molecular diagnosis in mitochondrial complex I 
deficiency using exome sequencing. J Med Genet, 49(4), 277-283 
Haack, T. B., Madignier, F., Herzer, M., Lamantea, E., Danhauser, K., Invernizzi, F., . . . 
Prokisch, H. (2012). Mutation screening of 75 candidate genes in 152 
complex I deficiency cases identifies pathogenic variants in 16 genes 
including NDUFB9. J Med Genet, 49(2), 83-89 
Hagn, F., Etzkorn, M., Raschle, T., & Wagner, G. (2013). Optimized Phospholipid 
Bilayer Nanodiscs Facilitate High-Resolution Structure Determination of 
Membrane Proteins. Journal of the American Chemical Society, 135(5), 
1919–1925 
Haider, M., Rose, H., Uhlemann, S., Kabius, B., & Urban, K. (1998). Towards 0.1 nm 
resolution with the first spherically corrected transmission electron 
microscope. Journal of Electron Microscopy, 47(5), 395-405  
Hatefi, Y., Haavik, A. G., Fowler, L. R., & Griffiths, D. E. (1962). Studies on the 
electron transfer system. XLII. Reconstitution of the electron transfer 
system. J Biol Chem, 237, 2661-2669  
Hatefi, Y., Haavik, A. G., & Griffiths, D. E. (1962). Studies on the electron transfer 
system. XL. Preparation and properties of mitochondrial DPNH-coenzyme Q 
reductase. J Biol Chem, 237, 1676-1680 
Henderson, R., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., & Downing, K. 
H. (1990). Model for the structure of bacteriorhodopsin based on high-
resolution electron cryo-microscopy. J Mol Biol, 213(4), 899-929 
Herrmann, J. M., & Riemer, J. (2010). The intermembrane space of mitochondria. 
Antioxid Redox Signal, 13(9), 1341-1358 
Hinttala, R., Smeets, R., Moilanen, J. S., Ugalde, C., Uusimaa, J., Smeitink, J. A., & 
Majamaa, K. (2006). Analysis of mitochondrial DNA sequences in patients 
with isolated or combined oxidative phosphorylation system deficiency. J 
Med Genet, 43(11), 881-886 
Hirst, J. (2013). Mitochondrial complex I. Annu Rev Biochem, 82, 551-575 
Hirst, J., Carroll, J., Fearnley, I. M., Shannon, R. J., & Walker, J. E. (2003). The nuclear 
encoded subunits of complex I from bovine heart mitochondria. Biochim 
Biophys Acta, 1604(3), 135-150 
  207 
Hirst, J., & Roessler, M. M. (2015). Energy conversion, redox catalysis and 
generation of reactive oxygen species by respiratory complex I. Biochim 
Biophys Acta 
Hoefs, S. J., Skjeldal, O. H., Rodenburg, R. J., Nedregaard, B., van Kaauwen, E. P., 
Spiekerkotter, U., . . . van den Heuvel, L. P. (2010). Novel mutations in the 
NDUFS1 gene cause low residual activities in human complex I deficiencies. 
Molecular genetics and metabolism, 100(3), 251-256 
Hoefs, S. J., van Spronsen, F. J., Lenssen, E. W., Nijtmans, L. G., Rodenburg, R. J., 
Smeitink, J. A., & van den Heuvel, L. P. (2011). NDUFA10 mutations cause 
complex I deficiency in a patient with Leigh disease. European journal of 
human genetics : EJHG, 19(3), 270-274 
Hofhaus, G., Weiss, H., & Leonard, K. (1991). Electron microscopic analysis of the 
peripheral and membrane parts of mitochondrial NADH dehydrogenase 
(complex I). J. Mol. Biol., 221(3), 1027-1043 
Hoppe, W., Schramm, H. J., Sturm, M., Hunsmann, N., & Gassmann, J. (1976). 3-
Dimensional Electron-Microscopy of Individual Biological Objects .3. 
Experimental Results on Yeast Fatty-Acid Synthetase. Zeitschrift Fur 
Naturforschung Section a-a Journal of Physical Sciences, 31(11), 1380-1390 
Horder, T. J. (2006). Gavin Rylands de Beer: how embryology foreshadowed the 
dilemmas of the genome. Nat Rev Genet, 7(11), 892-898 
Howell, N., Bindoff, L. A., McCullough, D. A., Kubacka, I., Poulton, J., Mackey, D., . . . 
Turnbull, D. M. (1991). Leber hereditary optic neuropathy: identification of 
the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet, 
49(5), 939-950 
Howell, N., Halvorson, S., Burns, J., McCullough, D. A., & Paulton, J. (1993). When 
does bilateral optic atrophy become Leber hereditary optic neuropathy? Am 
J Hum Genet, 53(4), 959-963 
Hutchin, T., & Cortopassi, G. (1995). A mitochondrial DNA clone is associated with 
increased risk for Alzheimer disease. Proc Natl Acad Sci U S A, 92(15), 6892-
6895 
Johansson, K., Ramaswamy, S., Ljungcrantz, C., Knecht, W., Piskur, J., Munch-
Petersen, B., . . . Eklund, H. (2001). Structural basis for substrate specificities 
of cellular deoxyribonucleoside kinases. Nat Struct Biol, 8(7), 616-620 
Jun, A. S., Brown, M. D., & Wallace, D. C. (1994). A mitochondrial DNA mutation at 
nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene 
associated with maternally inherited Leber hereditary optic neuropathy 
and dystonia. Proc Natl Acad Sci U S A, 91(13), 6206-6210 
Kao, M. C., Di Bernardo, S., Nakamaru-Ogiso, E., Miyoshi, H., Matsuno-Yagi, A., & 
Yagi, T. (2005). Characterization of the membrane domain subunit NuoJ 
(ND6) of the NADH-quinone oxidoreductase from Escherichia coli by 
chromosomal DNA manipulation. Biochemistry, 44(9), 3562-3571 
Karnkowska, A., Vacek, V., Zubacova, Z., Treitli, S. C., Petrzelkova, R., Eme, L., . . . 
Hampl, V. (2016). A Eukaryote without a Mitochondrial Organelle. Curr Biol, 
26(10), 1274-1284 
Karp, G. (2013). Cell and molecular biology : concepts and experiments. Hoboken, NJ: 
John Wiley 
Kazak, L., Reyes, A., & Holt, I. J. (2012). Minimizing the damage: repair pathways 
keep mitochondrial DNA intact. Nat Rev Mol Cell Biol, 13(10), 659-671 
208 
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P., Jr. (2006). Parkinson's disease 
brain mitochondrial complex I has oxidatively damaged subunits and is 
functionally impaired and misassembled. J Neurosci, 26(19), 5256-5264. 
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. (2015). The 
Phyre2 web portal for protein modeling, prediction and analysis. Nat 
Protoc, 10(6), 845-858 
Kim, M. R., Chang, H. S., Kim, B. H., Kim, S., Baek, S. H., Kim, J. H., . . . Kim, J. R. (2003). 
Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell 
proliferation. Biochem Biophys Res Commun, 304(1), 119-124  
Kirby, D. M., Crawford, M., Cleary, M. A., Dahl, H. H., Dennett, X., & Thorburn, D. R. 
(1999). Respiratory chain complex I deficiency: an underdiagnosed energy 
generation disorder. Neurology, 52(6), 1255-1264 
Kirby, D. M., McFarland, R., Ohtake, A., Dunning, C., Ryan, M. T., Wilson, C., . . . 
Taylor, R. W. (2004). Mutations of the mitochondrial ND1 gene as a cause of 
MELAS. J Med Genet, 41(10), 784-789 
Kimanius, D., Forsberg, B., Scheres, S., Lindahl, E. (2016) Accelerated cryo-EM 
structure determination with parallelisation using GPUs in RELION-2. 
bioRxiv 059717 
Kmita, K., Wirth, C., Warnau, J., Guerrero-Castillo, S., Hunte, C., Hummer, G., . . . 
Zickermann, V. (2015). Accessory NUMM (NDUFS6) subunit harbors a Zn-
binding site and is essential for biogenesis of mitochondrial complex I. 
Proceedings of the National Academy of Sciences of the United States of 
America, 112(18), 5685-5690 
Koene, S., Rodenburg, R. J., van der Knaap, M. S., Willemsen, M. A., Sperl, W., Laugel, 
V., . . . Smeitink, J. A. (2012). Natural disease course and genotype-
phenotype correlations in Complex I deficiency caused by nuclear gene 
defects: what we learned from 130 cases. J Inherit Metab Dis, 35(5), 737-747 
Krivov, G. G., Shapovalov, M. V., & Dunbrack, R. L., Jr. (2009). Improved prediction 
of protein side-chain conformations with SCWRL4. Proteins, 77(4), 778-795 
Krogh, A., Larsson, B., von Heijne, G., & Sonnhammer, E. L. (2001). Predicting 
transmembrane protein topology with a hidden Markov model: application 
to complete genomes. J. Mol. Biol., 305(3), 567-580  
Kuhlbrandt, W. (2014). Cryo - EM enters a new era. eLife, 3, e03678 
Kuhlbrandt, W. (2015). Structure and function of mitochondrial membrane protein 
complexes. BMC Biol, 13, 89 
Lazarou, M., McKenzie, M., Ohtake, A., Thorburn, D. R., & Ryan, M. T. (2007). 
Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-
encoded subunits into complex I. Mol Cell Biol, 27(12), 4228-4237 
Lebon, S., Rodriguez, D., Bridoux, D., Zerrad, A., Rotig, A., Munnich, A., . . . Slama, A. 
(2007). A novel mutation in the human complex I NDUFS7 subunit 
associated with Leigh syndrome. Molecular genetics and metabolism, 90(4), 
379-382 
Leo-Kottler, B., Luberichs, J., Besch, D., Christ-Adler, M., & Fauser, S. (2002). Leber's 
hereditary optic neuropathy: clinical and molecular genetic results in a 
patient with a point mutation at np T11253C (isoleucine to threonine) in 
the ND4 gene and spontaneous recovery. Graefes Arch Clin Exp Ophthalmol, 
240(9), 758-764 
Leonard, K., Haiker, H., & Weiss, H. (1987). Three-dimensional structure of NADH: 
ubiquinone reductase (complex I) from Neurospora mitochondria 
  209 
determined by electron microscopy of membrane crystals. J. Mol. Biol., 
194(2), 277-286 
Leshinsky-Silver, E., Lebre, A. S., Minai, L., Saada, A., Steffann, J., Cohen, S., . . . 
Lerman-Sagie, T. (2009). NDUFS4 mutations cause Leigh syndrome with 
predominant brainstem involvement. Molecular genetics and metabolism, 
97(3), 185-189 
Leshinsky-Silver, E., Lev, D., Malinger, G., Shapira, D., Cohen, S., Lerman-Sagie, T., & 
Saada, A. (2010). Leigh disease presenting in utero due to a novel missense 
mutation in the mitochondrial DNA-ND3. Molecular genetics and 
metabolism, 100(1), 65-70 
Letts, J. A., Degliesposti, G., Fiedorczuk, K., Skehel, M., & Sazanov, L. A. (2016). 
Purification of Ovine Respiratory Complex I Results in a Highly Active and 
Stable Preparation. J Biol Chem, 291(47), 24657-24675 
Letts, J. A., Fiedorczuk, K., & Sazanov, L. A. (2016). The architecture of respiratory 
supercomplexes. Nature, 537(7622), 644-648 
Li, X., Mooney, P., Zheng, S., Booth, C. R., Braunfeld, M. B., Gubbens, S., . . . Cheng, Y. 
(2013). Electron counting and beam-induced motion correction enable 
near-atomic-resolution single-particle cryo - EM. Nature methods, 10(6), 
584-590 
Lieber, D. S., Calvo, S. E., Shanahan, K., Slate, N. G., Liu, S., Hershman, S. G., . . . 
Mootha, V. K. (2013). Targeted exome sequencing of suspected 
mitochondrial disorders. Neurology, 80(19), 1762-1770 
Lill, R., Dutkiewicz, R., Freibert, S. A., Heidenreich, T., Mascarenhas, J., Netz, D. J., . . . 
Muhlenhoff, U. (2015). The role of mitochondria and the CIA machinery in 
the maturation of cytosolic and nuclear iron-sulfur proteins. Eur J Cell Biol, 
94(7-9), 280-291 
Liolitsa, D., Rahman, S., Benton, S., Carr, L. J., & Hanna, M. G. (2003). Is the 
mitochondrial complex I ND5 gene a hot-spot for MELAS causing 
mutations? Ann Neurol, 53(1), 128-132 
Lodish, H. F. (2008). Molecular cell biology. 
Loeffen, J., Elpeleg, O., Smeitink, J., Smeets, R., Stockler-Ipsiroglu, S., Mandel, H., . . . 
van den Heuvel, L. (2001). Mutations in the complex I NDUFS2 gene of 
patients with cardiomyopathy and encephalomyopathy. Ann Neurol, 49(2), 
195-201 
Loeffen, J., Smeitink, J., Triepels, R., Smeets, R., Schuelke, M., Sengers, R., . . . van den 
Heuvel, L. (1998). The first nuclear-encoded complex I mutation in a patient 
with Leigh syndrome. Am J Hum Genet, 63(6), 1598-1608 
Logan, D. C. (2006). The mitochondrial compartment. J Exp Bot, 57(6), 1225-1243 
Lu, H., & Cao, X. (2008). GRIM-19 is essential for maintenance of mitochondrial 
membrane potential. Mol Biol Cell, 19(5), 1893-1902 
Macmillan, C., Johns, T. A., Fu, K., & Shoubridge, E. A. (2000). Predominance of the 
T14484C mutation in French-Canadian families with Leber hereditary optic 
neuropathy is due to a founder effect. Am J Hum Genet, 66(1), 332-335 
Maklashina, E., Kotlyar, A. B., & Cecchini, G. (2003). Active/de-active transition of 
respiratory complex I in bacteria, fungi, and animals. Biochim Biophys Acta, 
1606(1-3), 95-103  
Mannella, C. A. (2006). Structure and dynamics of the mitochondrial inner 
membrane cristae. Biochim Biophys Acta, 1763(5-6), 542-548 
210 
Marabini, R., Masegosa, I. M., San Martin, M. C., Marco, S., Fernandez, J. J., de la 
Fraga, L. G., . . . Carazo, J. M. (1996). Xmipp: An Image Processing Package for 
Electron Microscopy. J Struct Biol, 116(1), 237-240  
Maret, W. (2005). Zinc coordination environments in proteins determine zinc 
functions. J Trace Elem Med Biol, 19(1), 7-12 
Margulis, L. (1970). Origin of Eukaryotic Cells. New Haven: Yale University Press. 
Marin, S. E., Mesterman, R., Robinson, B., Rodenburg, R. J., Smeitink, J., & 
Tarnopolsky, M. A. (2013). Leigh syndrome associated with mitochondrial 
complex I deficiency due to novel mutations In NDUFV1 and NDUFS2. Gene, 
516(1), 162-167 
Marina, A. D., Schara, U., Pyle, A., Moller-Hartmann, C., Holinski-Feder, E., Abicht, A., 
. . . Horvath, R. (2013). NDUFS8-related Complex I Deficiency Extends 
Phenotype from "PEO Plus" to Leigh Syndrome. JIMD Rep, 10, 17-22 
Martin, M. A., Blazquez, A., Gutierrez-Solana, L. G., Fernandez-Moreira, D., Briones, 
P., Andreu, A. L., . . . Arenas, J. (2005). Leigh syndrome associated with 
mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 
gene. Arch. Neurol., 62(4), 659-661  
Maximo, V., Botelho, T., Capela, J., Soares, P., Lima, J., Taveira, A., . . . Sobrinho-
Simoes, M. (2005). Somatic and germline mutation in GRIM-19, a dual 
function gene involved in mitochondrial metabolism and cell death, is 
linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J 
Cancer, 92(10), 1892-1898 
Mayorov, V., Biousse, V., Newman, N. J., & Brown, M. D. (2005). The role of the ND5 
gene in LHON: characterization of a new, heteroplasmic LHON mutation. 
Ann Neurol, 58(5), 807-811 
McFarland, R., Kirby, D. M., Fowler, K. J., Ohtake, A., Ryan, M. T., Amor, D. J., . . . 
Thorburn, D. R. (2004). De novo mutations in the mitochondrial ND3 gene 
as a cause of infantile mitochondrial encephalopathy and complex I 
deficiency. Ann Neurol, 55(1), 58-64 
McFarland, R., Tuppen, H., He, L., Blakely, E. L., Morris, A. A. M., Clarke, M., . . . 
Taylor, R. W. (2009). Recurrent mutations in the NDUFS2 gene causing 
isolated complex I deficiency in skeletal muscle. Neuromuscular Disorders, 
19(8-9), 562-562 
McGuffin, L. J., Bryson, K., & Jones, D. T. (2000). The PSIPRED protein structure 
prediction server. Bioinformatics, 16(4), 404-405 
McKenzie, M., & Ryan, M. T. (2010). Assembly factors of human mitochondrial 
complex I and their defects in disease. IUBMB Life, 62(7), 497-502 
Meents, A., Gutmann, S., Wagner, A., & Schulze-Briese, C. (2010). Origin and 
temperature dependence of radiation damage in biological samples at 
cryogenic temperatures. Proc Natl Acad Sci U S A, 107(3), 1094-1099 
Meyer, E. H. (2012). Proteomic investigations of complex I composition: how to 
define a subunit? Front Plant Sci, 3, 106 
Mi, H. L., Endo, T., Schreiber, U., & Asada, K. (1992). Donation of Electrons from 
Cytosolic Components to the Intersystem Chain in the Cyanobacterium 
Synechococcus Sp Pcc-7002 as Determined by the Reduction of P700+. 
Plant and Cell Physiology, 33(8), 1099-1105  
Michel, J., Deleon-Rangel, J., Zhu, S., Van Ree, K., & Vik, S. B. (2011). Mutagenesis of 
the L, M, and N Subunits of Complex I from Escherichia coli Indicates a 
Common Role in Function. PLoS One, 6(2), e17420 
  211 
Milazzo, A. C., Leblanc, P., Duttweiler, F., Jin, L., Bouwer, J. C., Peltier, S., . . . Xuong, N. 
H. (2005). Active pixel sensor array as a detector for electron microscopy. 
Ultramicroscopy, 104(2), 152-159 
Mishra, P., & Chan, D. C. (2014). Mitochondrial dynamics and inheritance during 
cell division, development and disease. Nat Rev Mol Cell Biol, 15(10), 634-
646 
Mitchell, P. (1975). The protonmotive Q cycle: a general formulation. FEBS Lett, 
59(2), 137-139 
Mitchell, P. (1979). Keilin's respiratory chain concept and its chemiosmotic 
consequences. Science, 206(4423), 1148-1159 
Moparthi, V. K., & Hagerhall, C. (2011). The evolution of respiratory chain complex 
I from a smaller last common ancestor consisting of 11 protein subunits. 
Journal of molecular evolution, 72(5-6), 484-497 
Morgan, D. J., & Sazanov, L. A. (2008). Three-dimensional structure of respiratory 
complex I from Escherichia coli in ice in the presence of nucleotides. 
Biochim Biophys Acta, 1777(7-8), 711-718 
Moritz, K. M., Lim, G. B., & Wintour, E. M. (1997). Developmental regulation of 
erythropoietin and erythropoiesis. Am J Physiol, 273(6 Pt 2), R1829-1844 
Moser, C. C., Farid, T. A., Chobot, S. E., & Dutton, P. L. (2006). Electron tunneling 
chains of mitochondria. Biochim Biophys Acta, 1757(9-10), 1096-1109 
Moslemi, A. R., Darin, N., Tulinius, M., Wiklund, L. M., Holme, E., & Oldfors, A. 
(2008). Progressive encephalopathy and complex I deficiency associated 
with mutations in MTND1. Neuropediatrics, 39(1), 24-28 
Murcha, M. W., Wang, Y., & Whelan, J. (2012). A molecular link between 
mitochondrial preprotein transporters and respiratory chain complexes. 
Plant Signal Behav, 7(12), 1594-1597 
Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. 
Biochem. J., 417(1), 1-13 
Naini, A. B., Lu, J., Kaufmann, P., Bernstein, R. A., Mancuso, M., Bonilla, E., . . . 
DiMauro, S. (2005). Novel mitochondrial DNA ND5 mutation in a patient 
with clinical features of MELAS and MERRF. Arch Neurol, 62(3), 473-476 
Nakamaru-Ogiso, E., Kao, M.-C., Chen, H., Sinha, S. C., Yagi, T., & Ohnishi, T. (2010). 
The membrane subunit NuoL(ND5) is involved in the indirect proton 
pumping mechanism of E. coli complex I. J Biol Chem 
Nicholls, D. G., & Ferguson, S. J. (2002). Bioenergetics 3.  
Nishioka, K., Vilarino-Guell, C., Cobb, S. A., Kachergus, J. M., Ross, O. A., Hentati, E., . . 
. Farrer, M. J. (2010). Genetic variation of the mitochondrial complex I 
subunit NDUFV2 and Parkinson's disease. Parkinsonism Relat Disord, 
16(10), 686-687 
Obayashi, T., Hattori, K., Sugiyama, S., Tanaka, M., Tanaka, T., Itoyama, S., . . . et al. 
(1992). Point mutations in mitochondrial DNA in patients with 
hypertrophic cardiomyopathy. Am Heart J, 124(5), 1263-1269 
Ohnishi, S. T., Salerno, J. C., & Ohnishi, T. (2010). Possible roles of two quinone 
molecules in direct and indirect proton pumps of bovine heart NADH-
quinone oxidoreductase (complex I). Biochim Biophys Acta, 1797(12), 1891-
1893 
Ohnishi, T. (1998). Iron-sulfur clusters/semiquinones in complex I. Biochim 
Biophys Acta, 1364(2), 186-206 
212 
Okun, J. G., Zickermann, V., Zwicker, K., Schagger, H., & Brandt, U. (2000). Binding of 
detergents and inhibitors to bovine complex I - a novel purification 
procedure for bovine complex I retaining full inhibitor sensitivity. Biochim. 
Biophys. Acta, 1459(1), 77-87 
Oteiza, P. I. (2012). Zinc and the modulation of redox homeostasis. Free Radic Biol 
Med, 53(9), 1748-1759 
Page, C. C., Moser, C. C., Chen, X., & Dutton, P. L. (1999). Natural engineering 
principles of electron tunnelling in biological oxidation-reduction. Nature, 
402(6757), 47-52 
Pagniez-Mammeri, H., Lombes, A., Brivet, M., Ogier-de Baulny, H., Landrieu, P., 
Legrand, A., & Slama, A. (2009). Rapid screening for nuclear genes 
mutations in isolated respiratory chain complex I defects. Molecular 
genetics and metabolism, 96(4), 196-200 
Paradies, G., Paradies, V., De Benedictis, V., Ruggiero, F. M., & Petrosillo, G. (2014). 
Functional role of cardiolipin in mitochondrial bioenergetics. Biochim 
Biophys Acta, 1837(4), 408-417 
Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., & Medicine 
Society, T. M. (2009). A modern approach to the treatment of mitochondrial 
disease. Curr Treat Options Neurol, 11(6), 414-430 
Peng, G., Fritzsch, G., Zickermann, V., Schagger, H., Mentele, R., Lottspeich, F., . . . 
Michel, H. (2003). Isolation, characterization and electron microscopic 
single particle analysis of the NADH:ubiquinone oxidoreductase (complex I) 
from the hyperthermophilic eubacterium Aquifex aeolicus. Biochemistry, 
42(10), 3032-3039 
Peng, L., Yamamoto, H., & Shikanai, T. (2010). Structure and biogenesis of the 
chloroplast NAD(P)H dehydrogenase complex. Biochim Biophys Acta 
Perkins, G. A., & Frey, T. G. (2000). Recent structural insight into mitochondria 
gained by microscopy. Micron, 31(1), 97-111 
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. 
C., & Ferrin, T. E. (2004). UCSF chimera - A visualization system for 
exploratory research and analysis. Journal of Computational Chemistry, 
25(13), 1605-1612 
Planas-Iglesias, J., Dwarakanath, H., Mohammadyani, D., Yanamala, N., Kagan, V. E., 
& Klein-Seetharaman, J. (2015). Cardiolipin Interactions with Proteins. 
Biophysical Journal, 109(6), 1282-1294 
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K., Markowitz, S. D., . . . Vogelstein, 
B. (1998). Somatic mutations of the mitochondrial genome in human 
colorectal tumours. Nat Genet, 20(3), 291-293 
Porterfield, J. Z., & Zlotnick, A. (2010). A simple and general method for 
determining the protein and nucleic acid content of viruses by UV 
absorbance. Virology, 407(2), 281-288 
Potluri, P., Davila, A., Ruiz-Pesini, E., Mishmar, D., O'Hearn, S., Hancock, S., . . . 
Procaccio, V. (2009). A novel NDUFA1 mutation leads to a progressive 
mitochondrial complex I-specific neurodegenerative disease. Molecular 
genetics and metabolism, 96(4), 189-195 
Procaccio, V., & Wallace, D. C. (2004). Late-onset Leigh syndrome in a patient with 
mitochondrial complex I NDUFS8 mutations. Neurology, 62(10), 1899-1901 
Radermacher, M., Wagenknecht, T., Verschoor, A., & Frank, J. (1987). Three-
dimensional reconstruction from a single-exposure, random conical tilt 
  213 
series applied to the 50S ribosomal subunit of Escherichia coli. J Microsc, 
146(Pt 2), 113-136 
Ragan, C. I., & Racker, E. (1973). Resolution and reconstitution of the mitochondrial 
electron transport system. IV. The reconstitution of rotenone-sensitive 
reduced nicotinamide adenine dinucleotide-ubiquinone reductase from 
reduced nicotinamide adenine dinucleotide dehydrogenase and 
phospholipids. J Biol Chem, 248(19), 6876-6884 
Ravn, K., Wibrand, F., Hansen, F. J., Horn, N., Rosenberg, T., & Schwartz, M. (2001). 
An mtDNA mutation, 14453G-->A, in the NADH dehydrogenase subunit 6 
associated with severe MELAS syndrome. European journal of human 
genetics : EJHG, 9(10), 805-809 
Rhein, V. F., Carroll, J., Ding, S., Fearnley, I. M., & Walker, J. E. (2013). NDUFAF7 
methylates arginine 85 in the NDUFS2 subunit of human complex I. J Biol 
Chem, 288(46), 33016-33026 
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012). Mitochondria as 
sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol, 13(9), 
566-578 
Robinson, J. M. (2008). Reactive oxygen species in phagocytic leukocytes. 
Histochem Cell Biol, 130(2), 281-297 
Rodenburg, R. J. (2016). Mitochondrial complex I-linked disease. Biochim Biophys 
Acta, 1857(7), 938-945 
Rohou, A., & Grigorieff, N. (2015). CTFFIND4: Fast and accurate defocus estimation 
from electron micrographs. J Struct Biol, 192(2), 216-221 
Rosenthal, P. B., & Henderson, R. (2003). Optimal Determination of Particle 
Orientation, Absolute Hand, and Contrast Loss in Single-particle Electron 
Cryomicroscopy. J. Mol. Biol., 333(4), 721-745  
Rossmann, M. G., Moras, D., & Olsen, K. W. (1974). Chemical and biological 
evolution of nucleotide-binding protein. Nature, 250(463), 194-199 
Rost, B., Yachdav, G., & Liu, J. (2004). The PredictProtein server. Nucleic Acids Res., 
32(Web Server issue), W321-326 
Rouault, T. A. (2015). Mammalian iron-sulphur proteins: novel insights into 
biogenesis and function. Nat Rev Mol Cell Biol, 16(1), 45-55 
Ruska, E. (1987). The Development of the Electron-Microscope and of Electron-
Microscopy. Bioscience Reports, 7(8), 607-629 
Russo CJ, Passmore LA. (2014) Ultrastable gold substrates for electron 
cryomicroscopy. Science. 346(6215), 1377-1380 
Sanchez-Caballero, L., Guerrero-Castillo, S., & Nijtmans, L. (2016). Unraveling the 
complexity of mitochondrial complex I assembly: A dynamic process. 
Biochim Biophys Acta, 1857(7), 980-990 
Sanz, A., & Stefanatos, R. K. (2008). The mitochondrial free radical theory of aging: 
a critical view. Curr Aging Sci, 1(1), 10-21 
Saraste, M. (1999). Oxidative phosphorylation at the fin de siecle. Science, 
283(5407), 1488-1493 
Sarewicz, M., & Osyczka, A. (2015). Electronic connection between the quinone and 
cytochrome C redox pools and its role in regulation of mitochondrial 
electron transport and redox signaling. Physiol Rev, 95(1), 219-243 
Sarzi, E., Brown, M. D., Lebon, S., Chretien, D., Munnich, A., Rotig, A., & Procaccio, V. 
(2007). A novel recurrent mitochondrial DNA mutation in ND3 gene is 
214 
associated with isolated complex I deficiency causing Leigh syndrome and 
dystonia. Am J Med Genet A, 143a(1), 33-41 
Sazanov, L. A. (2007). Respiratory complex I: mechanistic and structural insights 
provided by the crystal structure of the hydrophilic domain. Biochemistry-
Us, 46(9), 2275-2288 
Sazanov, L. A. (2015). A giant molecular proton pump: structure and mechanism of 
respiratory complex I. Nat Rev Mol Cell Biol, 16(6), 375-388 
Sazanov, L. A., & Hinchliffe, P. (2006). Structure of the hydrophilic domain of 
respiratory complex I from Thermus thermophilus. Science, 311(5766), 
1430-1436 
Sazanov, L. A., Peak-Chew, S. Y., Fearnley, I. M., & Walker, J. E. (2000). Resolution of 
the membrane domain of bovine complex I into subcomplexes: implications 
for the structural organization of the enzyme. Biochemistry-Us, 39(24), 
7229-7235  
Sazanov, L. A., Peak-Chew, S. Y., Fearnley, I. M., & Walker, J. E. (2000). Resolution of 
the membrane domain of bovine complex I into subcomplexes: implications 
for the structural organization of the enzyme. Biochemistry, 39(24), 7229-
7235 
Sazanov, L. A., & Walker, J. E. (2000). Cryo-electron crystallography of two sub-
complexes of bovine complex I reveals the relationship between the 
membrane and peripheral arms. J Mol Biol, 302(2), 455-464 
Schagger, H., & Pfeiffer, K. (2001). The ratio of oxidative phosphorylation 
complexes I-V in bovine heart mitochondria and the composition of 
respiratory chain supercomplexes. J Biol Chem, 276(41), 37861-37867 
Scheidelaar S, Koorengevel MC, Pardo JD, Meeldijk JD, Breukink E, Killian JA. 
Molecular Model for the Solubilization of Membranes into Nanodisks by 
Styrene Maleic Acid Copolymers. Biophysical Journal. 2015;108(2):279-
290. doi:10.1016/j.bpj.2014.11.3464. 
Scheres, S. H. (2012). RELION: implementation of a Bayesian approach to cryo - EM 
structure determination. J Struct Biol, 180(3), 519-530 
Scheres, S. H. (2014). Beam-induced motion correction for sub-megadalton cryo - 
EM particles. eLife, 3, e03665. doi:10.7554/eLife.03665 
Scheres, S. H., & Chen, S. (2012). Prevention of overfitting in cryo - EM structure 
determination. Nature methods, 9(9), 853-854 
Schuelke, M., Detjen, A., van den Heuvel, L., Korenke, C., Janssen, A., Smits, A., . . . 
Smeitink, J. (2002). New nuclear encoded mitochondrial mutation 
illustrates pitfalls in prenatal diagnosis by biochemical methods. Clin Chem, 
48(5), 772-775 
Schuelke, M., Smeitink, J., Mariman, E., Loeffen, J., Plecko, B., Trijbels, F., . . . van den 
Heuvel, L. (1999). Mutant NDUFV1 subunit of mitochondrial complex I 
causes leukodystrophy and myoclonic epilepsy. Nat Genet, 21(3), 260-261 
Sharma, L. K., Lu, J., & Bai, Y. (2009). Mitochondrial respiratory complex I: 
structure, function and implication in human diseases. Curr Med Chem, 
16(10), 1266-1277 
Sharpley, M. S., Hirst J. (2006). The inhibition of mitochondrial complex I 
(NADH:ubiquinone oxidoreductase) by Zn2+. J Biol Chem. 281(46), 34803-9 
Shinzawa-Itoh, K., Seiyama, J., Terada, H., Nakatsubo, R., Naoki, K., Nakashima, Y., & 
Yoshikawa, S. (2010). Bovine heart NADH-ubiquinone oxidoreductase 
  215 
contains one molecule of ubiquinone with ten isoprene units as one of the 
cofactors. Biochemistry, 49(3), 487-492 
Simon, D. K., Friedman, J., Breakefield, X. O., Jankovic, J., Brin, M. F., Provias, J., . . . 
Tarnopolsky, M. A. (2003). A heteroplasmic mitochondrial complex I gene 
mutation in adult-onset dystonia. Neurogenetics, 4(4), 199-205 
Spiegel, R., Shaag, A., Mandel, H., Reich, D., Penyakov, M., Hujeirat, Y., . . . Shalev, S. A. 
(2009). Mutated NDUFS6 is the cause of fatal neonatal lactic acidemia in 
Caucasus Jews. European journal of human genetics : EJHG, 17(9), 1200-
1203 
Steuber, J., Schmid, C., Rufibach, M., & Dimroth, P. (2000). Na+ translocation by 
complex I (NADH:quinone oxidoreductase) of Escherichia coli. Molecular 
microbiology, 35(2), 428-434 
Straka, J. G., Rank, J. M., & Bloomer, J. R. (1990). Porphyria and porphyrin 
metabolism. Annu Rev Med, 41, 457-469 
Stroh, A., Anderka, O., Pfeiffer, K., Yagi, T., Finel, M., Ludwig, B., & Schagger, H. 
(2004). Assembly of respiratory complexes I, III, and IV into NADH oxidase 
supercomplex stabilizes complex I in Paracoccus denitrificans. J Biol Chem, 
279(6), 5000-5007 
Stroud, D. A., Surgenor, E. E., Formosa, L. E., Reljic, B., Frazier, A. E., Dibley, M. G., . . . 
Ryan, M. T. (2016). Accessory subunits are integral for assembly and 
function of human mitochondrial complex I. Nature, 538(7623), 123-126 
Stuart, R. (2002). Insertion of proteins into the inner membrane of mitochondria: 
the role of the Oxa1 complex. Biochim Biophys Acta, 1592(1), 79-87  
Sturtz, L. A., Diekert, K., Jensen, L. T., Lill, R., & Culotta, V. C. (2001). A fraction of 
yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize 
to the intermembrane space of mitochondria. A physiological role for SOD1 
in guarding against mitochondrial oxidative damage. J Biol Chem, 276(41), 
38084-38089 
Sudhof, T. C. (2012). Calcium control of neurotransmitter release. Cold Spring Harb 
Perspect Biol, 4(1), a011353 
Sudo, A., Honzawa, S., Nonaka, I., & Goto, Y. (2004). Leigh syndrome caused by 
mitochondrial DNA G13513A mutation: frequency and clinical features in 
Japan. J Hum Genet, 49(2), 92-96 
Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., . . . Rao, Z. (2005). Crystal structure 
of mitochondrial respiratory membrane protein complex II. Cell, 121(7), 
1043-1057 
Szklarczyk, R., Wanschers, B. F., Nabuurs, S. B., Nouws, J., Nijtmans, L. G., & Huynen, 
M. A. (2011). NDUFB7 and NDUFA8 are located at the intermembrane 
surface of complex I. FEBS Lett, 585(5), 737-743 
Taylor, R. W., Morris, A. A., Hutchinson, M., & Turnbull, D. M. (2002). Leigh disease 
associated with a novel mitochondrial DNA ND5 mutation. European journal 
of human genetics : EJHG, 10(2), 141-144 
Thannickal, V. J., & Fanburg, B. L. (2000). Reactive oxygen species in cell signaling. 
Am J Physiol Lung Cell Mol Physiol, 279(6), L1005-1028  
Tocilescu, M. A., Zickermann, V., Zwicker, K., & Brandt, U. (2010). Quinone binding 
and reduction by respiratory complex I. Biochim Biophys Acta, 1797(12), 
1883-1890 
216 
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-
Itoh, K., . . . Yoshikawa, S. (1996). The whole structure of the 13-subunit 
oxidized cytochrome c oxidase at 2.8 A. Science, 272(5265), 1136-1144  
Tucker, E. J., Compton, A. G., Calvo, S. E., & Thorburn, D. R. (2011). The molecular 
basis of human complex I deficiency. IUBMB Life, 63(9), 669-677 
Tuppen, H. A., Hogan, V. E., He, L., Blakely, E. L., Worgan, L., Al-Dosary, M., . . . 
Taylor, R. W. (2010). The p.M292T NDUFS2 mutation causes complex I-
deficient Leigh syndrome in multiple families. Brain : a journal of neurology, 
133(10), 2952-2963 
Ushakova, A. V., Duarte, M., Vinogradov, A. D., & Videira, A. (2005). The 29.9 kDa 
subunit of mitochondrial complex I is involved in the enzyme active/de-
active transitions. J Mol Biol, 351(2), 327-333 
van den Bosch, B. J., Gerards, M., Sluiter, W., Stegmann, A. P., Jongen, E. L., 
Hellebrekers, D. M., . . . Smeets, H. J. (2012). Defective NDUFA9 as a novel 
cause of neonatally fatal complex I disease. J Med Genet, 49(1), 10-15 
van Heel, M., Gowen, B., Matadeen, R., Orlova, E. V., Finn, R., Pape, T., . . . 
Patwardhan, A. (2000). Single-particle electron cryo-microscopy: towards 
atomic resolution. Q. Rev. Biophys., 33(4), 307-369 
Vanniarajan, A., Rajshekher, G. P., Joshi, M. B., Reddy, A. G., Singh, L., & Thangaraj, K. 
(2006). Novel mitochondrial mutation in the ND4 gene associated with 
Leigh syndrome. Acta Neurol Scand, 114(5), 350-353 
Vartak, R., Deng, J., Fang, H., & Bai, Y. (2015). Redefining the roles of mitochondrial 
DNA-encoded subunits in respiratory Complex I assembly. Biochim Biophys 
Acta, 1852(7), 1531-1539 
Verkhovskaya, M., & Bloch, D. A. (2013). Energy-converting respiratory Complex I: 
on the way to the molecular mechanism of the proton pump. Int J Biochem 
Cell Biol, 45(2), 491-511 
Verkhovsky, M. I., Jasaitis, A., Verkhovskaya, M. L., Morgan, J. E., & Wikstrom, M. 
(1999). Proton translocation by cytochrome c oxidase. Nature, 400(6743), 
480-483 
Vinogradov, A. D. (1998). Catalytic properties of the mitochondrial NADH-
ubiquinone oxidoreductase (complex I) and the pseudo-reversible 
active/inactive enzyme transition. Biochim. Biophys. Acta, 1364(2), 169-185  
Vinothkumar, K. R., & Henderson, R. (2016). Single particle electron 
cryomicroscopy: trends, issues and future perspective. Q Rev Biophys, 49, 
e13 
Vinothkumar, K. R., Zhu, J., & Hirst, J. (2014). Architecture of mammalian 
respiratory complex I. Nature 
Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and 
molecular mechanisms of metformin: an overview. Clinical Science 
(London, England : 1979). 2012;122(6):253-270. 
Visch, H. J., Koopman, W. J., Leusink, A., van Emst-de Vries, S. E., van den Heuvel, L. 
W., Willems, P. H., & Smeitink, J. A. (2006). Decreased agonist-stimulated 
mitochondrial ATP production caused by a pathological reduction in 
endoplasmic reticulum calcium content in human complex I deficiency. 
Biochim Biophys Acta, 1762(1), 115-123 
Visch, H. J., Rutter, G. A., Koopman, W. J., Koenderink, J. B., Verkaart, S., de Groot, T., . 
. . Willems, P. H. (2004). Inhibition of mitochondrial Na+-Ca2+ exchange 
  217 
restores agonist-induced ATP production and Ca2+ handling in human 
complex I deficiency. J Biol Chem, 279(39), 40328-40336 
Vogel, R. O., Dieteren, C. E., van den Heuvel, L. P., Willems, P. H., Smeitink, J. A., 
Koopman, W. J., & Nijtmans, L. G. (2007). Identification of mitochondrial 
complex I assembly intermediates by tracing tagged NDUFS3 demonstrates 
the entry point of mitochondrial subunits. J Biol Chem, 282(10), 7582-7590 
Vonrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W., . . . Bricogne, 
G. (2011). Data processing and analysis with the autoPROC toolbox. Acta 
crystallogr. D, 67(Pt 4), 293-302 
Walker, J. E. (1992). The NADH - ubiquinone oxidoreductase (complex I) of 
respiratory chains. Q. Rev. Biophys., 25(3), 253-324  
Walker, J. E. (2013). The ATP synthase: the understood, the uncertain and the 
unknown. Biochem Soc Trans, 41(1), 1-16 
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M., . . . 
Nikoskelainen, E. K. (1988). Mitochondrial DNA mutation associated with 
Leber's hereditary optic neuropathy. Science, 242(4884), 1427-1430.  
Wallin, I. E. (1923). The mitochondria problem. American Naturalist, 57, 255-261 
Walther, D. M., & Rapaport, D. (2009). Biogenesis of mitochondrial outer 
membrane proteins. Biochim Biophys Acta, 1793(1), 42-51 
Wang, C., & Youle, R. J. (2009). The role of mitochondria in apoptosis*. Annu Rev 
Genet, 43, 95-118 
Wang, Q., Li, R., Zhao, H., Peters, J. L., Liu, Q., Yang, L., . . . Guan, M. X. (2005). Clinical 
and molecular characterization of a Chinese patient with auditory 
neuropathy associated with mitochondrial 12S rRNA T1095C mutation. Am 
J Med Genet A, 133a(1), 27-30 
Watt, I. N., Montgomery, M. G., Runswick, M. J., Leslie, A. G., & Walker, J. E. (2010). 
Bioenergetic cost of making an adenosine triphosphate molecule in animal 
mitochondria. Proc. Natl. Acad. Sci. U S A, 107(39), 16823-16827 
Weerakoon, D. R., & Olson, J. W. (2008). The Campylobacter jejuni 
NADH:ubiquinone oxidoreductase (complex I) utilizes flavodoxin rather 
than NADH. J Bacteriol, 190(3), 915-925 
Wiesner, R. J., Ruegg, J. C., & Morano, I. (1992). Counting target molecules by 
exponential polymerase chain reaction: copy number of mitochondrial DNA 
in rat tissues. Biochem Biophys Res Commun, 183(2), 553-559  
Wikstrom, M. (1984). Two protons are pumped from the mitochondrial matrix per 
electron transferred between NADH and ubiquinone. FEBS Lett., 169(2), 
300-304 
Wray, C. D., Friederich, M. W., du Sart, D., Pantaleo, S., Smet, J., Kucera, C., . . . Van 
Hove, J. L. (2013). A new mutation in MT-ND1 m.3928G>C p.V208L causes 
Leigh disease with infantile spasms. Mitochondrion, 13(6), 656-661 
Wu, M., Gu, J., Guo, R., Huang, Y., & Yang, M. (2016). Structure of Mammalian 
Respiratory Supercomplex I1III2IV1. Cell, 167(6), 1598-1609 e1510 
Xia, D., Yu, C. A., Kim, H., Xian, J. Z., Kachurin, A. M., Zhang, L., . . . Deisenhofer, J. 
(1997). Crystal structure of the cytochrome bc1 complex from bovine heart 
mitochondria. Science, 277(5322), 60-66 
Yakovlev, G., Reda, T., & Hirst, J. (2007). Reevaluating the relationship between 
EPR spectra and enzyme structure for the iron sulfur clusters in 
NADH:quinone oxidoreductase. Proc Natl Acad Sci U S A, 104(31), 12720-
12725.  
218 
Ye, H., & Rouault, T. A. (2010). Human iron-sulfur cluster assembly, cellular iron 
homeostasis, and disease. Biochemistry-Us, 49(24), 4945-4956 
Yip, C.-Y., Fearnley, I. M., Harbour, M. E., Jayawardena, K., & Sazanov, L. A. (2010). 
Purification and characterisation of complex I from Paracoccus 
denitrificans. Bba-Bioenergetics, 1797, 25-25 
Yip, C. Y., Harbour, M. E., Jayawardena, K., Fearnley, I. M., & Sazanov, L. A. (2011). 
Evolution of respiratory complex I: "supernumerary" subunits are present 
in the alpha-proteobacterial enzyme. J. Biol. Chem., 286(7), 5023-5033 
Yu-Wai-Man, P., & Chinnery, P. F. (1993). Leber Hereditary Optic Neuropathy. In R. 
A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, 
T. D. Bird, N. Ledbetter, H. C. Mefford, R. J. H. Smith, & K. Stephens (Eds.), 
GeneReviews(R) 
Zhang, K. (2016). Gctf: Real-time CTF determination and correction. J Struct Biol, 
193(1), 1-12 
Zhu, J., King, M. S., Yu, M., Klipcan, L., Leslie, A. G., & Hirst, J. (2015). Structure of 
subcomplex Ibeta of mammalian respiratory complex I leads to new 
supernumerary subunit assignments. Proc Natl Acad Sci U S A, 112(39), 
12087-12092 
Zhu, J., Vinothkumar, K. R., & Hirst, J. (2016). Structure of mammalian respiratory 
complex I. Natur 
Zhu, S., & Vik, S. B. (2015). Constraining the Lateral Helix of Respiratory Complex I 
by Cross - linking Does Not Impair Enzyme Activity or Proton 
Translocation. J Biol Chem, 290(34), 20761-20773 
Zickermann, V., Wirth, C., Nasiri, H., Siegmund, K., Schwalbe, H., Hunte, C., & Brandt, 
U. (2015). Structural biology. Mechanistic insight from the crystal structure 
of mitochondrial complex I. Science, 347(6217), 44-49 
Zwicker, K., Galkin, A., Drose, S., Grgic, L., Kerscher, S., & Brandt, U. (2006). The 
Redox-Bohr group associated with iron-sulfur cluster N2 of complex I. J. 
Biol. Chem., 281(32), 23013-23017   
